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Epidemiological studies have reported that ozone-pollution has a negative impact on 
human health. This pollutant is associated with high temperatures and is expected to 
continue to rise with the predicted global warming. People and athletes that exercise 
outdoors are of particular concern because, the more intense and the more prolonged the 
activity, the higher the ozone dose delivered to the lungs and potentially the higher the 
risk for performance impairment, lung function decrement, onset of lung inflammation, 
lung injury and oxidative stress.  
 
The main aim of the studies contained in this thesis was to evaluate the impact of 
ozone-pollution (0.1 ppm), heat and humidity on well trained runners taking part in an 8 
km time trial run. Different end points were investigated for an analysis of the impact 
on performance outcome, lung function, lung inflammation and oxidative stress. In 
addition, a second aim was to investigate whether a 2-week supplementation period of 
vitamin C (500 mg·day-1) and vitamin E (100 IU·day-1) would provide any beneficial 
effects to the participants.  
 
The participants’ lung function was measured by spirometry. Lung inflammation and 
oxidative stress status were assessed by a variety of markers both in the upper 
respiratory airways, by nasal lavage, and in the plasma. The markers assessed included: 
neutrophil count, clara cell protein (CC16), interleukin-8 (IL-8), uric acid, GSH/Protein 
and trolox equivalent antioxidant capacity. The results showed that the athletes 
performance was significantly decreased in the hot and humid condition (mean ± SD: 
32min 35sec ± 2min 25sec) and in the hot, humid and ozone-polluted condition (33min 
09sec ± 2min 44sec) when compared with the ozone alone condition (30min 27sec ± 
2min 23sec) and the control condition (30min 15sec ± 1min 58seg). Ozone alone had 
little effect on the performance variable. The participants’ lung function was not 
affected by the adverse environmental conditions. Evidence of early lung epithelial 
injury, however, was observed by an increase in CC16 in the upper respiratory airways 
immediately after the exercise trial in the hot, humid and ozone-polluted environment; 
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though this was not observed for any other marker of inflammation at this time point. In 
this same adverse environmental condition, an increase in the GSH/Protein 
concentration in the upper respiratory airways was found immediately after the exercise.  
 
It was observed that the 2-week supplementation protocol improved the runners’ time to 
complete the 8 km time-trial run in the hot, humid and ozone-polluted environment by 
2.6%. In addition, the supplementation was shown to be effective in decreasing the lung 
inflammation induced by the combination of ozone pollution, heat and intense exercise. 
This was observed by a smaller increase in the concentration of CC16 in both the upper 
respiratory airways (0.67 ± 0.5 mg·l-1) and plasma (39.4 ± 17.4 ng·ml-1) in the vitamin 
treatment compared to the placebo. In addition, in the vitamin treatment the, cortisol 
concentration (29.2 ± 14.8 ng·ml-1) after the run, the IL-8 concentration (75.8 ± 43.2 
pg·ml-1) and neutrophil percentage (22.6 ± 17.2 %) in the airways 6 h after the run were 
also reduced compared to the values in the placebo treatment (49.9 ± 13.4 ng·ml-1; 
126.6 ± 103.2 pg·ml-1; 25.2 ± 22.6 % respectively).  
 
Taken into consideration together, these results provide evidence that heat and humidity 
combined with ozone have a detrimental effect on athletes’ performance in an 8 km 
time trial, it cannot be discounted that this was simply due to the heat and humidity as 
there was no differences in the two heat performances. The hot, humid and ozone 
environment elicited an early epithelial damage characterized by increase in CC16 
concentration in the airways. Moreover, an increase in the antioxidant concentration in 
the upper respiratory airways in that same trial, as indicated by the nasal lavage 
GSH/protein, suggests a protective mechanism against the oxidative stress stimulated by 
the high intensity exercise in association with ozone, heat and humidity. Heat and 
humidity alone had a similar detrimental effect in performance. While, ozone alone had 
little effect on the variables. In addition, it can be suggested that 2 weeks of a low 
dosage of vitamin C and E supplementation might present some benefits for the 
performance outcome and immune system of trained individuals when taking part in a 
running competition in an ozone-polluted, hot and humid environment. These benefits 
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Since the industrial revolution, there has been a rapid global urbanization process. As a 
result, large urbanized areas suffer from, amongst other problems, a high concentration 
of pollutants such as sulfur dioxide (SO2), particulate matter (PM10), nitrogen oxides 
(NOx) and ozone (O3) (Baldasano et al., 2003). The analyses of recent epidemiological 
studies, conducted in various urban centres, have provided coherent evidence that 
elevated levels of air pollution are associated with an increased risk of respiratory 
disease and mortality, via impacts on the respiratory and cardiovascular systems 
(Brunekreef & Holgate, 2002; Katsouyanni, 2003; Bell et al., 2006). This has been 
shown to be the case in both developed and developing countries (Brunekreef & 
Holgate, 2002; Stedman, 2004; Bates, 2005; Bell et al., 2006). These adverse effects on 
health caused by pollution also lead to economic burden in the countries affected (Bates, 
2005). The World Health Organisation (WHO) and the government of various countries 
have proposed guidelines for maximum concentrations of the different pollutants. 
Nevertheless, this does not mean that the countries are able to consistently maintain the 
pollution levels within the guidelines. In addition, some countries such as China and 
Mexico, still have a series of anti-pollution measures to implement in order to promote 
some improvement in their air quality (An et al., 2006; Bell et al., 2006). 
 
One pollutant that is of concern to the general population and also to athletes is ozone. 
This pollutant is a strong oxidant gas and studies have shown that ozone alone has a 
negative impact on human health, being associated with, amongst other health 
problems, an increase in pulmonary diseases, reduced pulmonary function, increase in 
hospital admissions, and an increase in mortality (Xu et al., 1998; Knowlton et al., 
2004). Ozone pollution is derived from the interaction of nitrogen oxides, volatile 
organic compounds and solar radiation. The World Health Organization guideline 
(WHO, 2006) recommends a limit value equivalent to 0.05 ppm. This value is exceeded 
however, in a number of large cities, especially in developing countries (Baldasano et 
al., 2003), but also in developed ones (Fiala et al., 2003). This oxidant gas, which 
contributes to the urban air pollution, should be distinguished from the stratospheric 
ozone, which protects the Earth against the potentially harmful ultraviolet light.  
 
Ozone is mainly a summer time pollutant because the high temperatures and increased 
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sun light enhances its formation. In fact, temperature can be used as a marker for ozone-
pollution production (Bloomer et al., 2009) and interaction between ozone and 
temperature during hot weather can potentially be very harmful to the population. 
During summer and heat wave conditions, the population is affected by high levels of 
ozone and also by high temperatures, both of which have been shown to impact on 
mortality rates (Bloomer et al., 2009). Additionally, some epidemiological studies have 
reported that the ozone effect increases in size and significance when interacting with 
higher temperatures and humidity (Thurston & Ito, 2001; Stedman, 2004). This is quite 
worrying to the general population and to athletes, taking into consideration that the 
temperature across the globe has been increasing. According to the assessment report on 
climate change of the Intergovernmental Panel (IPCC, 2007), there is an estimate of an 
increase of around 0.3ºC/decade for some regions of the globe, while other regions 
might have an even larger increase due to other factors besides global greenhouse gas 
emissions. Therefore, due to the prediction of global warming, a simultaneous rise in 
the ozone levels is also expected. According to Bloomer et al. (2009) over the last 
couple of years, there has been a slight decrease in ozone levels in some regions despite 
a slight rise in temperature (0.002 ppm/ºC). This reduction was observed together with a 
reduction in the ozone precursor NOx in those regions. Assuming that the concentration 
of NOx is going to keep falling, then the ozone concentration will possibly continue to 
decrease (Bloomer et al., 2009). Nevertheless, the ozone levels have also been shown to 
have risen in certain areas with controlled pollution policies. This occurs because ozone 
is a gas and is easily shifted, for example via the wind, to different areas in spite of 
where it is generated. Taking into consideration that the emission of NOx is increasing 
in some regions of the world, ozone is most likely to increase more than expected if 
temperature also rises (Bates, 2005; Bloomer et al., 2009). Knowlton and colleagues 
(2004) estimate that by the year 2050 there will be an increase of 4.5% in deaths related 
to the increase of ozone due to the changes in climate alone. If the increase in its 
precursors is added to this estimation, this value has a 4.4% median increase. In 
addition, areas less densely populated would also be affected because of the 
translocation of this oxidant gas.  
 
This issue is of high relevance to the general population due to the adverse health 
effects of ozone. The active and athletic population is of special concern because of the 
amount of time they spend training outdoors eliciting high ventilation rates that result in 
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higher ozone delivery to the lungs. Another consequence of the urbanization process is 
that most of the major sports events (e.g. Summer Olympic Games, Football World 
Cup) take place within or near large cities that, besides having a relatively high 
pollution level, can experience high temperatures during the summer. The 
environmental conditions of the last Olympic Games venues (Barcelona 1992; Atlanta 
1996; Sydney 2000; Athens 2004; Beijing 2008), with exception of Sydney where the 
2000 Olympic Games was held during the spring season, proved to be hot, humid and 
polluted for the athletes (Peiser & Reilly, 2004; Streets et al., 2007). Other pollutants 
such as PM10 and NOx also have strong oxidant properties (Kelly, 2004), however it is 
the association of ozone-pollution with heat which makes it unique. In addition, due to 
the similar properties of these pollutants, the effect of ozone-pollution can be extended 
to the other pollutants.     
 
The impact of ozone-pollution, heat and humidity on athletic performance has indeed 
led to interest of researchers and governments. Part of the study conducted within this 
thesis was funded by the British Olympic Medical Institute, which was concerned about 
how these adverse environmental factors would affect the performance and lung 
function of British athletes travelling to Beijing 2008. The impact of the ozone toxicity 
to the exercising individuals and how it leads to lung inflammation and oxidative stress 
is also an area of interest which is analysed in this thesis. This area of study is 
interdisciplinary bringing together exercise physiology, exercise immunology and 
toxicology. Even though research in this field is methodologically challenging, more 
investigation is necessary in order to investigate how an environmentally relevant 
concentration of ozone, together with a higher temperature affects exercising 
individuals and what could minimize the adverse effects of such exposure. The data 
presented within this thesis will hopefully help this process.    
 
The main aim of the studies in this thesis was to evaluate the impact of ozone-pollution, 
heat and humidity on athletic performance, lung function, lung inflammation and 
oxidative stress of well trained runners taking part in a simulated competition in such 
adverse environment. In addition, analyzing if the ingestion of antioxidant vitamins 
would affect the outcome of the results was also of interest. In order to investigate these 
questions two main studies were conducted.  To allow for a better comprehension this 
thesis was divided into 8 chapters. Below is an overview of the chapters: 
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Chapter 1: Provides a general introduction to the research developed.  
 
Chapter 2:  Contains the main literature review relevant for the studies described in the 
thesis.  
 
Chapter 3: Details the general materials and methods used in the experimental part of 
the studies. Any specific methodology is described in the relevant chapter.  
 
Chapter 4: Presents part of the data from the first study.  This chapter focuses mainly on 
the effect of the different environmental factors – ozone-pollution, heat and humidity – 
on the performance, lung function and respiratory symptoms of runners. 
 
Chapter 5: Presents data from two separate studies. One study is a continuation of the 
study presented in Chapter 4 and focuses on the effect of ozone-pollution, heat and 
humidity on aspects of lung inflammation and oxidative stress. The second study in this 
chapter investigates the reliability of the nasal lavage method. This method is used to 
assess the inflammatory and oxidative stress markers of the upper respiratory tract of 
the individuals taking part in the studies presented within this thesis. 
 
Chapter 6: Provides data that is part of the third study of this thesis. This study was 
elaborated based on the results obtained in the previous chapters. This study investigates 
the effect of vitamin supplementation on athletic performance in an ozone-polluted, hot 
and humid environment. This chapter presents the results related to performance, 
antioxidant status, oxidative stress and lung function of the runners. 
 
Chapter 7: Presents further data from the third study. This chapter contains the results 
relative to lung inflammation and immunoendocrine response of the runners.  
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Chapter 8: Contains the general discussion and the conclusions of the studies presented. 
In addition, it covers the limitation of the research conducted in this thesis and discusses 












Chapter 2: Literature Review 
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This chapter provides a general overview of the relevant literature for the studies 
described within this thesis. Each of the subsequent chapters provides a more detailed 
reference to the relevant literature. It must be noted that the literature provided in this 
thesis is mainly focused on studies with humans. However, in vitro and animals studies 
have been cited whenever there is relevant or additional information. This chapter is 
divided into four main sections: Section 2.1 analyses the effect that ozone pollution has 
on lung function and inflammation in the lungs; Section 2.2 describes the role of Clara 
Cell Protein as a marker of inflammation and how ozone and exercise affects its 
concentration in the blood and lungs; Section 2.3 focuses on free radical and reactive 
oxygen species production. It provides information on how exercise influences 
oxidative stress in the human body and it also refers to the effect of air pollution on this 
process. Section 2.4 describes the role of antioxidants in reducing the oxidative stress 
levels that may arise during exercise. This last section focuses on three different 
antioxidants: vitamin C, vitamin E and glutathione. It also examines the conflicting 
literature on antioxidant supplementation for people partaking in exercise bouts both in 
a non-polluted and a polluted environment. 
 
2.1 OZONE EXPOSURE 
 
Several studies evaluating the effects of ozone exposure (0.08-0.40 ppm) on healthy 
subjects have shown airway inflammation and also deterioration of lung function not 
only on low and moderate exercising individuals, but also on athletes performing high 
intensity exercise (Horstman et al., 1990; Adams and Schelegle 1983; Devlin et al., 
1996). Some studies have also shown an increase in respiratory symptoms – amongst 
them are cough, throat tickle, headaches and breathlessness, all of which are associated 
with exposures to large concentrations of ozone (Schelegle and Adams 1986). 
 
When ozone (O3), or indeed any gas, is inhaled, it first comes into contact with the 
respiratory tract lining fluid (RTLF). In fact, ozone is not able to infiltrate further than 
the RTLF and the membranes of cells from the lung-air interface, yet it is still known to 
cause damage beyond the lungs (Pryor et al., 1995). The RTLF covers the respiratory 
epithelium cells and contains a great variety of antioxidants to help protect the lungs. 
These antioxidants include urate, GSH, ascorbic acid, and in a smaller concentration α-
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tocopherol (Van der Vliet et al., 1999). Thus, once O3 comes into contact with the 
RTLF, it induces a direct oxidative stress, the intensity of which varies depending on 
the O3 inhaled dose and also on the antioxidants present in the lining fluid. It also 
induces an indirect oxidative stress because, even though O3 does not react directly with 
the epithelial cells, these cells do react in response to the oxidation products produced in 
the RTLF, consequently releasing a variety of pro-inflammatory mediators and more 
reactive oxygen species. As a result, if the oxidative stress is sufficient there is an 
activation of an inflammatory response which may lead to an increase in airway 
neutrophilia and tissue injury (Pryor, 1994; Pryor et al., 1995).  
 
The airway inflammation is detected by an increase in inflammatory cells, such as 
neutrophils and macrophages, as well as inflammatory mediators, such as interleukin-6 
(IL-6) and interleukin-8 (IL-8). The depletion of antioxidants found in the airways, 
characterizes the oxidative process that triggers an inflammatory response due to 
epithelial damage (Mudway et al., 1999a; Bloomberg, 2000). Both the inflammatory 
mediators and the antioxidants can be measured using different techniques, each with its 
advantages and disadvantages. Bronchial biopsies and brochoalveolar lavage (BAL), 
though frequently used, are quite invasive procedures and, therefore, require local 
anesthesia and need to be performed in a medical environment (Jӧrres et al., 2000). 
Another technique is the sputum induction procedure which is less invasive and less 
technically difficult than bronchoscopy (Ratto et al., 2006). Similarly, the nasal lavage 
technique is not only a relatively noninvasive procedure but can be repeated at multiple 
time points (Mudway et al., 1999a). When reviewing studies, it is important to take into 
consideration that these different techniques could be sampling different airway 
compartments (Ratto et al., 2006), thus, explaining some differences in the outcome of 
studies.  
 
Lung function is usually assessed using spirometry, which is an important and efficient 
way to evaluate disorders of the respiratory tract (Booker, 2005; Wagner et al., 2006). A 
variety of lung function measurements can be assessed by spirometry. Nevertheless, 
some parameters have been shown to be more important when evaluating an 
individual’s lung function (Booker, 2005). Such parameters include forced vital 
capacity, forced expiratory volume in 1 second, forced mid-expiratory flow and peak 
expiratory flow (Gong et al., 1986; Folinsbee et al., 1984; Blomberg et al., 1999). 
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Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 second (FEV1): 
The FVC is the total volume of air expired, in litres, after full inspiration. It measures 
the respiratory stroke volume. The FEV1, on the other hand, is the volume of air 
delivered in the first second of the FVC manoeuvre and is affected by the airway 
resistance. In people with normal lung function both the FVC and the FEV1 should be 
above 80% of the predicted (Booker, 2005). Any reduction indicates a decrease in the 
individual’s ventilatory capacity, which is often associated with different lung diseases 
– e.g. fibrosis, asthma, bronchitis. Moreover, a significant increase in both these 
measurements or in either one indicates that the airflow obstruction is reversible 
(Pellegrino et al., 2005). Another important and much used index when assessing 
airflow obstruction is the ratio FEV1/FVC. The normal ratio for FEV1/FVC is 80% 
(West, 2003). A decrease in this percentage may be a sign of chronic obstruction 
pulmonary disease (Celli et al., 2004).    
  
Forced Expiratory Flow (FEF25-75%): Forced expiratory flow is the volume of expired 
air measured during the middle half (25-75%) of an FVC manoeuvre. It is the volume in 
litres divided by the time in seconds. Similarly to FEV1, FEF25-75% is affected by 
changes in the airway resistance and, therefore, these two measures are often closely 
correlated (West, 2003).   
 
Peak Expiratory Flow (PEF): The PEF can be defined as the maximum flow (rate) 
during a forced expiration after full inspiration (West, 2003). Taking into account that 
PEF is effort-dependent, factors such as the subjects’ motivation and their respiratory 
muscle strength will affect the PEF outcome. Furthermore, PEF is measured within the 
first 100 ms of the forced expiration and assesses the calibre of the large airways. Thus, 
if just this lung function variable is being measured, the subject need not make a 
prolonged forced expiration (Jain, 1998). The standard error of this measure is 
considered large, therefore, differences of up to 100 l·min-1 observed between different 
testing days does not necessarily represent an abnormal value. Equally, if individuals 
present normal PEF values, it does not necessarily mean that they may not present a 
small degree of airway obstruction (Gregg & Nunn, 1973). In addition, due to the 
variation in the neural mechanisms responsible for bronchoconstriction (Barnes, 1992), 
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the PEF varies throughout the day, achieving its peak in the afternoon around 4pm. 
Therefore, some intraindividual variation can also be explained by this circadian rhythm 
if the time of measurement is not consistent (Jain, 1998).  
 
When using the spirometer it is important to take into consideration some factors in 
order to optimize the results obtained. Firstly, a daily calibration check is recommended 
in order to determine the onset of any technical problem. Secondly, when an individual 
is re-evaluated the professional conducting the test should be the same and the time of 
the day should not exceed a two-hour difference from the previous tests. Moreover, it is 
important to explain the whole procedure for the subject and ensure that they understand 
what has to be done (Pellegrino et al., 2005). 
 
 Decreases in pulmonary function and increases in airway neutrophilia have been 
observed to be related to the total O3 effective dose (ED). This index is defined as the 
product of O3 concentration, average expired ventilation, and duration of exposure 
(Gibbons et al., 1984; Gong et al., 1986; Mudway & Kelly, 2004) and has been shown 
to be a reliable surrogate for the actual dose (Rigas et al., 2000).  It is important to take 
the ED into account when analyzing the pertaining scientific literature since athletes can 
achieve a higher ventilatory exchange ratio during exercise and, consequently, inhale 
more air and more ozone per minute than non-athletes. Hence, being exposed to the 
same ozone concentration but having higher minute ventilation, as seen in athletes, 
might result in more pronounced side effects.  
 
2.1.1 Ozone and Airway Inflammation 
Airway inflammation and any other inflamed tissue can be characterized by an increase 
in inflammatory cells, such as neutrophils and macrophages, as well as inflammatory 
mediators, IL-6, IL-8, and prostaglandins. Neutrophils are granulocyte cells and are part 
of the innate immune response, that is, these cells can recognise and act against a 
foreign particle, including bacteria and viruses, without prior exposure. The mechanism 
of action of a neutrophil consists of phagocytosis and digestion of the foreign particle or 
antigen. An increase in neutrophil numbers and percentage is a good indicator of the 
beginning of an inflammatory response because these cells account for 50-60% of the 
 12 
total white blood cells (leukocytes) in the circulation and are the first cell type to 
migrate to sites of injury and inflammation. When there is an inflamed tissue there is an 
increase on the expression of adhesion molecules of the selectin family (E- and P- 
selectin molecules) on the local endothelium, this is mediated by cytokines and other 
inflammatory mediators. Neutrophils present in the blood recognise the site of 
inflammation because of these adhesion molecules, which binds to molecules (mucin-
like cell-adhesion molecules, CAM) on the neutrophil surface. This step is referred to as 
rolling and is the first step to the attachment of neutrophils on the endothelium. In order 
for them to adhere firmly and be able to migrate through the endothelial to the inflamed 
site, the neutrophils are activated by various chemoattractants derived from epithelial 
cells exposed to a foreign body, IL-8 being an important one. Once the adhesion 
processes is successful the neutrophils can initiate their transendothelium migration 
(Figure 2.1). Upon arrival to the inflamed tissue neutrophils release a number of 
chemoattractants to amplify the inflammatory response by recruiting other cells (Pyne, 
1994).  
 
Figure 2.1. Neutrophil transendothelium migration. A- Four sequential steps in the migration 
process: 1- Rolling 2- Activation 3- Adhesion 4- Transendothelium migration. B- Cell-adhesion 




The cytokine IL-8 is a mediator of the immune function and helps to regulate the 
immune response. It is secreted by a variety of cells, including neutrophils, 
macrophages and endothelial cells, and is a chemotactic for cells such as neutrophils 
and T cells. In addition, it has been linked to a wide variety of pathologic conditions 
characterized by an increase in neutrophil count, thus an increase in IL-8 levels is linked 
to an increase in neutrophils (Holz et al., 1999). IL-6 is another important mediator in 
the development of an inflammatory process. It is produced mainly by T-cells and 
macrophages, and together with IL-1 and TNF-α stimulate both local and systemic 
changes seen in an inflammatory response. This cytokine has been thoroughly studied in 
immunological responses to exercise (Steensberg et al., 2000; Febbraio & Pedersen, 
2002). 
 
Athletes usually present at rest a clinically normal level of blood circulating neutrophil 
number, but there have been some studies that have reported lower neutrophil counts in 
trained distance cyclists (Blannin et al., 1996) and elite distance runners (Hack et al., 
1994).  The elite runners presented a lower neutrophil count at rest during a period of 
intense training (102 km·wk-1) compared with non-athletes. This baseline difference 
was not apparent when the training was of moderate intensity (89 km·wk-1) (Hack et al., 
1994). During and after exercise however, the number of circulating neutrophils is 
known to substantially increase, the magnitude of which depends mainly on the exercise 
mode, duration and intensity (Blannin et al., 1996; Mackinnon, 1999). This increase is 
seen in both trained and untrained individuals, and occurs mainly because of the 
detachment of these cells from the vascular endothelium. After endurance exercise the 
neutrophil count remains elevated for several hours (Steensberg et al., 2002).     
 
Contrary to the blood neutrophils, the basal neutrophil concentration in the airways of 
athletes and individuals who go through a chronic endurance training period, are usually 
higher than compared to the general population (Bonsignore et al., 2001; Morice et al., 
2004; Belda et al., 2008). This elevated number has been attributed to, amongst other 
factors, a prolonged period of high ventilation which can lead to epithelial damage in 
long distance runners and cyclists (Bonsignore et al., 2001; Morice et al., 2004; 
Denguezli et al., 2008).   
 
Inhalation of ozone has been shown to stimulate airway inflammation due to its 
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oxidative nature. Devlin et al. (1996) analyzed the concentration of a broad range of 
inflammatory mediators in BAL fluid 1 h after ozone exposure. In this study, volunteers 
performed intermittent heavy treadmill exercise (66 l·min-1) for 2 h in a chamber where 
the ozone concentration was of 0.4 ppm. An increase was observed in mediators of 
inflammation such as neutrophils, IL-6 and lactate dehydrogenase (LDH), which is an 
indicator of cell damage. Similarly Holz and colleagues (1999) observed a significant 
increase in neutrophil count and percentage in induced sputum 1 h after participants 
completed 3 h of light intermittent exercise - 14 l·min-1·m-2 of body surface area - 
exposed to 0.25 ppm of O3. Nevertheless when the participants performed the same 
exercise bout exposed to a lower O3 concentration (0.12 ppm) no changes in neutrophils 
were observed. Furthermore, sputum IL-8 concentration was reported to be elevated 
only after the 0.25 ppm exposure.  
 
Contrasting some of the previous findings, Blomberg et al. (1999) were unable to find 
either mucosal and airway neutrophilia or LDH increase at 1.5 h after a 2 h exposure to 
0.2 ppm O3 in subjects performing intermittent moderate cycling exercise producing an 
average minute ventilation of 20 l·min-1·m-2 of body surface area. This difference might 
be explained by the lower exercise and O3 levels in the latter study, consequently the 
inhaled O3 dose was also lower. Nevertheless, Blomberg et al. (1999) were able to 
detect in tissue obtained from bronchial mucosal biopsies increases in the expression of 
vascular endothelium P-selectin and ICAM-1 after the ozone exposure. These molecules 
mediate adhesion and rolling of leukocytes on the vessel walls. Hence, it was suggested 
that although there was an increase in the expression of vascular adhesion molecules in 
the vascular endothelium, this had not yet resulted in an increase in neutrophil numbers 
at the analyzed sites. Stenfors et al. (2002) using the same study design as the previous 
study, demonstrated a significant increase in BAL neutrophil number and percentage 6 
h after the exercise trial. In addition, vascular endothelium P-selectin and ICAM-1 were 
also elevated. This reinforces the role of these adhesion molecules in the inflammatory 
response, recruiting inflammatory cells into the airways of healthy individuals. 
    
The airway inflammation response to chronic ozone exposure has also been 
investigated, though more in-depth studies are also required. Christian et al. (1998) 
showed an attenuation of the inflammatory response in BAL after four consecutive 
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days’ exposure to ozone. Nevertheless, it seems that although neutrophil recruitment 
and IL-6 concentration in the respiratory tract is attenuated with multiday short-term 
exposures, airway epithelial injury may continue to occur. The data from Jörres et al. 
(2000) support the previous finding and additionally they reported that after four 
consecutive exposures an increase in airway mucosa inflammation as well as the 
neutrophil count was observed in bronchial mucosal biopsies. These data, thus, 
demonstrate that airway inflammation persists despite attenuation of some inflammatory 
markers in BAL. It is important to point out that this persistent injury could lead to 
airway remodeling, which has been observed in several animal studies, but needs further 
investigation in humans (Christian et al., 1998).  
 
Using a different technique, sputum induction, to assess airway inflammation, Ratto et 
al. (2006) found an increase in the percentage of neutrophils after 4 h of 0.2 ppm O3 
exposure during 4 consecutive days. This finding is in contrast to the previous 
mentioned studies using BAL where it was observed that attenuation of inflammatory 
response occurred. Nevertheless, it was consistent with the increased recruitment of 
neutrophils to proximal airway tissue demonstrated in endobronchial biopsies samples 
taken by Jörres et al. (2000). Once more, it shows that different techniques sample 
different airway compartments producing differing results. In addition, the exposure and 
exercise protocol is also essential for the outcome of the inflammatory process. An 
important additional factor that appears to affect results in these studies is individual 
responsiveness due to differences in ozone sensitivity of individuals (Holz et al., 1999; 
Mudway et al., 2001).  
 
All studies mentioned above were conducted in a thermoneutral environment. 
Unfortunately, they also used non-athletes and did not measure the performance 
response to O3 exposure. Therefore, it is difficult to establish the inflammatory 
responses that athletes would have had, and how it would affect their performance. It is 
essential to keep in mind that endurance sport athletes currently present airway 
neutrophilia, but they are not activated at rest or after exercise. In addition, this increase 
in the inflammatory cells is not necessarily associated with respiratory symptoms or 
functional impairment (Bonsignore et al., 2003). 
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2.1.2 Ozone and Lung Function 
Research evaluating the effect of ozone on lung function has been carried out in 
laboratory settings using either a mouth-breathing face mask (Adams and Schelegle 
1983, Gibbons and Adams 1984; Schelegle and Adams 1986; Ratto et al., 2006) or an 
environmental chamber (Christian et al., 1998; Blomberg et al., 1999; Horstman et al., 
1990; McDonnell et al., 1991). Other studies have been performed in outdoor settings 
(Brunekreef et al., 1994; Korrick et al., 1998) and show, in general, greater O3 
associated changes in pulmonary function than in controlled exposure settings, which 
could be attributed to the synergistic effect of other pollutants.  
 
Horstman et al. (1990) reported impaired lung function and an increase in non-specific 
airway reactivity in subjects exposed to an ozone concentration as low as 0.08 ppm O3. 
In this study, 22 individuals performed 5 h of moderate exercise (mean VE 
approximately 39 l·min-1) while exposed during 6.6 h to different concentrations of 
ozone – 0.00, 0.08, 0.10 and 0.12 ppm. The authors observed that the FEV1 was 
significantly reduced after only 3 h at 0.12 ppm, 4.6 h at 0.10, and 5.6 h at 0.08 ppm. 
This indicates that O3 at levels, often found in ambient air, decrease pulmonary 
responses in individuals engaged in activity representative of a typical day of moderate 
to heavy work or play. These findings were in accordance with a subsequent study by 
McDonnell et al. (1991) using a similar methodology.  
 
Impairment in lung function has also been reported with shorter ozone exposure 
durations. Blomberg et al. (1999) reported a depressed response of FEV1, FVC and 
FEF25-75, following a 2 h exposure of 0.2 ppm ozone. In this study, subjects performed 
intermittent cycling exercise at an average minute ventilation of approximately 20 
l·min-1·m-2 of body surface area. In contrast to the previous studies, this one used a 
higher ozone concentration but a shorter duration and a lower minute ventilation. Other 
studies utilized different ozone concentrations, with lower exposure duration but with 
exercise eliciting a much higher ventilatory exchange ratio. Schelegle and Adams 
(1986), using ten endurance athletes, evaluated the influence of different ozone 
concentrations – 0.12, 0.18, and 0.24 ppm - while performing a 1 h competitive cycling 
simulation protocol. One, five and seven subjects did not complete the 0.12, 0.18 and 
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0.24 ppm O3 protocol respectively. In addition, a significant increase in the number of 
reported respiratory symptoms and decreases in FEV1 and FVC were observed 
following the 0.18 ppm O3 exposure.  
 
In relation to studies carried out in the field, Korrick et al. (1998) evaluated the effects 
of ambient O3 on the pulmonary functions of healthy adults hiking on Mt Washington. 
The study population was composed by 530 healthy hikers of different ages and 
physical fitness tested throughout a period of 74 days. The average of each hourly O3 
concentration during each hike ranged from 0.021 to 0.074 ppm. In addition, the 
average temperature and exercise time were of 19 ºC and 8 h respectively. After 
adjusting to potential confounding variables – age, gender, other pollutants etc – a 
significant decrement in FEV1 and FVC after the exercise was observed. These results 
are closely related to those of Brunekreef et al. (1994), although the former presented a 
larger decrease in pulmonary function probably due to the amount of time the subjects 
were exercising in comparison to the latter. Brunekreef et al. (1994) conducted a field 
study on a group of amateur cyclists investigating the effect of outdoor ozone exposure 
during the Netherlands’ summer season. The ozone levels varied between 0.044 and 
0.098 ppm, the cycling had an average duration of 75 min and the mean temperature 
was 17.9 ºC. The authors reported that even though extreme lung function impairments 
were not present, there was a significant relationship between ozone exposure and lung 
function decrements. These field studies are very important because they are conducted 
in a real ambient environment and give us some idea of the implication of athletes 
competing in a polluted site. On the other hand, it is difficult to point out the true effect 
of O3 since there are other influencing variables, some of which may not yet have been 
even associated with lung function impairments.  
 
Besides ozone, the parameters of heat and humidity per se have been shown to have a 
detrimental effect on exercise performance (Galloway & Maughan 1997; Gozalez-
Alonso et al., 1999; Parkin et al., 1999; Nybo & Nielsen, 2001). However, there is very 
little research that evaluates the combined effect of pollution with heat and humidity. 
There are two important studies that have investigated the impact of both heat and 
ozone on lung function and exercise performance (Gibbons & Adams, 1984; Gong et 
al., 1986). Unfortunately the humidity was kept low in these studies. The authors 
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arrived at the conclusion that the combined effects of an ozone polluted environment, 
heat, and exercise produced a greater negative impact on performance and respiratory 
discomfort than ozone and exercise alone (Gibbons & Adams, 1984; Gong et al., 1986).  
 
2.2 CLARA CELL PROTEIN 
 
Clara cells are nonciliated, secretory columnar cells found exclusively in the pulmonary 
airways - predominantly in the respiratory bronchioles and in the terminal bronchioles. 
The function of these cells is mainly the protection of the respiratory tract (Hermans & 
Bernard, 1999). They present a high content of xenobiotic metabolizing enzymes which 
protect our system against inhaled particles (Robin et al., 2002) such as pollutants. The 
main protein secreted by the Clara cells is a small protein of 16 kDa, that has been given 
various names throughout the literature, such as Clara cell protein, CC16, CC10 and 
Uteroglobin. However, hereafter it will be referred to as Clara cell protein or CC16. The 
exact function of this protein is not clear thus far, but it is believed it plays an important 
role in decreasing the inflammation of the respiratory tract and protecting it against the 
harmful effects of oxidative stress (Broeckaert & Bernard, 2000). 
 
CC16 is also produced by the nasal mucosal epithelial cells (Lindahl et al., 1999; 
Benson et al. 2004) making it easy to quantify this protein by the nasal lavage method 
(Johansson et al., 2005). Small amounts of Clara cell proteins have also been found in 
other organs such as the male and female urogenital tract, endometrium, fetal lung and 
kidney, and in the amniotic fluid. Nonetheless, the level of CC16 expression in these 
organs is on average 20 times lower than in the pulmonary airways (Broeckaerte et al., 
2000a). CC16 can also be found in the blood, where it is derived almost exclusively 
from the airways (Hermans & Bernard, 1999). In normal healthy individuals, the serum 
level of CC16 ranges on average from 10 to 15 ug·l-1 (Helleday et al., 2006). Yet, as a 
result of pulmonary inflammation and increases in the permeability of the lung 
epithelial barrier the concentration of this protein in the blood has been shown to 
increase (Hermans et al., 1999). The mechanisms involved with the transudation of 




2.2.1 Mechanisms of Changes in Serum Levels of CC16 
The lung–blood barrier offers some resistance to the bi-directional movement of large 
proteins such as albumin. Nevertheless, the high concentration of CC16 in the 
respiratory tract secretions and its small size permits its diffusion into the blood 
(Broeckaert et al., 2000a). The CC16 concentration in the blood can easily be detected 
by conventional enzyme immunoassays (Gioldassi et al., 2003).  
 
The bi-directional exchange of proteins between lung and blood is regulated by several 
factors, among which are the size of the proteins, the epithelium permeability and the 
driving force of the transepithelial concentration gradient. The concentration gradient 
will allow the movement of proteins from an area of high concentration to an area of 
low concentration. In the case of CC16 it will be from the lung to the blood; but 
albumin, for example, moves in the opposite direction. The large difference between the 
concentration gradients can be related to the difference in the compartment sizes in 
which the proteins are diluted. The concentration gradient is also influenced by the 
removal of the protein from the compartment into which it is leaking - proteins that 
enter the lung interstitium are rapidly cleared by lymphatic drainage (Broeckaert et al., 
2000a).   
 
The changes that occur in serum concentrations of CC16 may result from three different 
mechanisms. The first mechanism would be a result from the increase in the 
permeability of the lung epithelial barrier, which has as a consequence a higher 
diffusion of CC16 to the blood. This can happen following exposure to ozone, which 
causes epithelial lung injury (Christian et al., 1998), more specifically, damage to the 
tight junctions of the cells (Broeckaert et al., 2000a). A second possibility is the 
decrease or increase in the production or secretion of CC16 from the Clara cells present 
in the respiratory tract. A reduction in the number of Clara cells has been shown to 
occur following chronic exposure to lung toxicants such as silica particles (Bernard et 
al., 1994). Finally, the levels of serum CC16 can also be altered if there is a reduction of 
the clearance of the protein by the kidney. Serum CC16 has a half-life of approximately 
2-3 h due to the rapid clearance through the kidney (Hermans & Bernard, 1999). Hence, 
the variation in CC16 serum levels can only be used as a specific biomarker of the 
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airway epithelium integrity if the subjects in the study do not present renal function 
problems. For a fuller explanation see Figure 2.2.  
 
Figure 2.2. Movement of CC16 from the airways to the blood across the different barriers under 
normal conditions (A) and after exposure to ozone (B). The thickness of the arrows is used to 
illustrate the relative permeability of the different barriers and increase in the CC16 flux after 
ozone exposure.  Abbreviations: Ep – epithelium; In - interstitium; En – endothelium (adapted 
from Broeckaert et al. 2000b). 
 
An important point which has to be taken into account when carrying out experiments 
or comparing studies is the diurnal variation in the serum concentration of CC16. In 
addition, there is also a large inter-individual variation in this protein. Halleday et al. 
(2006) demonstrated diurnal variations on the serum levels of CC16 presenting a 
significant drop in the concentration between 11:30 am and 10:00 pm. Even though 
there is a large inter-individual variation, this study showed that the time-dependent 
diurnal change was similar in all individuals regardless of the baseline concentrations. 
 
2.2.2 Lung Injury   
Both acute and chronic exposure to toxicants has been shown to elicit changes in serum 
CC16 levels. This supports the theory that this protein is a sensitive and suitable 
biomarker of lung toxicity and lesions involving the respiratory epithelium, which can 
be assessed in a simple and noninvasive way (Bernard et al., 1994, Hermans & Bernard, 
1999). 
 
Acute smoke inhalation has been shown to significantly increase the serum levels of 
CC16 (Bernard et al., 1997). This study was conducted on firefighters; who in 
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addition to inhaling the smoke also performed physically demanding tasks. Serum 
CC16 concentration was measured immediately after exposure and was three fold 
higher when compared to control subjects. The authors attributed this change in the 
serum CC16 concentration to a transient increase in the lung epithelial permeability.  
Moreover, this increase occurred in the absence of any functional sign of lung 
impairment. Ten days after exposure the CC16 concentration had returned to baseline 
levels.  
 
A chronic toxic effect on Clara cells has been shown in workers inhaling silica-rich dust 
for an average of 15 months (Bernard et al., 1994). This study compared two groups of 
workers, one composed of workers exposed to silica and the other a control group, 
matched for age, body mass index and proportion of smokers. The mineworkers 
presented a significant reduction of serum CC16, even though they did not present any 
lung function impairment or abnormalities in their chest X-ray. The decrease was 
reported for both the nonsmokers and the smokers. An additional and significant effect 
of tobacco smoking was also found. The authors associated this decrease with a 
reduction in the release of CC16 from the Clara cells probably due to their damage from 
the toxic action of silica.  
 
A similar chronic toxic effect on these cells has been shown in tobacco smokers, who 
presented a significant decrease in serum CC16 when compared to nonsmokers (Robin 
et al., 2002). The authors suggested that the toxic metabolites of tobacco smoke not 
only increases the permeability of the lung epithelium, reflected by an increase in serum 
concentration of  the small surfactant-associated protein B, but it also causes the 
progressive destruction of the Clara cells.  
 
2.2.3 Ozone, Exercise and CC16 
Few studies have investigated the effect that exercise or ozone or the combination of 
both has on Clara cells and CC16. The majority of these studies however, investigating 
exercise and Clara cells, have utilized an ozone polluted environment, mainly because 
of the established relationship between CC16 and lung inflammation. Therefore the 




A study conducted by Nanson et al. (2001) was carried out to detect the effect of 
different exercise intensities on serum CC16 levels. For this, 14 healthy subjects went 
through three different trials; no ozone was used in this study. One trial consisted of a 
no exercise session, another of 30 min moderate exercise simulating firefighting tasks, 
and a third session composed of a 60 min high-intensity exercise. Blood samples were 
collected 1 h post-exercise. The results showed a significant increase in serum CC16 for 
both exercise sessions despite differences in the intensity and duration of the exercise. 
The authors suggested that this result could be due to an increase in the pulmonary 
CC16 concentration resulting in a larger diffusion gradient from the lung to the serum. 
Alternately, the alveolar-capillary permeability could have increased slightly permitting 
the passage of small molecules. It is important to point-out that the subjects that took 
part in this study did not participate in regular physical activity. Carbonelle et al. (2002) 
also found an increase in serum CC16 levels of swimmers immediately after a 45 min 
training session.  
 
The effect of exercise associated with ozone was investigated in the study of Broeckaert 
et al. (2000b) where 24 non-smoking cyclists, performed 2 h of cycling at moderate 
intensity during episodes of photochemical smog. The average concentration of ozone 
was 0.076 ppm. Immediately before and after each ride the participants provided blood 
samples and also performed lung function tests. Significant correlations were found 
between O3 concentration and the serum levels of CC16 of the cyclists both pre and 
post-exercise. By contrast when comparing pre and post rides no decrements on lung 
function performance were found - these parameters are usually impaired by O3 
exposure. Thus, this study shows that short-term exposures to ambient-levels of O3 
induces an early increase in serum CC16 which takes place before other manifestations 
of lung toxicity. However there was no control group to verify if this increase was due 
to the exercise, the ozone or a combination of both. The authors suggested that the 
increase seen in the serum CC16 was due to an increase in the pulmonary epithelium 
permeability and not to an increase in the production of this protein. As this study was 
conducted in the field, it is difficult to attribute these results directly to the O3 exposure, 
as there may have been other pollutants that could also have influenced the epithelial 
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leakage. In addition, the levels of serum CC16 pre-ride were also correlated with the 
levels of ambient O3, indicating that the cyclists initiated the exercise with an increased 
permeability of the lung epithelium.   
 
In another study (Blomberg et al., 2003), this one conducted in the laboratory, 22 
subjects performed 2 h of moderate intermittent exercise exposed to two different 
environment conditions: 0.2 ppm of O3 and filtered air. The participants’ lung function 
was assessed and peripheral blood samples were obtained 2 h pre, immediately pre, 
immediately post, 2 and 4 h post-exercise. Significant decreases in the lung function 
parameters, FEV1 and FVC, were observed immediately post O3 exposure. However, at 
2 and 4 h post-exercise this decrease was not observed anymore. Moreover, a significant 
increase in serum levels of CC16 was observed around 2 and 4 h post O3 exposure. No 
relationship was noted between CC16 and lung function at any time point. Serum CC16 
concentrations were shown to have returned to baseline 18 h post-exposure. Other 
epithelial permeability markers, albumin and total protein concentration, that were also 
assessed did not show a significant increase. The data from this study supports the 
theory that serum CC16 is a more sensitive marker of altered lung epithelial 
permeability than traditional markers.  
 
Even though the latter findings are in agreement with the enhanced serum levels of 
CC16 mentioned in the previous study of Broeckaert et al., (2000b), it is important to 
note some differences between these studies. Firstly, the concentration of ozone varied a 
lot between the studies. In addition, while in the first study (Broeckaert et al., 2000b) 
the participants were trained cyclists, the second (Blomberg et al., 2003) only 
mentioned that the subjects were healthy individuals. Neither study detailed the 
participants’ aerobic capacity nor the exercise intensity elicited during the trials. An 
additional confounding factor is the degree of pre-exposure between the two studies: the 
first study took place during the summer and the other during the winter. This could be 
one of the causes for which the former study (Broeckaert et al., 2000b) showed an 
increase in serum CC16 levels immediately post-exposure. Nonetheless, it cannot be 
excluded that other air pollutants present in the photochemical smog could have 
influenced the CC16 leakage immediately post-exercise.      
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Contrary to the previous studies, Lagerkvist et al. (2004) did not find any significant 
changes in serum levels of CC16 in children (10-11 years of age). They performed 2 h 
of outdoor exercise, where the maximal O3 value reached 0.059 ppm. Blood samples 
and lung function performance were obtained pre and post-exercise. Yet, no decrease in 
lung function or changes in CC16 were observed. In relation to CC16 concentration, the 
authors reported that children who regularly visited chlorinated indoor swimming pools 
presented significantly lower levels of serum CC16 both before and after the outdoor 
exercise when compared to the non-swimming children. In this study, it is important to 
observe that the maximum level of O3 reported is lower than in the previous studies 
discussed above. Furthermore, the authors mentioned that the children performed light 
exercise; though, they did not report the type of exercise nor how the exercise intensity 
was controlled for. More investigation is needed to establish the effect that ozone and 
exercise have on the airway permeability as there are still contradictions in the literature 
using CC16 as a marker of lung injury. 
 
2.3 OXIDATIVE STRESS 
 
2.3.1 Free Radicals and Reactive Species 
Free radicals can be broadly defined as molecules or ions containing an unpaired 
electron and capable of existing independently (Halliwell & Gutteridge, 2007). As a 
result of the unpaired electron, free radicals easily react with other molecules to gain 
another electron and therefore become stabilized (Radák, 2000). Reactive species are 
molecules that are capable of oxidizing other molecules. Many of these molecular 
species are oxygen centred (O3, H2O2, etc) and thus denominated reactive oxygen 
species (ROS). Some ROS are also free radicals such as superoxide anion (O2-) and 
nitric oxide (NO) because they have an unpaired electron (Radák, 2000). Reactive 
species can also be formed by a wide range of other atoms such as nitrogen and chlorine 
(Halliwell & Gutteridge, 2007). Both free radicals and ROS, due to their molecular 
instability, promote oxidation reactions with cellular proteins, lipids or DNA. However, 
the body has an elaborate antioxidant defence system that neutralizes the reactive 
species and free radicals in order to achieve a balance (homeostasis). But, if there is an 
increase in the oxidant concentrations, overwhelming the available antioxidants, or if 
the antioxidants are depleted due to disease or poor diet, then oxidative stress and 
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impaired cellular function may occur (Powers et al., 2004). In fact, oxidative stress has 
been proved to be the cause and consequence of many diseases (Halliwell & Gutteridge, 
2007). Different antioxidants and their mechanisms of action are described in section 
2.4. 
 
On the other hand, free radicals and ROS are essential to our well-being. For example, 
ROS are produced by immune cells – neutrophils and macrophages - during the process 
of respiratory burst in order to eliminate invading microorganisms (Kuby, 1997). 
Moreover, other processes can be highlighted as examples such as the stimulation of 
genes - which encode transcription factors, differentiation, and development; cell-cell 
adhesion; cell signalling; involvement in vasoregulation and fibroblast proliferation 
(Sen, 2001). 
 
2.3.2 Measurements of Oxidative Stress in Humans 
The molecular detection of free radical species is technically challenging because of 
their high reactivity and low steady-state concentration. Thus, to analyze acute oxidative 
stress in response to exercise, different stress markers in the blood, urine, expired air, 
nasal lavage fluid, and muscle tissue from humans have been examined (Leaf et al., 
1997; Sienra-Monge et al., 2004; Child et al., 1999; Hellsten et al., 1996).  
 
The by-products of lipid peroxidation are the markers most commonly measured (e.g. 
F2-isoprostane and malondialdehyde). Lipid peroxidation is a process of chemical 
reactions that occurs when free radicals attack polyunsaturated fatty acids, such as those 
found in cell membranes (Urso & Clarkson, 2003). In addition to lipid peroxidation, in 
order to examine the oxidative stress, other processes have also been examined. These 
include changes in the status of antioxidants compounds, such as glutathione, uric acid, 
analysis of protein and DNA oxidation products, and antioxidant enzyme activities 
(Watson et al., 2005). Nonetheless, these are all measures of oxidative stress and not 
necessarily reflection of ongoing ROS and free radical production. A direct measure, 
used in some studies (Ashton et al., 1999), is the electron spin resonance (ESR) 
technique. This technique enables the detection of species that have an unpaired 
electron, generally meaning that it is a free radical. 
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2.3.3 Exercise-Induced Oxidative Stress: Experimental Evidence 
Under basal conditions the skeletal muscle produces superoxide anions and NO at a low 
rate. However, during contractile activity, this rate is drastically increased. In fact, 
physical exercise is associated with an increase in oxygen uptake both by the whole 
body and especially by the contracting muscle group. Sen (1995) reported an increase of 
10-15 fold in the rate of whole body oxygen consumption and an increase of more than 
100 fold in the oxygen flux in active muscles during exercise. How the increase in O2 
uptake results in increased ROS production is explained later in this review.   
 
Studies that measured the oxidative stress induced by physical exercise have been 
reported. Sastre et al. (1992) investigated the influence that exhaustive exercise had on 
the levels of oxidative stress. For this, they analysed the ratio between cellular oxidized 
glutathione and reduced glutathione (GSSG-to-GSH). Although the GSH levels did not 
change significantly, they reported an increase in the GSSG-to-GSH ratio due to an 
increase in the cellular oxidized glutathione levels. Hence, it evidenced an occurrence of 
oxidative stress post-exercise.  
 
On the other hand, Niess et al. (1996) measured plasma levels of malondialdehyde 
(MDA) at rest before and after an exhaustive bout of exercise. They found no 
significant increase in MDA following a treadmill test to exhaustion, neither at 15 min 
post-exercise nor at 24 h post-exercise. Yet they did demonstrate the occurrence of 
DNA damage in white blood cells following the exercise protocol. More recently, 
Watson et al. (2005) measured exercise-induced oxidative stress by the concentration of 
F2-isoprostane in the blood during two different exercise protocols performed in 
sequence. Initially, the subjects ran for 30 minutes at 60% of their VO2 max and 
performed an incremental running test to exhaustion immediately after that. As a result, 
they reported a decrease in the concentration of F2-isoprostanes both during and 1 h 
after the exercise. Nevertheless, it is important to highlight that these studies present 
some limitations concerning the analytical techniques employed, as all of them were 
indirect methods, and the reactive intermediates do present different properties 
contributing to the inconsistencies reported in the literature (Bailey et al., 2003). 
Furthermore, analyses of ROS generation are mainly collected immediately after 
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exercise, whereas the true rate of ROS production has been shown to decrease rapidly 
within the first 1-2 min after muscle contraction ceases (O’Neill et al., 1996). Therefore, 
the majority of studies probably underestimate the real time of reactive species 
production during exercise. 
 
Using the direct technique of ESR and also changes in MDA concentrations, Ashton et 
al. (1999) examined free radical production of subjects that cycled to volitional fatigue. 
They reported an increase in free radical production by both methods. In accordance, 
Bailey et al. (2004) analysed an incremental knee extensor exercise preformed at 25, 70 
and 100% of single-leg maximal work rate. Besides ESR, other parameters, including 
measurements of plasma catecholamines, biomarkers of tissue damage and uric acid 
were also used to assess oxidative stress. The findings provided direct evidence for an 
exercise intensity-dependent increase in free radical production. It also provided 
additional insight into potential sources and mechanisms associated with exercise-
induced free radical generation that is addressed further on.  
 
It is important to keep in mind that the exercise models used in the studies also deserve 
critical evaluation since they recruit different muscle groups and different modes of 
contraction (Bailey et al., 2003). Coupled with the fact that they use different 
population groups, it is comprehensible that these studies present different rates of 
oxidative stress as the result of exercise performance.  
 
2.3.4 Mechanisms of Increased Free Radical Production with Exercise 
The causes of increased free radical and ROS production during exercise have not been 
totally clarified. Although various mechanisms have been identified, there is still a lack 
of understanding concerning how each of them contributes to the total amount of 
oxidative stress produced. In addition, the mechanisms may act synergistically, and 
different types of exercise probably elicit different pathways of free radical production 
(Vollaard et al., 2005). The mechanisms are described below.  
 
1. Electron leak at the mitochondrial electron transport chain. This theory has led 
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to the interpretation that a substantial increase free radical generation is to be 
expected during exercise due to a “leak” of electrons in the respiratory chain in 
the mitochondrial inner-membrane. This would occur due to the inadequate 
coupling of the electron transfer between the complexes (Figure 2.3) (Vollaard 
et al., 2005). Despite this theoretical appeal, there is little direct evidence that 
mitochondrial superoxide anion production is increased during exercise. To 
further contradict this theory, there are studies with isometric exercise where the 
oxygen pressure (PO2) in the mitochondria was proven to be low but still 
demonstrated an increase in the oxidative stress (Alessio et al., 2000). Bailey et 
al. (2004), mentioned earlier, also demonstrated that free radical outflow of a 
contracting muscle was associated with decreases in intracellular PO2 rather 
than with conditions of increased oxygen flux. Although there is a lack of direct 
evidence for this mechanism it is unlikely that an increase in mitochondrial 
oxygen flux is the only, or main, cause for increases in radical production during 
exercise (Vollaard et al., 2005).   
 
Figure 2.3. The mitochondrial respiratory chain. Electrons are transferred from complexes I, II 
and III to IV. However, inadequate coupling of electron transfer can cause leakage, generating 
superoxide anions at different complex levels (adapted from Vollaard et al., 2005). 
 
2. Ischemia-reperfusion and activation of endothelial Xanthine oxidase. During 
exercise, blood flow is shunted from many organs and tissues and redirected to 
the working muscles. The ischemic conditions trigger the conversion of the 
enzyme xanthine dehydrogenase to xanthine oxidase. When the exercise ceases 
and the tissues are reoxygenized, xanthine oxidase produces superoxide (O-2) 
and H2O2 as by-products of the degradation of hypoxanthine into xanthine, and 
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Figure 2.4. A suggested mechanism for the production of free radicals upon reoxygenation of 
ischemic or hypoxic tissues (adapted from Halliwell & Gutteridge 2007). 
 
3. Neutrophils and the inflammatory response. When neutrophils are activated, 
they release ROS. Despite the fact that this inflammatory response is critical to 
the removal of damaged proteins and infections, ROS and other oxidants 
released from neutrophils can also cause secondary damage, such as lipid 
peroxidation. It has been shown that exercise can elicit muscle injury 
accompanied by the activation of neutrophils (Ji, 1999). Boyum et al. (2002) 
showed not only an increase in neutrophil number following cycling exercise 
(65 min 75% VO2max), but also an increase in their respiratory burst activity 
measured as chemiluminescence. An increase in neutrophil counts has also been 
described in short duration (less than 20 min) resistance exercise (Ramel et al., 
2004). This reinforces the fact that there is an increase in plasma neutrophils 
even when oxygen consumption is only moderately increased. 
 
4. Auto-oxidation of catecholamines. Adrenaline, noradrenaline and dopamine are 
often referred to collectively as catecholamines. With exercise, there is an 
increase of these substances (Shinkai et al., 1996; Suzuki et al., 1999) The 
oxidation of the catecholamines can produce superoxide anion, H2O2, and other 
non-oxygen-derived species in a complicated series of reactions. This can lead 
to a depletion of cellular glutathione concentrations in the blood (Halliwell & 
Gutteridge, 2007).  
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5. Other factors also regulate exercise-induced oxidative stress, including level of 
fitness, type and intensity of exercise, and dietary antioxidant ingestion.  
 
Despite the need for a better comprehension of how these mechanisms of ROS 
generation interact, the mechanism by which they affect the exercising muscles is well 
established. At rest, the low concentration of ROS in the muscles is critical for force 
generation. During contractile activity there is a rise in ROS production. On one hand, 
production of reactive species during non exhaustive exercise has been shown to be 
important for the adaptation of the muscle fibres (Gomez-Cabrera et al., 2008). 
Nevertheless, during strenuous exercise, the production of ROS can be higher than the 
buffering capacity of the muscles’ antioxidants. As ROS accumulates in the contracting 
muscles the oxidation of proteins and lipids might cause, amongst other things, 
inhibition in force production contributing to the development of acute fatigue (Reid, 
2001). In addition, this exaggerated increase in ROS levels in response to exercise can 
also lead to oxidative DNA modification, damage to cell membrane and other cellular 
compounds (Niess & Simon, 2007). 
 
In order to attenuate the muscle oxidative stress generation and thus improve the 
muscular performance several researchers have analysed the efficacy of dietary 
antioxidant supplementation, these are analysed in the next section. Interestingly it has 
been well documented that training causes an enhancement in the antioxidant enzyme 
activity in various tissues (Kanter, 1998; Wilson & Johnson, 2000; Gomez-Cabrera et 
al., 2007). This is an adaptation process that happens because the free radicals produced 
during muscle contraction act as signaling molecules stimulating the gene expression 
and hence increased production of antioxidant enzymes and modulates other oxidative 
stress protection pathways, such as enhancing the activity of DNA repair enzymes in 
skeletal muscles (Radak et al., 2003; Gomez-Cabrera et al., 2008). This strengthens the 
body’s antioxidant network system which, hence, minimizes the oxidative stress process 
(Gomez-Cabrera et al., 2008). This stimuli associated with enhanced antioxidant 
protection occurs not only in the muscles but systemically, so vital organs such as liver 
and brain also go through this beneficial adjustment (Radak et al., 2008). This 
adaptation process resultant from regular exercise stimulus can be explained by the 
hormesis theory. This theory postulates that chemicals and toxic substances may have a 
low-dose stimulation high-dose inhibitory effect. That means they can provide positive 
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responses when present in small amount (Radak et al., 2005).  In this regard the type 
and duration of the training are the key for a significant up-regulation of the endogenous 
antioxidants with long-duration high-intensity endurance training having been shown to 
be more effective (Powers et al., 1999). Niess et al. (1996) reported that trained 
individuals presented less DNA damage after an exhaustive bout of exercise compared 
to untrained men. Other evidence for this training adaptation was reported by Miyazaki 
et al. (2001), where the free radical production was reduced after 12 weeks of endurance 
training. More specifically, they reported a decrease in the neutrophil superoxide anion 
production and attenuation in the lipid peroxidation process. The contrary is also true as 
sedentarism not only reduces various physiological functions but also decreases the 
body’s oxidative stress protection mechanisms. Consequently there may be an increase 
in the occurrence of oxidative stress associated with diseases such as cancer, 
atherosclerosis, cardiovascular and neurodegenerative diseases (Radak et al., 2008).  
  
2.3.5 Oxidative stress and air pollutants 
Air pollution is a major public health issue in urban areas all over the globe. Air 
pollutants such as ozone, particulate matter and nitrogen dioxide have been shown to be 
associated with an increase and exacerbation of respiratory and cardiovascular diseases 
(Katsouyanni, 2003; Bell et al., 2006). Little is known, however, about their effects as 
oxidant compounds in the lungs or about the role and the effectiveness of respiratory 
tract lining fluid (RTLF) antioxidants in scavenging and protecting against their harmful 
effects. Data have shown that pollutants such as diesel exhaust particles can induce lung 
inflammation through stimulation of the oxidative stress process (Baulig et al., 2002).  
Nevertheless, as has also been confirmed, endogenous antioxidants can attenuate this 
process, particularly if the inhaled pollutant dose is low (Behndig et al., 2006).  
 
A great variety of antioxidants can be found in human respiratory tract lining fluids 
(RTLF) and these can easily be accessed by nasal lavage procedure (Mudway et al., 
1999). The distribution and concentration of these antioxidants throughout the airways 
is not equally distributed, with high levels of GSH in the alveolar epithelial regions and 
uric acid predominating in the upper airways (Penden et al., 1990; Cantin et al., 1987).  
 
Numerous studies have investigated the effects by which the oxidant gas ozone affects 
the human lungs. Nevertheless, the mechanisms responsible for such adverse effects, 
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such as an increase in the airway inflammation and impairment in lung function, are 
only partly understood.  It is known that when O3, or indeed any gas, is inhaled, it first 
comes into contact with the RTLF. In fact, ozone is not able to infiltrate further than the 
RTLF and the membranes of cells from the lung-air interface, yet it is still known to 
cause damage beyond the lungs (Pryor et al., 1995). Once O3 enters in contact with the 
RTLF, it induces a direct oxidative stress, the intensity of which varies depending on 
the O3 inhaled dose and also on the antioxidants present in the lining fluid. It also 
induces an indirect oxidative stress because, even though O3 does not react directly with 
the epithelial cells, these cells do react in response to the oxidation products produced in 
the RTLF. As a consequence they release a variety of pro-inflammatory mediators and 
more ROS (Pryor 1994; Pryor et al., 1995). As a result, if the oxidative stress is 
sufficient there is an activation of an inflammatory response, characterized by an intense 
arrival and activation of neutrophils. These neutrophils produce further ROS through 
the respiratory burst process. Hence, the overproduction of ROS might result in 
oxidative stress in the airway tissues (Corradi et al., 2002). It has been hypothesized that 
the antioxidants present in the epithelial lining fluid of the lungs would neutralize the 
excess production of free radicals and ROS. Thus, it would reduce the ozone induced 




Due to the potential role that ROS and free radicals have in lipid, protein and DNA 
damage, it is not surprising that there are a variety of antioxidant defense mechanisms 
present in the body. In general, antioxidants are often reducing agents that have the 
capacity to react with free radicals and ROS minimizing their reactivity and thus 
decreasing oxidative stress. They can be both synthesized in vivo and absorbed through 
the diet. A great variety of antioxidant defense mechanisms exist endogenously, both 
intracellular and extracellular, working synergistically to minimize the generation of 
free radicals and also to remove ROS (Powers et al., 2004).  
 
Antioxidants can be divided into two groups: enzymatic and non-enzymatic. Enzymatic 
antioxidants include superoxide dismutase (SOD), glutathione peroxidase (GPX) and 
catalase (CAT). Each of these enzymes is responsible for the reduction of a different 
ROS and they are located in different cellular compartments. For example, GPX, 
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located in both the cytosol and the mitochondria of cells, is responsible for the removal 
of organic hydroperoxides and hydrogen peroxides (H2O2); while SOD, present in the 
cytosol of cells catalyses the reaction of superoxide radicals into oxygen and hydrogen 
peroxides (Powers et al., 1999). In the muscles, the activity of these enzymatic 
antioxidants varies depending on the muscle fibre type, with the greatest activity present 
in type I fibres that are the slow twitch fibres with higher oxidative capacity. The non-
enzymatic antioxidant group includes glutathione, vitamin C, vitamin E, carotenoids, 
uric acid and others. A more detailed explanation on the mechanisms of action of the 
specific antioxidants glutathione, vitamin C and vitamin E, will be given in the 
subsequent sections. Similarly to the enzymatic antioxidant, these are present in 
different cellular compartments and elicit distinct antioxidant properties which 
maximize their effectiveness (Powers et al., 2004).  
  
Production of ROS during muscle contraction and specifically exhaustive exercise is 
well established (Sen & Roy, 2001). As a consequence the excess in ROS release can 
inhibit locomotory and bactericidal activity of neutrophils, reduce the proliferation of T-
lymphocytes and B-lymphocytes, and inhibit Natural Killer cells. In addition it can lead 
to a decrease in muscle force and hence premature fatigue (Reid, 2001). It has been 
hypothesized that the increase in the production and release rate of ROS during exercise 
would be neutralized by an increase in antioxidant concentration in the organism. 
Studies that have analyzed the efficacy of antioxidant supplementation have used 
changes in oxidative stress, inflammation and exercise performance as outcome 
measures. There has been, however, a variety of different results making it hard to draw 
definite conclusions about this issue. Unfortunately, there are few studies that have 
investigated the effect of antioxidant supplementation on exercise performance, and the 
ones to date report little evidence of a positive effect on performance. It is important to 
point out that on one hand, even though exercise can increase the production of reactive 
species in the body and thus oxidative stress, on the other hand, when practiced 
systematically it can be considered an antioxidant as explained previously.  
 
2.4.1 Glutathione 
Reduced glutathione (GSH) is a water-soluble low-molecular-weight tripeptide formed 
from the amino acids glutamate, cysteine and glycine. These three amino acids can be 
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obtained from food intake. All types of cells are capable of synthesizing GSH. This 
synthesis process occurs through two sequential reactions and necessitates the action of 
two enzymes: for the first reaction, γ-glutamylcysteine; and GSH sythetases for the 
consecutive reaction (Figure 2.5). Cysteine is the key substrate for the production of 
GSH limiting the production-rate. In addition, the levels of GSH act as a negative 
control for the first reaction, this helps maintain the adequate production (Anderson, 
1998).   
 
Figure 2.5. GSH synthesis illustrated by two reactions. Enzymes that catalyze the reactions are 
γ-glutamylcysteine synthetase and GSH sythetase (Adapted from Wu et al., 2004). 
 
GSH can also be obtained directly from food, but only small amounts of the intact 
tripeptide are absorbed by the gut; most is broken down into amino acids, which are 
then used in the synthesis cycle. Thus, a healthy diet with a balanced protein intake is of 
the essence for an adequate GSH homeostasis in the body (Valencia et al., 2001; Wu et 
al., 2004).  
 
GSH exerts various essential functions in the body. Amongst these functions is the 
detoxifying role that GSH plays when it reacts with xenobiotics and their metabolites. 
GSH also stores the amino acid cysteine which, due to its instability outside the cells, 
easily oxidizes to cystine producing ROS (Lu, 1999). In addition, GSH is essential for 
the production of an adequate immune response: it is necessary for the proliferation of 
lymphocytes, for the production of cytokines and is crucial for the activation of T-
lymphocytes and neutrophils (Wu et al., 2004). Another major function of GSH, which 
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is of particular interest here, is its antioxidant role. It efficiently scavenges ROS and free 
radicals preventing an increase in the oxidative stress process. In these reactions, the 
reduced GSH is oxidized to form glutathione disulfide (GSSG), this reaction is 
catalysed by the enzyme glutathione peroxidise. Note that GSSG is formed by two GSH 
molecules linked via a disulfide bond due to oxidation of the thiol (SH) groups. Once 
oxidised, GSSG can be reduced back to its original GSH form by the enzyme GSSG 
reductase and nicotinamide adenine dinucleotide phosphate (NADPH). Nevertheless, 
when there is a high level of oxidative stress, NADPH becomes depleted and there is an 
intracellular accumulation of GSSG. This excess GSSG can either be exported out of 
the cell or it can form a mixed disulfide. Despite what happens to the oxidized 
glutathione, depletion of cellular GSH can be observed when an intense oxidative stress 
process occurs (Lu, 1999).  
 
As mentioned previously GSH is produced in the cells’ cytoplasm, with the liver being 
the most active organ for its production and delivery. The intracellular concentration of 
GSH ranges from 0.5-10 mmol·l-1, and about 10 to 20% of this GSH is present in cell’s 
mitochondria. Nonetheless, this organelle is not capable of producing this antioxidant 
and has to obtain it from the cytoplasm through transporters in the inner membrane 
(Halliwell & Gutteridge, 2007). The intracellular GSH concentration is quite high, 
especially when compared to the relatively low plasma concentration which varies from 
2-20 umol·l-1. Most of the blood GSH is present in the erythrocytes, which explains the 
low plasma concentration. In addition, the plasma GSH is derived mainly from the liver 
production, this organ is also responsible for most of the GSH that is taken up by the 
kidneys and lungs (Lu, 1999). In fact, the respiratory tract lining fluid has a high 
concentration of reduced GSH, around 300-400 μmol·l-1. It has been shown that, where 
smokers are concerned, these values are greatly increased to protect these individuals 
against the exacerbated oxidative stress levels (Dalle-Donne et al., 2006). Inflammatory 
cells present in the respiratory tract, such as macrophages, lymphocytes and fibroblasts 
are also responsible for the GSH levels in the lung seeing as they release this 
antioxidant (Cantin et al., 1987). 
 
The change in plasma GSH concentration has been linked to a variety of 
pathophysiological conditions including cancers, diabetes mellitus, HIV, cardiovascular 
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diseases and lung inflammatory diseases. Indeed, it has been shown that the GSH levels 
are decreased in the epithelial lining fluid of asthmatics or during an asthma 
exacerbation episode, whereas in chronic smokers the concentration of this antioxidant 
is increased (Dalle-Donne et al., 2006).  
 
Measuring the plasma level of GSH or its oxidized form (GSSG) is a widely accepted 
method of detecting oxidative stress and can be reported as GSH concentration, GSSG 
or GSH/GSSG ratio. It is not only a good indicator of systemic oxidative status, but also 
a useful indicator of disease risk (Rossi et al., 2002). It has been used in various studies 
to indicate the free radical production during exercise (Gohil et al., 1988; Sastre et al., 
1992; Sen et al., 1994; Medved et al., 2003). However, these studies do present some 
divergent results. This could possibly be explained by the difference in subject fitness, 
exercise protocol and method of determining the glutathione concentration.  
 
Gohil et al. (1988) were the first to show that throughout a submaximal exercise, 90 min 
of cycling at 65% VO2 peak, there was a significant increase in blood GSSG and a 
decrease in the reduced GSH form. In the study of Sastre et al. (1992), trained athletes 
performed a bout of running to exhaustion, according to the Bruce protocol. Blood GSH 
and GSSG concentration were measured pre-exercise, immediately post-exercise, 30 
and 60 min within the recovery period. There were no differences in blood GSH 
concentration when pre and immediately post values were compared. However, after 30 
and 60 min of exercise cessation, these values had significantly dropped below pre-
exercise levels. With the oxidized glutathione, the pattern was slightly different: GSSG 
levels had a significant increase after the exhaustive exercise, with the concentration 
returning to pre-exercise levels after 60 min of recovery. Similar GSH and GSSG 
patterns were encountered by Medved et al. (2003) when healthy subjects performed a 
high intensity intermittent exercise to exhaustion. Furthermore, the study of Sen et al. 
(1994) concurs partially with the previous studies. They reported a significant increase 
in blood GSSG concentration following 3 different exercise bouts: a maximal test and 
two submaximal 30 min exercise bouts. In contrast to the previous studies, however, 
there were no changes in the reduced GSH concentration post-exercise. Nevertheless, in 
the latter study, blood samples were taken only pre-exercise, immediately post-exercise 
and 24 h post-exercise. It could be that the change in reduced GSH was not observed 
 37 
due to time of sampling. The increase in blood GSSG concentration reflects an increase 
in the oxidative stress process during the exercise protocols. As for the decrease in 
blood GSH concentration during the recovery period, this can be attributed to a decrease 
in the GSH synthesis which has been shown to occur with adrenergic stimulation 
(Sastre et al., 1992).  
 
2.4.2 Vitamin C  
Vitamin C is a water-soluble vitamin and refers to both ascorbic acid and 
dehydroascorbic acid (DHA). Ascorbic acid is the main form of the vitamin found in 
vivo. This vitamin, also referred to as ascorbate, has clearly been shown to play an 
essential role in connective tissue biosynthesis and its deficiency results in scurvy, a 
disease which leads to the deterioration of collagen production and results in fragile 
blood vessels and impaired lesion healing. This disease is reversible once the individual 
restarts the ingestion of ascorbate. Vitamin C is also a strong reducing agent, due to its 
facility in donating electrons, with important antioxidant properties (Institute of 
Medicine, 2000). It can inactivate a variety of reactive species minimizing damage to 
body tissues.  
 
Ascorbate is found in relatively high levels in different tissues throughout the body. It 
occurs in high concentration in activated neutrophils and macrophages, present 
predominantly in the cells’ cytosol. This vitamin is implicated in a variety of anti-
infective functions, including promotion of T-lymphocyte proliferation, prevention of 
corticosteroid-induced suppression of neutrophil activity, production of interferon, and 
inhibition of virus replication. Vitamin C also occurs in high concentration in the 
adrenal glands and is necessary for the production of several hormones that are secreted 
in relation to stress, such as adrenalin, noradrenalin, and cortisol as previously described 
(Jukendruop & Gleeson, 2004). Furthermore, it is also present in the brain, eye tissue 
and respiratory tract lining fluid providing a high antioxidant defense. This antioxidant 
is also present, in low concentration, in plasma and in saliva (Institute of Medicine, 
2000). 
 
When ingested, vitamin C is absorbed in the intestines either by active transport, if the 
availability of the vitamin is low, or by simple diffusion if present it high 
concentrations. If ingested in excess, it is degraded in the intestines and can cause 
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diarrhea and intestinal discomfort. Besides the absorption and degrading mechanisms 
occurring in the intestines, the kidneys are also responsible for conserving or 
eliminating unmetabolized ascorbic acid to help maintain the body’s ascorbic acid 
balance (Institute of Medicine, 2000). The average limit uptake of vitamin C by the 
body is 200 mg daily. This amount is enough to saturate cells and body fluids and it can 
be achieved with no difficulty by ingesting five serving of fruits and vegetables per day 
(Halliwell & Gutteridge, 2007). It has been shown that, 2 h after supplementation there 
is a significant increase in the ascorbic acid concentration in both the plasma and in the 
nasal lavage fluid. The levels in the nasal lavage represent the ascorbic acid 
concentration present in the respiratory tract lining fluids. The correlation between the 
increases of this antioxidant in both these compartments suggests a permeable and 
efficient communication between them when ascorbic acid is concerned (Schock et al., 
2004). During oxidation reactions, only small amounts of ascorbate are lost because, 
once it is oxidized, it can be reduced back to ascorbic acid by reductants such as 
glutathione, nicotinamide adenine dinucleotide (NADH) and NADPH. Similarly, 
vitamin C is also known to regenerate other antioxidants, such as vitamin E and 
glutathione, back to their reducing state, thus maintaining a balanced network of 
antioxidants (Rietjens et al., 2002).  
 
It has been hypothesized that, by increasing the plasma ascorbate levels, there would be 
a greater availability of this antioxidant to react with ROS and free radicals and 
consequently minimize the oxidative stress process that may occur with exercise 
(Mudway et al., 1999b). Enhancing intrinsic antioxidant defense, by increasing vitamin 
C intake, is therefore theorized to benefit athletes engaged in heavy training and 
competition (Peters, 1997). This issue, however, has generated some conflicting data. 
Nieman et al. (1997) found that 8 days of vitamin C supplementation (1000 mg) had no 
influence on immune parameters after a 2.5 h run (75-80% VO2max). Here blood 
samples were analyzed for cortisol, cathecolamines, and a variety of immune measures 
such as leukocyte subsets, NK-cell activity, neutrophil phagocytosis and activated 
oxidative burst. Similar results were encountered for a 1500 mg·day-1 of vitamin C 
intake on a group of ultramarathon runners (Nieman et al., 2002). No significant 
correlation was found between plasma ascorbic acid levels, immune or oxidative stress 
measures after the race. Importantly, Nieman et al. (2002) controlled for carbohydrate 
ingestion during the ultramarathon. This is an essential process in field studies since it is 
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known that carbohydrate ingestion, throughout an exercise bout, affects stress hormones 
and inflammation markers response after exercise. In these studies, plasma ascorbic acid 
was significantly higher post-race, whether in supplemented or non-supplemented 
athletes. This could represent an up-regulation of several major antioxidant enzymes, in 
spite of its additional intake, and an enhancement of overall antioxidant status during 
periods of greater oxidative stress, minimizing excessive cellular damage (Dekkers et 
al., 1996). This natural increase in plasma vitamin concentration could possibly abolish 
the effect of additional vitamin supplementation, though this needs to be further 
explored. No impact on the athletes’ performance was reported. 
 
Adrenal hormones (cortisol, adrenaline and noradrenaline) possess potent anti-
inflammatory and immunosuppressive properties. During intensive physical exercise, 
there is an increase in the circulating concentration of these hormones (Shinkai et al., 
1996, Suzuki et al., 1999). This has an impact on the magnitude of the post–exercise 
immunodepression (Pedersen & Ullum, 1994). Whether vitamin C affects the response 
of adrenal hormones to exercise is an issue which has raised contradictory discussions. 
Palmer et al. (2003) measured the influence of vitamin C supplementation in relation to 
placebo on oxidative stress markers (F2-isoprostane and lipid hydroperoxides) in 
runners during and following an ultramarathon race. The athletes in the supplemented 
group ingested 1500 mg·day-1 during a 7 day period prior to the race. Vitamin C did not 
show any protective effect on the exercise-induced oxidative stress. Additionally, the 
authors reported that vitamin C had no influence in cortisol increases post-exercise.  
 
The afore mentioned results are in contrast to those of Nieman et al. (2000) and Peters 
et al. (2001) as they support the hypothesis that vitamin C supplementation attenuates 
an exercise induced increase in cortisol levels. In both these studies (Nieman et al., 
2000; Peters et al., 2001), the athletes undertook an ultramarathon race in the same way 
as in the study of Palmer et al. (2003). The supplementation protocols were different, 
though; consisting of 1500 mg·day-1 during a 1-week period for Nieman et al. (2000) 
and 1000 mg·day-1 during a 1-week period for Peters et al. (2001). The cortisol response 
was blunted after the long duration exercise, but there were no differences in the 
inflammatory markers between placebo and the vitamin C supplemented group (Peters 
et al., 2001). In addition, while the pre-exercise levels of plasma vitamin C was 
significantly increased in the supplemented group, post-race there were no alteration 
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in these values, contrary to the placebo group that despite presenting lower  levels  of 
vitamin C pre-exercise presented an increased value after the race. This result suggests 
that there was mobilization of ascorbic acid into the plasma in the placebo group. 
Conflicting findings between the studies can possibly be explained when one takes into 
consideration that subjects were not randomized, that there were different numbers of 
subjects in the treatment groups in the last studies (Peters et al., 2001; Palmer et al., 
2003), and that carbohydrate intake was not controlled for. Although these studies have 
inherent limitations, such as not having used a crossover design, they do have the 
advantage of being field studies.  
 
A more recent vitamin C supplementation study has shown that acute intake of vitamin 
C during a prolonged exercise bout (2.5 h of cycling at 60% VO2max) did not alter the 
plasma levels of IL-6 or cortisol post-exercise in moderately trained males (Davison & 
Gleeson, 2005). The lack of changes in this study could be explained by the 
supplementation protocol used. As vitamin C was given to the participants only during 
the exercise period, there might have been a lack of uptake of this antioxidant by the 
leukocytes and muscle tissues. Conversely, in a subsequent study, the same authors 
(Davison & Gleeson, 2006) used a different supplementation protocol and obtained 
slightly different results. The supplementation consisted of daily vitamin C (1000 
mg·day-1) or placebo intake during a 2 week period. The study was carried out with 
trained cyclists using a randomized crossover design with a washout period of at least 
14 days. The athletes performed the same exercise bout as in the previous study. Again 
the authors showed that the antioxidant had no effect on plasma IL-6 or on 
malondialdehyde (marker of lipid peroxidation) levels post-exercise and it did not affect 
the decrease in neutrophil functional capacity. Nonetheless, the supplementation 
resulted in slightly lower leukocytosis, neutrophilia and cortisol responses. This 
suggests that vitamin C might have a direct effect on cortisol synthesis or release. It is 
important to mention that the subjects in this study only presented a modest oxidative 
level post-exercise so it might have been necessary to undergo a more strenuous 
exercise protocol to observe greater benefit of the antioxidant supplementation. It can 
also be suggested that healthy subjects who consume a balanced diet present sufficient 
ascorbic acid in their organism to exert the necessary antioxidant defense so additional 
supplementation would not promote extra benefits. However, it could be speculated that 
the supplementation might be beneficial if the athletes were to experience an increased 
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oxidative stress burden such as with the addition of ozone-pollution.  
 
Even though there has been many studies analyzing the effect of vitamin C on different 
aspects of the immune system and oxidative stress, there is still controversy in the 
results. The different doses and supplementation periods together with the exercise 
protocol and fitness level of the subjects analyzed are the main variables which may 
explain the discrepant results. There has been little recent interest in how this 
antioxidant impacts on the well being and performance of athletes and whether or not it 
has an effect on oxidative stress and immune function. In the 1970s, when the first 
studies analyzing the effect of vitamin C on exercise were conducted, researchers did 
focus on the effect of this vitamin on exercise performance. These studies however, did 
not find any strong evidence of an improved aerobic or anaerobic performance for 
people taking vitamin C supplementation (for review see Urso & Clarkson, 2003). In 
the study of Howard et al. (1975), for instance, athletes were supplemented for a 2-week 
period with both placebo and 1000 mg of vitamin C. The authors investigated the 
impact of the placebo and the antioxidant on the performance of a cycling incremental 
test to exhaustion. They reported that for a given submaximal workload, when subjects 
ingested vitamin C, they presented a lower heart rate. This could mean a more economic 
heart function during exercise and, thus, a better work capacity. Nevertheless, this was 
not translated into a better total work performance with the vitamin C ingestion. The 
mechanism through which vitamin C would exert a positive effect on performance 
remains unclear. It seems, though, that healthy subjects ingesting sufficient vitamin 
through their diets would not gain any further benefits, be it enhancing their immune 
system, antioxidant capacity or performance, with such vitamin supplementation. 
 
Vitamin C is not only associated with immune and oxidative stress parameters, but there 
is also a link between vitamin C and aspects of pulmonary function. In fact, a number of 
epidemiological studies have shown evidence that consuming a diet rich in fruits and 
vegetables results in a reduced risk of COPD and have a beneficial effect against asthma 
in adults (Romieu et al., 2006; Varraso et al., 2007a; Varraso et al., 2007b). Even 
though studies do report a positive effect of such a diet, there is some inconsistency, 
especially in regard to vitamin C, that seems to have a greater effect on lung function 
than on respiratory symptoms (Romieu et al., 2006). Studies analysing the effect of 
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vitamin C supplementation on asthmatic subjects have provided different results. 
Fogarty et al. (2003) studied the effect of a 16 week supplementation period of vitamin 
C (1000 mg·day-1) on a cohort of over 200 patients with asthma. The authors reported 
no correlation between the antioxidant and asthma in these patients. Yet, contrary to 
those findings, a recent study by Tecklenburg et al. (2007) reported a positive effect of 
vitamin C supplementation on exercise-induced bronchoconstriction in asthmatic 
individuals. The authors investigated the impact that a diet supplemented with vitamin 
C had not only on pulmonary function, but also on various biological markers of airway 
inflammation in asthmatic subjects after an exercise bout to exhaustion. This study had 
a double-blind, randomized crossover design and 8 subjects took part in it. All subjects 
had mild to moderate asthma and also exercise induced bronchoconstriction (EIB), 
characterized by a 10% decrease in FEV1 after an exercise bout (Rundell & Jenkinson, 
2002). The supplementation consisted of 3 x 500 mg·day-1 of vitamin C during a 2-
week period. There was also a 1 week washout period before they were assigned to the 
alternate treatment/placebo period. The authors reported an improvement in the post-
exercise pulmonary function and reduced severity of EIB when subjects ingested 
vitamin C. They also reported a decrease in the severity of respiratory symptoms post-
exercise and a decrease in the airway inflammation markers. It is important to point out 
that the airway inflammation markers assessed in this study were obtained from urine. It 
is difficult to directly compare these 2 studies, because of the added exercise variable. 
Nevertheless, other studies investigating the effect of vitamin C on lung function seem 
to concur with the later study (Smit et al., 1999). Thus, it seems reasonable to suggest 
that vitamin C does have a positive impact on lung function and provides some 
protection against airway inflammation and airway narrowing in asthmatic subjects after 
exercising.  
 
2.4.3 Vitamin E  
Vitamin E, also referred to as α-tocopherol, is a lipid-soluble vitamin. There are a 
variety of vitamin E molecules that differ in structure. The various forms of this vitamin 
differ significantly in their metabolic functions and bioavailability. In humans, over 
90% of vitamin E encountered in the body is α-tocopherol. However, not all the α-
tocopherol forms are maintained in the plasma. The α-tocopherol, that is encountered 
naturally in food together with synthetic forms of the α-tocopherol (the isomeres RRR-, 
RSR-, RRS-, and RSS- α-tocopherol), can be maintained in the human plasma and 
 43 
tissues. When ingesting α-tocopherol supplements, the RRR- α-tocopherol form is 
preferable (Lodge et al., 2000; Institute of Medicine, 2000).   
 
This vitamin has been shown to have beneficial effects in some diseases, it has also 
been associated with a decreased risk in cardiovascular disease, and it can help slow the 
progress of degenerative diseases such as atherosclerosis. In addition, α-tocopherol 
deficiency, in patients that present impairment in intestinal fat absorption, has been 
associated with neuronal degeneration (Cerqueira et al., 2007). Nevertheless, a recent 
review study (Bjelakovic et al., 2007), which thoroughly analyzes over 47 antioxidant 
supplementation research papers on all-cause mortality, has unexpectedly shown the 
negative effect of some supplements. Vitamin E, for example was one of the 
antioxidants that was associated with an increase in mortality. Vitamin C, on the other 
hand, did not have such an effect, but there was also no evidence that it might increase 
longevity. It is difficult to determine the specific biochemical and physiological 
mechanisms that may have led to this result. More investigation is, therefore, necessary 
to answer questions that such research generates. In addition, these results concerning 
synthetic antioxidants should not be transferred to effects that fruit and vegetables have 
on human health.  
 
Similarly to vitamin C, vitamin E has important antioxidant properties. Due to its 
capacity for scavenging ROS and free radicals, particularly peroxyl radical (ROO•), it 
exerts the important function of protecting cellular membranes and plasma lipoproteins 
against lipid peroxidation. This is possible because vitamin E has a great affinity for 
reducing peroxyl radicals, preventing their interaction with the membrane phospholipids 
or lipoproteins (Institute of Medicine, 2000). Indeed, vitamin E can be considered one 
of the major inhibitors of lipid peroxidation in vivo (Halliwell & Gutteridge, 2007). 
Once oxidized, it can be regenerated back to its reduced state by vitamin C, as 
mentioned previously. Nevertheless, it has been shown that increased levels of α-
tocopherol radicals that are not converted back to the reduced form can act as pro-
oxidants, initiating oxidative stress processes by themselves. In addition, an 
environment that lacks other antioxidants or that has a high level of oxidative stress will 
contribute for vitamin E to act as a pro-oxidant (Rietjens et al., 2002).  
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Once ingested, vitamin E is absorbed from the intestinal lumen via chylomicrons, 
however it has been shown that depending on the availability of fatty acids, vitamin E 
can also be incorporated and transported by high-density lipoprotein (HDL) (Rigotti, 
2007). These structures are taken up by the liver, which is the main storage site of 
tocopherols. In the liver, specifically the α-tocopherol form will be incorporated 
selectively into the very low-density lipoproteins (VLDL) secreted into the blood. 
Tissues acquire α-tocopherol and other tocopherol forms from the lipoproteins present 
in the circulation. Indeed plasma α-tocopherol levels are highly correlated to plasma 
lipid levels as lipoproteins are the major transporters of vitamin E (Institute of 
Medicine, 2000; Rigotti, 2007). Moreover, the amount of supplemented vitamin E that 
is actually absorbed is dependent not only on the fat content of the meal that the 
supplement is taken with, but also the type of food that is ingested. For example, in a 
randomized crossover study subjects ingested 200 IU of vitamin E supplementation 
with different types of food. The labeled plasma α-tocopherol concentration was higher 
when ingested with meals that had a greater fat percentage. Surprisingly, when subjects 
ingested toast with butter they presented a higher labeled plasma α-tocopherol 
concentration compared to when they ingested cereal with full fat milk, even though 
these two meals were matched for total fat content (Lodge et al., 2004). A potential 
explanation for this is that foods have different effects on gastric emptying, therefore 
also influencing absorption.  
 
As mentioned at the start of this section, vitamin E has been found to protect cellular 
membranes from lipid peroxidation. Hence, it is logical to assume that this vitamin 
could protect the muscle cells against exercise-induced damage. Early studies analyzing 
the effects of vitamin E supplementation and exercise investigated its effect on 
performance. Most of the studies, however, reported no benefit of vitamin E whether for 
muscle strength or for endurance performance (Urso & Clarkson, 2003). Furthermore, it 
has been hypothesized that vitamin E supplementation could have a protective effect 
against the contraction-induced muscle damage oxidative stress that may occur after an 
intense exercise bout. This rationale is based on the knowledge that this vitamin can 
stabilize muscle membranes by interacting with its phospholipids which would, thus, 
provide some protection against the increase in oxidative stress or muscle damage 
observed after certain types of exercise (Urso & Clarkson, 2003). Yet results of the 
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various studies have been quite contradictory (Jackson et al., 2004). 
  
In a study by Nieman et al. (2004), athletes were divided into 2 groups: one taking a 
daily supplementation of 800 IU α-tocopherol, the other taking placebo during a 2 
month period prior to an Ironman competition (Triathlon World Championship in Kona, 
Hawaii). Plasma α-tocopherol levels were significantly higher before the race, and this 
difference was maintained post-race. There was no significant difference in the 
performance time between the 2 groups.  Nevertheless, unexpectedly, the plasma levels 
of IL-6, IL-8 and F2-isoprostanes increased significantly after the race in the 
supplemented compared with the placebo group. This surprising result may have 
occurred due to the dualist behavior that vitamin E can have. As explained previously, 
when there is an antioxidant balance in the body, vitamin E would have an effective 
antioxidant action. If, however, there is high quantity of this vitamin especially under 
conditions of high oxidative stress and low levels of other antioxidants, the increase in 
α-tocopherol radicals would result in a pro-oxidant effect (Rietjens et al., 2002). In fact, 
in this study, the amount of vitamin E given to the athletes does greatly exceed the 
recommended daily allowances (RDA) of 30 IU (Institute of Medicine, 2000). 
Moreover, the plasma α-tocopherol levels were positively correlated with the IL-6 
concentration post-race, but that was not correlated to the athletes’ performance. 
 
It has also been suggested that a high vitamin E intake would reduce the incidence of 
asthma, by decreasing the oxidative stress and consequently the epithelial cell injury 
that exacerbates the asthma process. The study of Pearson et al. (2004), however, has 
shown no such association. In this study, 72 individuals with mild to moderate asthma 
were randomly assigned to either a placebo or a vitamin E supplemented group. The 
supplementation had a 6 week duration period with the participants having a daily 
ingestion of 500 mg of vitamin E. Although, there was an increase in the plasma levels 
of vitamin E in the supplemented group, no effect on bronchial reactivity or other 
asthma aspects were observed. The authors suggested that, to see any improvements in 
such a group, the ingestion of a combination of antioxidants and not just an isolated one 
might be necessary. 
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2.4.4 Supplementation with antioxidant combinations 
In the last section, the potential pro-oxidant toxicity of vitamin E has been briefly 
reviewed. This pro-oxidant toxicity also occurs with other antioxidants, such as vitamin 
C, carotenoids and flavonoids (Rietjens et al., 2002). With respect to vitamin C, in 
addition to its scavenging properties, it has been shown to play an important role in 
reducing the vitamin E radical back to its original state. Through this process, however, 
vitamin C is oxidized to a vitamin C radical (semiascorbyl). One way to recycle 
semiascorbyl back to its original vitamin C form is via interaction with other 
antioxidants, such as glutathione (Powers et al., 2004). Moreover, when vitamin C is 
found in high concentrations together with the presence of transitional metals (Fe3+ or 
Cu2+) it reduces these metals, transforming them into potent catalysts in the production 
of free radicals (Powers et al. 2004). All together, these facts clearly indicate the need 
for a balanced antioxidant network in order to maximize the benefits and reduce 
potential toxic effects of the antioxidants. Taking this into consideration, many studies 
have investigated the effects of a combined antioxidant supplementation protocol on 
different post-exercise variables. 
  
In Petersen et al. (2001), subjects were divided into a supplemented (500 mg vitamin C 
+ 600 IU of vitamin E daily for 2 weeks) and a placebo group. The exercise protocol 
consisted of a 5% downhill treadmill run for 1.5 h, the workload corresponding to 75% 
of VO2max. No group differences were measured for exercise-induced changes in 
cytokine and lymphocyte subsets. The authors concluded that exercise induced 
inflammatory responses are not induced by free radicals. However, in this study, the 
authors did not report any oxidative stress measurements. The study of Mastaloudis et 
al. (2006) investigated the effect of antioxidant supplementation (vitamins E and C) on 
exercise-induced muscle damage and recovery rate from a muscle-damaging exercise 
bout. There were 2 groups: supplemented and placebo. The former received a 6-week 
supplementation period (450 IU vitamin E + 1000 mg vitamin C) before taking part in 
an ultramarathon competition. No statistically significant differences between the 
supplemented and placebo group were reported in the time to complete the race. In 
addition, the antioxidant supplementation protocol elicited no difference on exercise-
induced muscle damage or recovery.    
 
In an attempt to specifically investigate the antioxidant supplementation effect on 
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oxidative stress caused by an eccentric exercise bout, Goldfarb et al. (2005) had 
participants randomly assigned to either a placebo or a supplemented group (400 IU 
vitamin E + 1000 mg vitamin C + 90 ug of selenium daily for 2 weeks). The exercise 
protocol consisted of a total of 4 sets of 12 repetition of eccentric arm exercise, and 
blood samples were collected up to 48 h post-exercise to analyze protein, lipid and 
glutathione oxidation after the eccentric exercise. The antioxidant supplemented group 
did present a smaller increase in the blood protein oxidation and MDA following the 
exercise bout. Nevertheless, no effect could be observed for the blood glutathione 
levels. It is possible to conclude that a combined antioxidant therapy was effective in 
minimizing the oxidative stress elicited by a bout of eccentric arm exercise in non-
trained subjects (Goldfarb et al., 2005). Yet it is with caution that these results should 
be extended to other population performing different types of exercise.  
 
Davison et al. (2007) showed that a 4-week period of combined antioxidant 
supplementation (1000 mg vitamin C + 400 IU vitamin E daily) might blunt the cortisol 
responses to a 2.5 h of cycling at an intensity of about 60% of VO2max. This result was 
similar to their previous study, which was mentioned earlier (Davison and Gleeson 
2006). Nevertheless, this study used an antioxidant combination instead of just vitamin 
C supplementation. The supplementation protocol was also different between studies. 
Contrary to the previous study, however, no leukocytosis or neutrophilia was observed 
after exercise in the supplemented group. Both studies reported similarly that the 
reduction in cortisol levels post-exercise occurred in spite of any changes in plasma 
oxidative stress markers, IL-6 concentration and neutrophil function when compared to 
the non-supplemented group. The authors concluded that even though further 
investigation is required in this field, it seems that daily supplementation of a high 
antioxidant dose does not provide any practical benefit.  
 
There are also studies that have restricted the participants’ dietary antioxidants intake. 
Watson et al. (2005) investigated the effect of a dietary antioxidant restriction on 
exercise performance, antioxidant defenses and oxidative stress of athletes. The exercise 
protocol consisted firstly of a 30 min run at a submaximal speed corresponding to 60% 
of their VO2max, followed immediately by a running incremental test to exhaustion. The 
results showed that at rest there was no difference in plasma F2-isoprostane levels when 
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participants restricted their antioxidant intake. This indicates that the body’s antioxidant 
reserve was still capable of protecting against resting production of reactive species. 
However, in response to the exercise bout, the F2-isoprostane levels in the restricted diet 
group increased significantly when compared to the group which maintained normal 
antioxidant intake even though there was no difference in the exercise time to 
exhaustion. As for the plasma antioxidant concentrations, they did not differ between 
the groups. The authors concluded that for athletes participating in acute high intensity 
exercise with up to 40 min duration, there would be no reason to recommend 
antioxidant supplements because the amount obtained from their diet would suffice to 
protect them. All in all, these studies present mixed results on the effectiveness of 
antioxidant supplementation in decreasing exercise-induced oxidative stress. It is 
important however, to keep in mind that the different training status of the participants, 
the exercise performed, and the supplementation protocol all have a great influence on 
the outcome of the studies. 
 
2.4.5 Air pollution, exercise and antioxidant supplementation 
Air pollutants, and especially ozone, can cause oxidative stress and trigger 
inflammatory response in the lungs, as has been well documented and discussed in 
previous sections. Thus, it has been proposed that an increase in the antioxidant intake 
which consequently increases the availability of antioxidant defenses in the respiratory-
tract lining fluid might provide protection against the adverse effects of ozone pollution.  
 
Antioxidant supplementation has been proposed to be beneficial for people exercising in 
an ozone-polluted environment. The rationale behind such hypothesis is that increasing 
the availability of antioxidants in the respiratory-tract lining fluid will provide 
additional sacrificial substrates for ozone which will in turn decrease oxidation reactions 
occurring within this fluid and the underlining epithelial cells. As a result, its toxicity 
would be decreased limiting the inflammation response of the cells from the epithelium 
tract (Kelly, 2004). Indeed, some studies have shown a small protective effect on lung 
function when subjects are supplemented with a mix of antioxidants (Grievink et al., 
1998, Grievink et al., 1999; Romieu et al., 1998; Samet et al., 2001). Nevertheless, the 
results have not been shown to prevent the increase in inflammatory markers (Samet et 
al., 2001; Mudway et al., 2006). Moreover, there is limited information about the 
effects of antioxidant supplementation and performance in a polluted environment and 
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pollution combined with heat and humidity.  
  
2.4.6 Antioxidant combination, asthma and ozone 
It has been suggested that the ingestion of combined antioxidants might indeed 
attenuate the severity of asthma. A study that analyzed the effect of antioxidants 
supplementation by asthmatics together with their exposure to ozone has shown a 
protective effect (Trenga et al., 2001). The supplementation consisted of a 4-week 
period of daily ingestion of vitamin C (500 mg) and vitamin E (400 IU). The 
participants were exposed to 0.12 ppm of O3 during 45 min while taking part in 
intermittent exercise. The degree of ozone induced bronchial hyperresponsiveness was 
measured through SO2 challenge after the exposure protocol. The group that received 
supplementation showed a decrease in the bronchial hyperresponsiveness. It is 
important to note that the protective effect of the vitamin mixture was more pronounced 
among participants that had more severe asthma and that showed a higher sensitivity to 
SO2. Still in respect to asthmatic individuals, there have been other studies which 
support a beneficial effect of vitamin supplementation. Sienra-Monge et al. (2004) 
observed that asthmatic children, with low intake of vitamin E, supplemented with a 
combination of vitamin E and C presented a decrease in nasal lavage inflammatory 
mediators (IL-6 and IL-8). These children lived in Mexico City and, therefore, were 
constantly exposed to air pollution. 
 
Even though there is still controversy in the literature, it has been better established that 
asthmatics or non-asthmatic individuals exercising in a polluted environment will have 
more beneficial results from the antioxidant supplementation (Grievink et al., 1998, 
Grievink et al., 1999; Samet et al., 2001; Trenga et al., 2001) than exercising in a non-
polluted environment (Peters et al., 2001; Nieman et al., 2002; Palmer et al., 2003). A 
possible explanation for this fact is that, as mentioned previously, exercise training can 
be considered an antioxidant. So if an athlete already has an antioxidant system that 
balances the oxidative process that occurs during exercise, there will not be any positive 
effects of extra antioxidants intake. Still, if the same athlete were to exercise in a 
polluted environment, they would have, in addition to the reactive species produced 
during exercise, more reactive species production stimulated by inhaling the polluted 
air. In this case, it would be beneficial to increase the availability of antioxidants 
through supplementation. In addition, the antioxidant supplementation is more efficient 
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in protecting against oxidative stress if it consists of a mixture of antioxidants. Finally, 
more investigation is required to analyze how an antioxidant supplementation might 
benefit athletic performance in a polluted environment.  
 
2.5 SUMMARY  
 
The literature review suggests that an individuals’ health is deteriorated with exposure 
to air pollution. Taking into consideration that the levels of ozone-pollution rises with 
increase in temperature, it is possible that over the next decades we will see an increase 
in this pollutant due to the prediction of global warming. This oxidant gas has been 
shown to decrease lung function and lead to lung inflammation and oxidative stress. 
Athletes and active individuals who exercise outdoors would be quite a susceptible 
population to this pollutant because of the increased dose inhaled when performing 
exercise. Some people have been shown to be more sensitive to ozone, resulting in 
exacerbated symptoms. It has been suggested that adding heat to the ozone exposure 
further impairs lung function, performance and increases respiratory symptoms, but 
how the combined stressors would affect lung inflammation and oxidative stress has not 
yet been investigated.  
 
The mechanism responsible for the adverse effect of ozone in the lungs, which might 
possibly also lead to a systemic outcome, would be its oxidative reaction with 
molecules and cells present in the airways. The presence of a network of antioxidant in 
the respiratory tract lining fluid helps to balance out the oxidation reactions of ozone 
and thus, diminishing the oxidative stress. This fact leads to the hypothesis that 
supplementing an individual with antioxidants might enhance the concentrations of 
sacrificial molecules in the lungs which would provide a further protection for the 
adverse effects of ozone pollution. Nevertheless, there is little evidence to fully back up 
this theory. One of the reasons for that is because most of the studies in the literature 
have investigated the effects of vitamin supplementation on performance and 
inflammation of exercising individuals without the addition of ozone-pollution; and, 
because of the diversity in the methodology used those studies yielded rather 
inconsistent results.  
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All in all, there is a lack of literature investigating the effects of ozone pollution and 
heat on athletes’ health and performance. In addition, there is also limited evidence on 
methods to counteract the adverse effects. As stated in Chapter 1 the main aim of this 
thesis was to specifically address that question and be able to provide data that can add 
to the current body of knowledge in this area that is still quite novel in the Sport Science 
realm. Furthermore, it is hoped that this thesis provide some practical insight in 
improving and maintaining the immune health of athletes and the general population 
exposed to air pollution. The specific aims of the data chapters comprised in this thesis 
were as follows:  
 
Chapter 4: To investigate how four different environmental conditions (Control; 
Control + ozone; Heat and humidity; Heat, humidity and ozone), set to resemble that of 
large urbanized centres, affect lung function, performance and respiratory symptoms of 
well-trained male runners taking part in an 8 km time-trial run. 
 
Chapter 5: To examine how four different environmental conditions (Control; Control + 
ozone; Heat and humidity; Heat, humidity and ozone) affects lung inflammation, lung 
injury and oxidative stress after well-trained runners performed an 8 km time-trial run. 
The aim of the second study presented in this chapter was to assess the reliability of the 
nasal lavage method to assess the upper respiratory tract. 
 
Chapter 6: To examine if a 2-week supplementation period with the antioxidants 
vitamin C and E would have an impact on performance, oxidative stress and respiratory 
symptoms of well-trained runners when taking part in an 8 km time-trial run in a hot, 
humid and ozone-polluted environment.  
 
Chapter 7: To investigate the impact of a 2-week supplementation period with vitamin 
C and E on the immunoendocrine response, lung injury and lung inflammation of well-



















This chapter is divided into five main sections that describe the general methodology 
used in the studies. Specific methods and participants’ characterization is elucidated in 
detail in the appropriate chapter. Section 3.2 describes the criteria for recruitment of the 
participants. Section 3.3 details the exercise protocols and the variables accessed during 
the trials. Section 3.4 outlines the biochemical assays used for analyses of the 
participants’ plasma and nasal lavage fluid. The statistical analysis is described in 
section 3.5. All chemicals and reagents used were purchased from Sigma-Aldrich, 
Dorset - UK, unless stated otherwise. 
 
3.2 RECRUITMENT CRITERIA FOR PARTICIPANTS 
 
The same criteria for recruiting participants was used for the two main studies 
comprised within this thesis. This included selecting participants that were healthy, well 
trained male runners of a decent competitive standard; this was assured by recruiting 
participants that achieved a minimum of 60 mlO2·kg-1·min-1 on a max2OV test. This test 
was undertaken during the familiarization trial (see below). The participants were asked 
to complete a general medical history questionnaire, a specific medical questionnaire 
and a physical activity questionnaire where they described their weekly training levels 
(see Appendices I, II and III for these). For the reliability study described in Chapter 5, 
the volunteers had to be non-smoking, healthy and physically active individuals. All 
participants received a document with information about the study, the benefits and 
possible risks and discomforts they might experience when taking part in the 
experimental protocols. In addition, they were fully aware about their right to withdraw 
from the study at any time without need to justify their reasons to the investigator. All 
participants signed an informed consent form. Ethical approval was obtained from 
Edinburgh Napier University, Faculty of Health, Life and Social Sciences ethics 
committee and the study was conducted in accordance with the Declaration of Helsinki. 
 
3.2.1 Preliminary Measurements 
All participants, prior to the data collection, were required to go through a 
familiarization trial where they performed a max2OV test (Simpson et al., 2006) on a 
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treadmill (Woodway, ergo ELG 55, Germany), practiced the lung function test and also 
the nasal lavage procedure.  The max2OV test was initiated with the participant running at 
a speed of 10 km·h-1 and 0% gradient. The speed of the treadmill was increased by 3 
km·h-1 every 3 min until achieving a maximum speed of 16 km·h-1. After running 3min, 
at this speed, the gradient of the treadmill increased 2.5% every minute until the runner 
reached volitional fatigue. During this test, the participant’s oxygen uptake ( 2OV ) was 
measured using online gas analysis (CPX MedGraphics, Oldham, UK). The runner had 
previously been fitted with a face-mask which was connected to the gas analyser by a 
sample line. In addition to the 2OV  being measured, the carbon dioxide production 
( 2COV ), the respiratory exchange ratio (RER) and the ventilation rate (VE) were also 
measured. The criteria used to establish that the runners had reached their max2OV  was 
the following: heart rate was approximately 220 beats·min-1 minus the runner’s age; 
RER value was greater than 1.10; and VO2 had reached a plateau (Withers et al., 2000). 
During the familiarisation trial the participants practiced the lung function test and 
became accustomed to the nasal lavage procedure. Prior to the preliminary 
measurements, all equipments were carefully calibrated 
  
3.3 EXERCISE PROTOCOL 
 
All participants were asked to refrain from any intense physical activity for 24 h prior to 
the trial. On the day of the test they were required to drink 500 ml of water 2 hours 
before arriving at the lab to standardize their hydration state and guarantee that they 
would initiate the exercise hydrated. In addition, the participants completed a daily 
health questionnaire (Appendix IV) to ensure they did not present any cold or flu 
symptoms and that they were in good health to partake in the exercise. They also signed 
a blood donation form (Appendix V). The exercise consisted of an 8 km time trial run 
on a treadmill (Woodway, PPS 55 Med, Germany), which the participants were required 
to complete as fast as they could. As an incentive for the athletes to perform maximally, 
a cash prize was offered for the participant who completed the trials in the shortest 
amount of time. The exercise trials were performed in an environmental chamber 
(Weis-Gallenkamp, UK) where the temperature and humidity could be programmed and 
controlled. The ozone was generated with a silent generator (Ozone Tech Systems 
ACT5000) and the concentration in the chamber was continuously monitored by a 
second device (ATNI Satellite R, Germany) to ensure that the concentration was at the 
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required level.  
 
Once the exercise protocol commenced, subjective ratings of perceived exertion – RPE 
– on a scale of 6-20 (Borg, 1998) and heart rate (Polar Electro, Finland) were recorded 
at the end of each kilometre ran. In addition, the athletes’ running speed was recorded 
every 500 metres – the participants had control of the speed they were running at, 
however, they did not have access to the value of the speed nor to the total time they 
took to complete each trial. In addition, a 30 second air sample was collected, at the 7.5 
km, in a Douglas Bag (Douglas Bags 100 L, Cranlea, England) to analyze the athletes’ 
minute ventilation and to calculate the O3 effective dose. For safety reasons, core 
temperature was measured throughout the trials using a rectal probe (Grant, Cambridge, 
England).  
 
3.3.1 Assessment of Respiratory Symptoms 
The severity of respiratory symptoms was assessed by a written questionnaire 
(Schelegle & Adams, 1986) after the athletes completed the exercise protocol. The 
symptoms comprised shortness of breath, cough, excess sputum, throat tickle, raspy 
throat, wheezing, congestion, pain on deep inspiration, headache, nausea and eye 
irritation. In addition, the participants also answered if they thought they would be able 
to compete maximally in a competition if it took part in such an environment (see 
appendix VI).  
 
3.3.2 Lung Function Tests  
All participants received the same verbal instructions each time they performed the lung 
function test. In a standing position the participants would inhale filling their lungs 
maximally and would then blow into the mouthpiece of the spirometer (Compact II: 
Type C, Vitalograph Ltd., UK) as hard and as long as they could until all air was 
expired. Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), 
forced expiratory flow in the middle half of an expiration (FEF25-75) and peak expiratory 
flow (PEF) were measured. The participants performed the test three times and the best 
values were recorded. 
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3.3.3 Blood Sample Collection and Plasma Separation 
Samples of whole blood were collected in 6ml vacuum tubes containing EDTA or 
Sodium heparin as anticoagulant (Becton-Dickinson, Oxford, UK). Whole blood was 
collected from anticubital vein by venepuncture. The tubes were centrifuged for 10 min 
at 1000g at room temperature (Mistral 2000R, Sanyo, Leicester, UK). The plasma was 
removed, aliquoted into eppendorfs and immediately stored at -80°C until further 
analysis. 
 
3.3.4 Nasal Lavage Procedure 
The nasal lavage (NL) procedure was collected according to methods described by 
(Keman et al., 1998). This method consists of having the participants seated with their 
head tilted backwards during all nasal lavage collection. All participants were instructed 
in the same way each time they went through this procedure. They were asked to elevate 
the palate to close the nasopharynx, 4 ml of sterile pre-warmed (37°C) saline was then 
inserted into one nostril with a 10ml sterile pipette. After 10 seconds, the participant 
would put his head forward and expire the lavage into a 15ml centrifuge tube via a 
polyamide gauze-filtered funnel (100 meshes) to separate the mucus. This procedure 
was repeated with the other nostril. The tube was immediately placed on ice and the 
total volume collected was recorded. The tube was centrifuged for 10 min at 600g 
(Mistral 2000R, Sanyo, Leicester, UK) at a temperature of 4°C. The supernatant was 
aliquoted into eppendorfs (400µl) and immediately stored at -80°C until further 
analysis.  
 
The remaining cell pallet (200µl) was re-suspended with 100µl of saline. In an 
eppendorf tube, 25µl of the nasal lavage suspension was mixed with 10µl of trypan 
blue. From this mixture 20µl was placed into a Neubauer haemocytometer (Assistant, 
Germany) and the cell count was performed immediately with the microscope set with 
the x10 lens. On each side of the haemocytometer, four 1 mm2 squares were counted 
and then averaged. The amount found was multiplied by 1 x 104 to determine the 
number of cells per ml. From the remaining re-suspended volume, 150µl was used for 
the cytospin (Cytospin3, Shandon, England), 1000 rpm for 5 min. After this procedure, 
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the slide was left to dry and then stained with Romanowsky stain (Raymond A. Lamb, 
London, UK). The cells were counted and differentiated according to their 
morphological appearance. This procedure was conducted in a blinded manner to 
eliminate the possibility of examiner bias.  The nasal lavage sampling technique and the 
processing of the samples were performed in a consistent and tightly regulated manner 
to ensure reliability of the results. 
 
3.4 BIOCHEMICAL ASSAYS 
 
3.4.1 Inflammatory Markers 
3.4.1.1 IL-6 and IL-8  
Nasal lavage pro-inflammatory cytokines, IL-6 and IL-8, were measured using 
commercially available enzyme linked immunoabsorbent assay (ELISA) kits (R&D, 
Abigdon, UK) in accordance with the manufacturer’s instructions. The nasal lavage 
supernatant samples were thawed to room temperature before initiating the experiment. 
In brief, 96-microwell plates were coated with the specific capture antibody (100μl in 
PBS), sealed and left overnight at room temperature. The following morning, after the 
plates were washed twice using the washing buffer, they were coated with the blocking 
buffer (0.5% BSA, in PBS). The plates were then placed on a microplate shaker for 2 
hours. Following this period, the plates were washed again; standards and samples were 
added to the microwells in duplicate. For IL-6 the standard concentrations varied from 
1000 to 15.12 pg·ml-1, while for IL-8 they varied from 400 to 6.25 pg·ml-1. Once more, 
the plates were placed on a microplate shaker for 2 hours after which they were washed 
three times. Then, the detection antibody was added to the microwells (100μl in 
standard diluent), and the plates were left for another 2 h-period on the microplate 
shaker. Following this incubation, the plates were washed (x4) and streptavidin-HRP (in 
standard diluent) was added to each microwell. The plates were then incubated in the 
dark for 20 minutes, following that, they were washed four times again. Finally, 100 μl 
of substrate solution was added and another 20 min incubation period in the dark was 
necessary for the colourimetric reaction. The reaction was terminated by the addition of 
50 μl of 1M sulphuric acid to each well. Within 30 minutes, the plates were read on a 
plate reader (Dynex Magellan Bioscience MRX Revelation, West Sussex, UK) at a 
wave length of 450 nm. The standard curve was obtained on a log-log fitted line plot 
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against absorbance. The cytokine concentrations of each sample were obtained from the 
standard curve.  
 
3.4.1.2 Clara Cell Protein 
Nasal lavage and plasma CC16 were measured using an ELISA kit (DiaMed EuroGen, 
Turnhout, Belgium) in accordance with the manufacturer’s instructions. The nasal 
lavage and plasma samples were thawed to room temperature before initiating the 
experiment. Due to the high concentration of this protein in the nasal lavage samples, 
these were diluted 1in100, while plasma samples were diluted 1in 20 with the Sample 
Diluent. Standards (5 ng·ml-1 – 0.1 ng·ml-1) and diluted samples (125µl) were pipetted 
in duplicate in the 96 microwell plate provided by the manufacturer. The plates were 
then incubated in a moist atmosphere for 2 h at 37°C. After this, the plates were washed 
5 times, before adding 125µl of Biotin-anti-CC16 Conjugate. The plates were incubated 
again, in a moist atmosphere, for 1 h at 37°C. The washing process was repeated and 
125µl of Streptavidin-HRP Conjugate was added. Once more the plates were incubated 
in a moist atmosphere, at 37°C, this time for a 20 min period, after which the washing 
process was repeated. Chromogen Solution (100µl) was then added before incubating it 
at room temperature for 20 min. Following this, 50µl of Stopping solution was added to 
each microwell and the absorbance read with a 450 nm wavelength (Dynex MRX II, 
West Sussex, UK). The standard curve was obtained on a log/linear fitted line plot 
against absorbance. The CC16 concentrations of each sample were obtained from the 
standard curve and the average value of the duplicate used.  
 
3.4.2 Oxidative stress markers 
 
3.4.2.1 GSH/Protein  
The method used to assess the nasal lavage and plasma GSH was adapted from Hissin 
and Hilf (1976) and is described as follows: after samples had been thawed, 250μl of 
each sample was placed into an eppendorf and 500μl of the Extraction buffer (9mM 
tetra sodium EDTA in 14% perchloric acid, PBS was added just prior to use, pH 7.4) 
was added. Samples were left for 15min on ice and then centrifuged at 5000rpm for 
5min at 4ºC (Mistral 2000R, Sanyo, Leicester, UK). The supernatant was transferred to 
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flow falcon tubes and 500μl of Neutralisation buffer (1M potassium hydroxide and 1M 
potassium bicarbonate in distilled water) was added before centrifugation at 5000rpm 
for 5min at 4ºC. The supernatant was separated and 10μl of each sample was added in 
duplicate in a 96 microwell plate. GSH standards were made up using GSH buffer (1M 
sodium dehydrogen orthophosphate and 0.005M tetra sodium EDTA in distilled water, 
pH 8). For the plasma assay, the standard curve varied from GSH 50μM to 3.125μM; 
whereas, for the nasal lavage assay, the standard curve varied from GSH 12.5μM to 
0.7813μM. GSH buffer (180μl) was added into each well as was 10μl of OPT (o-
phthaldehyde in methanol). The plate was read using a fluorescence microplate reader 
(FLUOstar Optima, BMG Labtech) at 350 nm excitation and 420 nm emission wave 
length. The GSH concentrations of each sample were obtained from the standard curve 
and the average value of the duplicate used.  
 
Total protein was measured using the BioRad protein assay which quantifies 
colourimetrically the protein concentrations using the dye Coomassie Brilliant Blue G-
250. BioRad stock reagent was diluted 1 in 5 with distilled water and filter through a 
paper filter. BSA, diluted in distilled water, was used for the standard curve which 
varied from 2 to 0.03 mg·ml-1 for the plasma samples and 1 to 0.03 mg·ml-1 for the 
nasal lavage samples. The plasma samples were diluted 1 in 100 with distilled water. 
Standards and samples were added in duplicate into 96-well plates. The BioRad, 200μl, 
was then added to the wells. The absorbance values were measured using a plate reader 
(Dynex Magellan Bioscience MRX Revelation) at a wavelength of 595 nm. The total 
protein concentrations of each sample were obtained from the standard curve and the 
average value of the duplicate used. 
 
3.4.2.2. Trolox  
The trolox equivalent antioxidant capacity of plasma and nasal lavage samples were 
measured by a colourimetric assay (Cayman Chemical Company, Boldon, UK) that 
compares the capacity of the antioxidants in the sample to prevent 2,2-azinobis 3-
ethylbenzothiazoline-6sulfonic acid (ABTS) oxidation with that of a water-soluble 
tocopherol analogue, Trolox. The result is quantified as milimolar trolox equivalents. 
Firstly, 10μl the Trolox standards and samples were pipetted in duplicate into the 
microwells of a 96 well plate. Before initiating the experiment, the plasma samples were 
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diluted 1 in 20 with the Assay buffer. The standard curve varied from 0.33 to 0.044 mM 
Trolox. Metmyoglobin (10μl) and chromogen (150μl) were added into each well. The 
reaction was then initiated by the addition of hydrogen peroxide working solution (40μl) 
and the covered plates were left to incubate, on a shaker, for 5 min at room temperature. 
The absorbance was then read at 750 nm (Dynex MRX II, West Sussex, UK). The total 
antioxidant capacity of each sample were obtained from the standard curve and the 
average value of the duplicate used. 
 
3.5 STATISTICAL ANALYSIS 
 
All statistical analysis was conducted using Minitab15 Statistical Software. Specific 
statistical tests used to analyse the data within each chapter is provided in the respective 
methods section. All data were checked for normality before statistical analysis and if 
necessary normalised. The majority of the results are represented as mean values and 
standard deviation (SD), unless stated otherwise. Statistical significance was accepted at 











Chapter 4: Investigating Performance and Lung Function in a 





This chapter will describe and discuss some of the results obtained in the first study of 
this thesis. In this study, trained individuals took part in a time-trial run in different 
environmental conditions. This chapter presents the results related to performance, lung 
function and respiratory symptoms, while Chapter 5 analyses the results related to 
oxidative stress and lung inflammation of these individuals. 
 
Ozone and Lung Function 
Several studies evaluating the effects of ozone exposure on healthy subjects have shown 
airway inflammation and also deterioration of lung function not only at low and 
moderate exercise levels, but also in athletes performing high intensity exercise (Adams 
& Schelegle, 1983; Devlin et al., 1996; Horstman et al., 1990; McDonnell et al., 1991). 
As detailed in Chapter 2, the methods used in these studies vary considerably, whether 
in relation to the different settings - mouth-breathing face mask, chamber and field 
studies – or to the large range in ozone concentration (0.07-0.4 ppm), most of which are 
not environmentally relevant. The diversity in the exercise protocols employed and 
fitness level of the participants are other factors, which together contribute to the 
different outcomes reported. Most studies investigating the effect of ozone on lung 
function have shown impairment in this function after exposure, but this is not a 
unanimous conclusion. For example, Holz et al. (1999) reported no change in lung 
function of neither healthy nor asthmatic individuals following exposure to 0.12 ppm of 
ozone. The exposure consisted of a 3 h duration period with an intermittent cycling 
exercise divided by 15 min of rest and 15 min of a low intensity cycling exercise 
eliciting a minute ventilation of 14 l/(min·m2). A similar result was reported by Krishna 
et al. (1997) when individuals were exposed to the same ozone concentration (0.12 
ppm), but to a 2 h period. A small but significant impairment in lung function was 
reported by Brunekreef et al. (1994) in a field study conducted with amateur cyclists. 
As described in Chapter 2, the study of Brunekreef and colleagues (1994) took place 
throughout the summer, the mean temperature was a temperate 17.9 degrees and the 
ozone levels varied between 0.04 and 0.1 ppm. The cyclists exercised for an average 
duration of 75 min on each occasion and the authors reported a significant relationship 
between ozone exposure and lung function decrements, which means that the higher the 
ozone values the greater the lung function decrements observed. Horstman et al. (1990) 
and McDonnell et al. (1991) reported a significant impairment in lung function after 
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participants were exposed to ozone during a long period of time (6.6 h) performing light 
intermittent exercise. They analyzed different concentrations of ozone: 0.00, 0.08, 0.10 
and 0.12 ppm. Significant reductions in FEV1 were observed after 3 h in the exposure 
period when the ozone concentration was at its highest (0.12 ppm); after 4.6 h of 
exposure at 0.10 ppm of ozone, and after 5.6 h of exposure when the concentration was 
at the lowest value 0.08 ppm.  
 
Impairment in lung function has also been reported with higher ozone concentration and 
shorter exposure durations. Blomberg et al. (1999) reported a depressed response of 
FEV1, FVC and FEF25-75, following a 2 h exposure of 0.2 ppm ozone. In this study, 
subjects performed intermittent cycling exercise at low intensity 20 l/(min·m2). As for 
the use of a high intensity exercise protocol, Schelegle and Adams (1986), using a 1 h 
competitive cycling simulation protocol, evaluated the response of ten endurance 
athletes exposed to different ozone concentrations – 0.12, 0.18, and 0.24 ppm - while 
performing. The authors reported a significant relationship between impairment of 
performance and ozone concentration: one, five and seven subjects did not complete the 
0.12, 0.18 and 0.24 ppm O3 protocol respectively. In addition, a significant increase in 
the number of reported respiratory symptoms and decreases in FEV1 and FVC were 
observed following the 0.18 ppm O3 exposure. As described, most studies have used a 
high ozone dose or a high exercise protocol, or the combination of both. Nevertheless, 
when analyzing the pertinent scientific literature, it is essential to take into not only the 
ozone concentration, but also the amount that is inspired and the exposure duration. 
This would represent the total effective dose of ozone (ED). This index has been related 
to both decreases in pulmonary function and increases in airway neutrophilia. ED is 
defined as the product of O3 concentration, average inspired ventilation, and duration of 
exposure (Gibbons & Adams, 1984; Gong et al., 1986; Mudway & Kelly, 2004). For a 
summary of the studies mentioned above see Table 4.1. 
 
The decrease in lung function occurring immediately after exposure, as has been 
reported in various studies, has been explained by different mechanisms. One of them is 
by an airway narrowing process mediated by parasympathetic stimulation (Becket et al., 
1985; Blomberg et al., 1999; Holz et al., 1999). Another possible explanation is by the 
exacerbation of respiratory symptoms, such as pain on deep inspiration, which would 
lead to a decrease in maximal inspiration volume, affecting the lung function as a 
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consequence (Passannante et al., 1998). This would occur via neural stimulation of 
sensory fibers present in the lungs (Hazucha et al., 1989). In more reactive individuals, 
the ozone could activate “irritant” receptors leading to changes in respiratory muscle 
force or mechanic properties of the lungs due to contraction of alveolar smooth muscles 
(Hazucha et al., 1989). Endurance exercise alone has also been shown to alter the lung 
function by means of affecting the airway smooth muscles due to hyperventilation 
(Scichilone et al., 2005). It has been reported that the lung function has returned to 
baseline values as quick as 2 h after the termination of the exercise protocol (Blomberg 
et al., 2003), showing that the changes which occur are temporary. In addition, multiple 
exposures to ozone have been shown to elicit an adapted response that would depend 
both on intensity of the exposures and on individual sensitivity to ozone (Jörres et al., 
2000; Frank et al., 2001). Yet, the exact mechanism leading to this adaptation is still 
unclear. 
 
















1 h training or 
competition simulation 
0; 0.2; 0.35 ppm 
↓ Lung function at 0.2 and 0.35 ppm 
↑ Respiratory symptoms with higher O3 






1 h competitive cycling 
simulation protocol 
0; 0.12; 0.18; and 
0.24ppm 
↓ Lung function following 0.18 and 0.24ppm 
↑ Respiratory symptoms with higher O3 







6.6 h light intermittent 
exercise 
0.08; 0.10 and 0.12ppm 
↓ Lung function after 3h at 0.12 ppm            
↓ Lung function after 4.6h at 0.10 ppm         
↓ Lung function after 5.6 h at 0.08 ppm          






Training:  75 min                       
Mean 17.9 ºC                       
O3: 0.04 – 0.1 ppm 
Small ↓ Lung function 
Relationship between O3 exposure and 
degree of lung function impairement  




2 h intermittent cycling 
0.12 ppm 





2 h intermittent cycling 
0.2 ppm  
↓ Lung function following 
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3 h intermittent cycling 
0.12 ppm 
No effect on lung function 
*Non-smokers, male and female, the study does not report their physical fitness level. 
 
Heat, Ozone-Pollution and Performance 
As mentioned at the outset, large urbanized areas have a polluted environment and can 
also reach high temperatures and humidity levels. It has been well documented that heat 
(González-Alonso et al., 1999; Parkin et al., 1999; Nybo & Nielsen, 2001) and heat and 
humidity (Galloway & Maughan, 1997; Nielsen et al., 1997) can have a significant 
detrimental effect on exercise performance. This is true for exercises that depend on 
muscle force production (Nybo & Nielsen, 2001), submaximal, maximal and 
supramaximal VO2 max intensity (Galloway & Maughan, 1997; González-Alonso et al., 
1999; 2008; Parkin et al., 1999) as well as events with different durations, i.e. marathon 
races (Ely et al., 2007), middle distance cycling and running events (Peiser & Reilly, 
2004; González-Alonso et al., 2008). Performance impairment in a hot environment is 
caused by a multifactorial system. An increased demand for skin blood flow, in an 
attempt to dissipate the extra heat and the metabolic demands of the contracting muscles 
to increase local blood flow, especially when the exercise recruits large muscle groups, 
such as running, will result in a compromised skin circulation leading to an increase in 
body temperature. The high level temperatures of the body and the central nervous 
structures, specifically the brain, combined with cardiovascular strain from the exercise 
limits the individual’s ability to continue the exercise. However, a variety of factors 
play a part in influencing the fatigue: body temperature before the exercise; 
dehydration; thermoregulatory capacity; fitness level and exercise duration are just a 
couple of examples. The thermoregulatory capacity of the individual will be affected in 
part by the humidity of the environment. Indeed, it has also been shown that when heat 
is combined with high levels of humidity it results in a higher stress to the body due to 
the difficulty in dissipated the heat through the evaporation process impairing 
performance to a higher degree (Nielsen et al., 1997).  
 
As ozone-pollution occurs with high temperatures it is relevant to study these two 
variables together. The addition of humidity is also important because in lots of regions 
the summer time is hot and humid, which adds another stressor to exercising 
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individuals. Nevertheless, there is very little research evaluating the combined effect of 
pollution with heat and humidity. Two important studies have investigated the impact of 
both heat and ozone, but not the addition of high humidity levels, on lung function and 
exercise performance (Gibbons & Adams, 1984; Gong et al., 1986). One of these 
studies was conducted by Gibbons and Adams (1984). The authors came to the 
conclusion that the combined effects of an ozone polluted environment with heat 
produces a greater negative impact on performance than ozone and exercise alone. In 
their study, 10 female participants underwent 6 randomized protocols at different 
temperatures, 24 and 35 °C, and at different ozone concentrations: filtered air, 0.15, and 
0.30 ppm. The exercise regime consisted of cycling for 1 h, eliciting a minute 
ventilation of approximately 55 l·min-1. All participants were able to complete the trials 
in the filtered air condition irrespective of the ambient temperature. Nonetheless, three 
women stopped cycling prematurely when exposed to ozone (0.30 ppm) in the hot 
environment (35°C); one could not complete the trial in the moderate heat (24 °C) with 
the same ozone concentration; and one stopped the trial prematurely in the moderate 
heat with the lower ozone concentration (0.15 ppm). In addition, at all ozone 
concentrations tested, the volunteers reported a higher respiratory discomfort. 
 
A subsequent study by Gong et al. (1986) also reached similar conclusion. In this study 
competitive cyclists exercised for 1 h at 70% of their VO2 max followed by an 
incremental test to exhaustion on a cycle ergometer. In addition to ozone (0.12 and 0.20 
ppm), the subjects were exposed to a high temperature of 31 ºC, while the humidity was 
low (37%). The authors reported a decrease in FVC and FEV1 at 0.12 that intensified at 
0.20 ppm O3. Impairment in the maximal exercise performance was also observed for 
the higher O3 concentration. Albeit the lack of explanatory mechanisms underlining this 
outcome, the stress in certain physiological variables and subjective limitations is 
clearly possible when ambient heat is associated with photochemical ozone during 
exercise performance.   
 
At present there is still a need to investigate the effect of ozone-pollution, at an 
environmentally relevant burden, on lung function and performance of exercising 
individuals. The addition of heat and humidity is of essence, seeing as during the 
summer months there is an increase in the number of people that practice outdoor 
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sports. In addition, important sports events also take place during the summer and 
therefore athletes are exposed to these potentially harmful environmental stressors. The 
current study investigates how different environmental conditions, set to resemble that 
of large urbanized centres, affect lung function, performance and respiratory symptoms 
of well trained male runners taking part in a time-trial run. Aspects of the immune 
system and oxidative stress were also investigated, but these will be explored in 
Chapter 5. Even though there are various studies that have separately investigated 
similar aspects of this study, the novelty of the current research is that these variables 
are investigated together for the first time. In addition, this study has a crossover 
randomized design that allows for the analysis of different environmental conditions 
with each participant acting as their own control. Part of this study was done in 
association with the British Olympic Medical Institute and, therefore, the choice of 
using well-trained individuals as the participants was made so as to allow the 
extrapolation of these results to the competitive population. It was hypothesized that 
performance, lung function and respiratory symptoms would be affected by the 
environment that contained just ozone pollution and that the addition of heat and 





Detailed descriptions of the methods are elucidated in Chapter 3. Any methodology that 
was used specifically in this study will be fully described in this section, while the 
methods previously described will be summarized. The specific methods and 
participants used in this study are identical to those used in Chapter 5. 
 
4.2.1 Participants 
Ten male well trained runners took part in this study (mean ± SD = 24 ± 6 years; 72.9 ± 
7.1 kg; 180.8 ± 8.5 cm; 64.4 ± 4.4 mlO2∙kg-1∙min-1). The participants were all 
competitive runners who had to achieve a criterion max2OV  minimum value of 60 
mlO2∙kg-1∙min-1. The adequacy of each subject’s max2OV  was tested during the 
familiarization trial (see section 3.2.1 for further details).  
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4.2.2 Experimental Procedures  
After the familiarization trial, the athletes completed four trials with the same exercise 
protocol, each in a different environmental condition, and separated by at least 7 to a 
maximum of 10 days. When the participants arrived in the lab they completed a health 
questionnaire to assess if they were in good health to take part in the exercise trial 
(appendix IV). If they presented signs of cold or flu they did not take part in the exercise 
and were asked to return 2 weeks after they had recovered. Before the exercise the 
participants performed the lung function test and values of FVC, FEV1, FEF25-75 and 
PEF were measured. The exercise trials took place in an environmental chamber (details 
are given in the section 3.2). The exercise consisted of an 8 km time trial run on a 
treadmill (Woodway, PPS 55 Med, Germany), which the participants were required to 
complete as fast as they could. The runners controlled their own speed, but they did not 
have access to the value of the speed. The environmental conditions were Control: 
filtered air at 20 ºC + 50% relative humidity (rh); Control + O3: 0.1 ppm O3 at 20 ºC and 
50% rh; Heat: filtered air at 31 ºC and 70% rh; Heat + O3: 0.1ppm O3 at 31 ºC and 70% 
rh. Immediately after the run the participants completed a respiratory symptom 
questionnaire (appendix VI), had blood samples taken, performed the lung function test 
again and then went through the nasal lavage procedure (see Figure 4.1). The trials were 
single blinded and performed with a crossover randomized design with each subject 
acting as their own control. The tests were carried out at the same time of the day for 
each athlete, to avoid any diurnal variation of the analyzed variables. In addition, the 




Figure 4.1. Single-blinded randomized crossover design. 
 
Once the exercise protocol commenced, subjective ratings of perceived exertion (RPE) 
(Borg, 1998), heart rate (Polar Electro, Finland) and the athletes’ running speed were 
continuously recorded. In addition, a 30 seconds air sample was collected, at 7.5 km, in 
a Douglas Bag (Douglas Bags 100 L, Cranlea, England) to analyze the athlete’s minute 
ventilation in order to calculate the ED of ozone. The athletes had access to water ad 
libitum during the trial.  
 
Statistical Analysis 
All data were checked for normality and homogeneity of variance before statistical 
analysis. Results are represented as mean values ± standard deviation (SD). Data were 
analyzed using General Linear Model ANOVA (Minitab15 Statistical Software) with 
Tukey’s Post-hoc test. Statistical significance was accepted at P < 0.05. Correlations 





4.3.1 Medical Questionnaires 
After analyzing the participants’ medical questionnaires it was seen that none of the 
participants presented asthma. Two out of the ten runners presented hay fever as an 
allergic problem, however as this study was conducted during the autumn and winter 
period this did not interfere with the participants’ health.  
 
4.3.2 Temperature, Humidity and Ozone Levels 
The average temperature, humidity and ozone levels for each of the trials were recorded 




Table 4.2. Average values for temperature, humidity and ozone levels in each trial 
 Control Control + O3 Heat Heat + O3 
Temperature (°C) 20.0 ± 0.5 20.0 ± 0.5 31.0 ± 0.5 31.0 ± 0.3 
Humidity (%) 50.5 ± 1.2 50.9 ± 1.0 69.6 ± 1.0 70.0 ± 0.8 
Ozone (ppm) 0.0 0.10 ± 0.02 0.0 0.10 ± 0.02 
Values are mean ± SD. 
 
4.3.2 Performance Variables 
The results for total time to complete each trial are shown in Figure 4.2. Both the Heat 
and the Heat + O3 trials resulted in a significant increase in time required to complete 
the 8 km trial compared to either the Control or the Control + O3 trials (P<0.001). 

































Figure 4.2. Individual time to complete each trial. Mean value for each trial is represented by 
____ . §§ Significantly different from Control and Control + O3 trial. P < 0.001.  





     Control   Control + O3        Heat   Heat + O3 
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were: 
• Control Trial subtracted from: 
Control + O3 Trial (-45.1; 69.7) Heat Trial (73.9; 188.7) Heat + O3 Trial (116.5; 231.3) 
• Control + O3 Trial subtracted from: 
Heat Trial (61.6; 176.4) Heat + O3 Trial (104.2; 219.0) 
• Heat Trial subtracted from: 
Heat + O3 Trial (-14.8; 100.0) 
 
Results for heart rate, RPE, speed, expired air and 2OV  for each of the trials are 
presented in Table 4.3. The Control trial and the Control + O3 trial presented a 
significantly higher speed when compared to both the Heat and Heat + O3 trial 
(P<0.001). There was no significant difference between the average speed in the 
Control + O3 compared with the Control trial. There were no significant differences 
between the trials for the runners’ mean heart rate or the peak heart rate. The Heat and 
Heat + O3 trials presented a significant higher peak RPE when compared to the other 
two trials (P<0.01). At 7.5 kms the average expired air volume for all trials was 120 
l·min-1. The subjects presented an average decrease of 28 l of expired air at the end of 
the Heat + O3 trial when compared to the Control trial, this value was significantly 
different (P<0.05). The 2OV  that the subjects were working at during the end of the run 
(km 7.5) was significantly lower for the Heat and the Heat + O3 trial when compared to 
the control trial (P<0.05). There was no significant difference between the Heat and the 
Heat + O3 trial for the 2OV  capacity. Moreover, the difference for this variable between 
Heat + O3 and the Control + O3 trial was borderline significant, with P = 0.056.  
 
Table 4.3. Effect of exercise trial on heart rate, RPE, speed, expired air and oxygen 
consumption.  
 Control Control + O3 Heat Heat + O3 
 
Average Speed (km·h-1) 
 
16.1 ± 0.9 
 
15.9 ± 1.6 
 
14.9 ± 1.2† 
 
14.6 ± 1.2†  
Mean Heart Rate (beats·min-1) 168 ± 3 170 ± 6 172 ± 3 170 ± 6 
Peak Heart Rate (beats·min-1) 187 ± 6 190 ± 6 192 ± 3 190 ± 6 
Mean RPE 14 ± 0.9 15 ± 0.9 15 ± 0.9 16 ± 0.9* 
 73 
Peak RPE 17 ± 0.9 17 ± 0.9 18 ± 0.9 19 ± 0.9† 
Expired Volume (l·min-1) 134 ± 16.7 124 ± 21.1 109 ± 17.4 106 ± 19.2* 
2OV consumption (mlO2.kg-1.min-1) 58.1 ± 4.3 56.4 ± 7.4 49.4 ± 7.4* 48.4 ± 5.3*
§ 
O3 Effective Dose (ED) 0 383.9 ± 86.8 0 366.5 ± 68.5 
* Significantly different from Control Trial, P < 0.05. † Significantly different from both 
Control and Control + O3 trial, P < 0.01. § Borderline significance, P = 0.056 compared with 
Control + O3. Values are mean ± SD. 
 
4.3.3 Respiratory Symptoms Response 
An overview of the respiratory symptoms reported by the subjects in response to the 
trials is given in Figure 4.3. In the Heat trial there is a tendency to increase the severity 
of respiratory symptoms experienced by the athletes. This increase becomes even more 
pronounced in the symptoms reported for the Heat + O3 trial, but it did not reach 
statistical significance. In response to the question of whether they felt that they would 
be able to perform maximally in a competition in the environmental conditions tested, 





 Figure 4.3. Respiratory symptoms presented by the subjects in all 4 trials. 
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4.3.4 Lung Function 
Changes in lung functions pre and post run were compared between trials. No 
significant differences were found for any of the analyzed variables (FVC, FEV1, FEF25-
75 and PEF) within the same trial or between trials (Table 4.4). In addition, when the 
runners’ pre and post FEV1 was analyzed it was seen that none of them presented 
exercise induced asthma, which is characterized by 10% or more decrease in this 
variable (Rundell & Jenkinson, 2002).   
 
 
Table 4.4. Lung function measures in all four trials. 
 Control Control + O3 Heat Heat + O3 
Pre FVC (l) 5.0 ± 0.9 5.2 ± 0.6 5.1 ± 0.9 5.1 ± 0.9 
Post FVC (l) 5.2 ± 0.9 5.1 ± 0.9 5.2 ± 0.9 4.9 ± 0.9 
Pre FEV1 (l) 4.4 ± 0.6 4.6 ± 0.9 4.6 ± 0.6 4.5 ± 0.6 
Post FEV1 (l) 4.5 ± 0.6 4.4 ± 0.6 4.7 ± 0.6 4.4 ± 0.9 
Pre PEF (l·min-1) 611 ± 65 610 ± 66 616 ± 74 607 ± 63 
Post PEF (l·min-1) 599 ± 66 594 ± 56 621 ± 71 585 ± 53 
Pre FEF25-75 4.7 ± 1.2 4.9 ± 0.9 5.1 ± 1.2 4.8 ± 0.6 
Post FEF25-75 4.9 ± 0.9 4.7 ± 0.9 5.4 ± 0.9 5.1 ± 0.6 
Values are mean ± SD. 
 
4.3.5 Ozone Effective Dose (ED)  
The relationship between the ED inhaled by the participants and the average speed 
developed in both ozone trials is presented in Figure 4.4A. There was a significant 
negative correlation between these two variable (R=-0.27, P<0.05). When the post-
exercise lung function parameters were analyzed a significant positive correlation 




Figure 4.4. Relationship between the ED and the athletes’ average speed (A), and FVC (B) 




This study evaluated the effect of four different environmental conditions in lung 
function, performance and respiratory symptoms of trained runners performing an 8 km 
time-trial run. The environmental conditions were: (1) Control: filtered air at 20 ºC + 
50% relative humidity (rh); (2) Control + O3: 0.1 ppm O3 at 20 ºC and 50% rh; (3) Heat: 
filtered air at 31 ºC and 70% rh; (4) Heat + O3: 0.1ppm O3 at 31 ºC and 70% rh. These 
conditions were successfully achieved. The main findings described in this chapter were 
the following. That the environmental conditions did not affect the runners’ lung 
function post-exercise. There was a significant detriment in performance in both Heat 
and Heat + O3 trial compared to Control and Control + O3. Plus, there was a trend 
towards increased severity in reported respiratory symptoms by the participants after the 
run in the Heat + O3 trial. 
  
The first important finding of the present study was that the average speed attained by 
the runners during the Heat trial (14.9 km∙h-1) and during the Heat + O3 trial (14.6 km∙h-
1) was significantly lower when compared to the Control trial (16.1 km∙h-1). 
Consequently, this impacted the total time required to complete the 8 km run in both the 
Heat (32 min 35 sec) and the Heat + O3 (33 min 09 sec) trials. This drop in performance 
occurred with all the runners. In relation to the Control trial (30 min 15 sec), the athletes 
had an average significant increase of 2 min 54 sec in their total time to complete the 
Heat + O3 trial. When the performance in the Heat and the Heat + O3 trials are 
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compared, the time to complete the Heat + O3 trial was on average 34 seconds longer 
than the time to complete the Heat trial. Such difference did not reach statistical 
significance, but is equivalent to a 1.7% increase in the time to complete the trial with 
the addition of ozone. When analyzing the individual values, 8 out of 10 runners 
performed worse in the Heat + O3 trial when compared to the Heat trial. Contrary to 
what had been hypothesized ozone alone had no significant impact on either average 
speed or on total time to complete the trial as a consequence. On average the athletes 
took an additional 12 seconds, equivalent to a 0.7% increase, to complete the Control + 
O3 trial (30 min 27 sec) compared to the Control.  
 
It could be hypothesized that the addition of ozone to the heat and humidity results in a 
higher strain being placed on the athletes than when the ozone is added in a 
thermoneutral environment, but this study was not able to fully support this hypothesis. 
Hopkins and Hewson (2001) demonstrated that, in short duration running events an 
athlete’s performance does not have a large variation between competitions, therefore 
there is a low coefficient of variation between races. Half marathons and marathons 
would possibly present a higher variation due to less familiarity of the athletes in 
competing these distances. Analysing the variation in performance outcome of athletes 
in endurance running events, the authors suggest that an improvement of 1% for half 
and full marathons, and 0.5% for shorter endurance events would significantly increase 
the chances of an athlete obtaining a medal. It is with caution that those results are 
extrapolated for the present study, but the runners in the present study were all current 
competitors at a club or national level. In addition, the percentage improvement in the 
runners’ performance time in both environments without ozone is higher than the 
percentage improvement reported by Hopkins and Hewson (2001) to be medal relevant. 
Thus, it can be suggested that the ozone had an impact in performance that might be 
ecologically significant. Moreover, when heat and humidity was added to the ozone, 
this percentage increased a further 1%. This suggests that heat might exacerbate the 
toxic effect of ozone in the lungs, resulting in a pronounced increase in the oxidative 
stress and inflammation process in the lungs. These would in turn increase the runners’ 
perception of discomfort and respiratory symptoms leading to a decrease in the running 
speed as a protective mechanism. In fact it could be seen that in the Heat + O3 trial the 
volume of expired air was significantly reduced compared with the Control. The 
reduction in ventilatory exchange could be due to respiratory discomfort experienced by 
 77 
the athletes which might have impaired their maximum effort. The fact that the mean 
and peak heart rate did not differ between trials suggests that the cardiovascular strain 
was similar in all four conditions. A total of 10 athletes were used for this study. A 
power calculation suggests that an n value of 25 would be required to achieve statistical 
significance. 
 
Other studies have shown a significant impairment of exercise performance when heat 
is combined with ozone (Gibbons & Adams, 1984; Gong et al., 1986). The investigators 
in the current study used humidity in addition to heat and a lower concentration of 
ozone, which is more representative of the levels encountered in large urbanized areas. 
It is very challenging to compare most of the available literature to the results of the 
present study because of the different exercise protocols, ventilation rates elicited and 
participants assessed in the studies. In this research the runners were well trained and 
had a high aerobic capacity (mean value of 64.4 mlO2.kg-1.min-1). As a result, during the 
exercise trial, they were able to achieve a high minute ventilation and, consequently, 
inhale more air and more ozone per minute than if non-athletes were exposed for the 
same exercise duration. In fact, the ventilatory rates (mean value of 120 l∙min-1) and 
work intensity elicited by the 8 km time trial run is much higher than that reported in the 
literature studied to date (Christian et al., 1998; Jörres et al., 2000; Krishna et al., 1998; 
Ratto et al., 2006). Nevertheless, it is important to point out that the motivation and 
training status of the participants that took part in the present study may be different to 
those of athletes who are actually in a competitive event. Perhaps most importantly, in 
big cities, there are a variety of pollutants, such as sulphur dioxide (SO2), particulate 
matter (PM10), nitrogen oxides (NOx) in addition to ozone (Baldasano et al., 2003) and 
it is the combined effect of this cocktail of pollutants that could affect the athlete 
adversely. It is practically and ethically very difficult to replicate this type of pollution 
environment and hence this is recognised as one of the limitations of studies conducted 
in laboratory setting. However, the mechanism of oxidative stress produced by using 
ozone is similar to that which may occur with a cocktail of pollutants and it is, thus, 
thought that using ozone alone is an appropriate model to gauge the effect that ambient 
pollution has on performance. 
 
The decrease in performance, observed in both the Heat and Heat + O3 trial, can be 
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explained by the high temperature and humidity of these trials in which we would 
expect a large stress on the athletes’ thermoregulatory system (González-Alonso et al., 
2008). It has also been shown that a decrease in exercise performance in the heat could 
be associated with a temperature-induced metabolic perturbation, decrease in 
neuromuscular activation and stress on the cardiovascular system (González-Alonso et 
al., 2008; Morrison et al., 2006; Parkin et al., 1999). Physiological variables specific to 
thermoregulatory mechanisms (i.e. skin temperature, sweat rate) were not measured, as 
it was not the main aim of this study. 
 
Regarding the mean subjective post-exercise symptom responses, an increase in the 
overall respiratory symptoms was observed in the Heat trial, with an exacerbation of the 
symptoms with the further addition of ozone. Some athletes reported feeling additional 
symptoms such as chest tightness and dizziness after completing the Heat + O3 trial. 
Once more, this suggests the differences in individual susceptibility to this pollutant 
(Passannante et al., 1998; Holz et al., 1999; Blomberg et al., 1999). All runners 
following the Heat + O3 trial reported that they would not be able to perform maximally 
in a competition in such an environment. The increase in subjective discomfort can also 
be seen when the RPE is analyzed. It has been shown that exercise in the heat can act 
directly on the central nervous system of the individual reducing motivation and 
increasing perceived exertion (Nybo & Nielsen, 2001). Nevertheless, the mean RPE 
was significantly higher only in the trial in which ozone was combined with heat and 
humidity compared to the Control trial. Even though these values are not very different, 
the statistical test takes into account the interval of the values in each trial. Thus, the 
runners were feeling more exhausted, but developed a lower speed, and were working at 
a significantly lower 2OV  capacity. The same is true for the peak RPE presented by the 
runners. Therefore, another explanation for the decrease in performance in the Heat + 
O3 trials is related to the athletes’ subjective feeling of exhaustion and respiratory 
symptoms. It could be speculated that the combination of heat and ozone during 
exercise performance would have an overwhelming effect on the organism - influencing 
not only performance, but also enhancing subjective limitations.  
 
The lack of changes in the lung function parameters is in accordance with a previous 
study that used a higher ozone concentration of 0.12 ppm (Holz et al., 1999), although 
they are in contrast with a variety of other studies (Brunekreef et al., 1994; Gong et al., 
1986, Jörres et al., 2000; Schelegle & Adams, 1986). It is relevant, however to 
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highlight that all of those studies used a different exposure protocol to the one utilized 
in the present study. The O3 concentration used in this study was environmentally 
relevant compared to the outdoor concentration (Baldasano et al., 2003). Usually the 
decrease in lung function is reported after subjects are exposed to higher levels of O3, 
such as 0.12 ppm; 0.2 ppm and 0.24 ppm, for a period of time of at least 1 h, performing 
moderate exercise. In fact, Horstman et al. (1990) reported significant decrements in 
pulmonary responses when subjects were exposed to 0.1 ppm O3, which is the same 
concentration as the one in this study, but only after 4.6 h of exposure. This exposure 
duration is over nine fold higher than the average time of exposure in the current 
research. Moreover, the findings of Gibbons and Adams (1984) also corroborate the 
present study in that they reported no significant decrements in pulmonary function 
when subjects were exercising in an environment where the ozone concentration was 
0.15 ppm, performing moderate continuous exercise for 1 h. In the present research, the 
presence of heat and humidity might have contributed to minimize the transient airway 
narrowing that can lead to exercise-induced bronchospasm. In fact, it has been shown 
that athletes’ would experience significant airway narrowing mainly when exercising in 
a dry and cold environment (Rundell & Jenkinson, 2002) and not a hot and humid one. 
The increase in respiratory symptoms in this study might not have been intense enough 
to reduce the runners’ maximal inspiration volume, or the exercise might not have been 
long enough to affect airway smooth muscle through hyperventilation. In addition, in 
this study, we did not measure the respiratory muscle force or mechanic properties of 
the lung - factors that have been linked to a reduction in lung function post ozone 
exposure (Passanante et al., 1998; Hazucha et al., 1989; Scichilone et al., 2005). 
Nevertheless, it is probable that these factors were not affected by the ED of O3 of this 
study since no alterations in lung functions were observed. 
 
The magnitude of decrement in lung function has been shown to be related with the ED 
of ozone, which depends on the ozone concentration, duration of exposure and athletes’ 
ventilatory rate (McDonnell et al., 1997). Schelegle and Adams (1986) suggested that 
lung function impairments would be observed when the ED of ozone is greater than 900 
ppm∙l. In this present study, the mean ED was 375.2 ppm∙l. Some individuals, however, 
did show a greater decrease in their lung function following the ozone trials. This 
corroborates with the fact that inter-subject variability in lung function changes is 
related to differences in individual responsiveness to ozone (Holz et al., 1999, Mudway 
et al., 2006). In addition, there was a positive relationship between FVC and ED of 
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ozone. This relationship, though not very strong (R= 0.34), is statistically significant 
(P=0.02) and it was an expected result since an athlete that has a larger lung capacity, 
has higher FVC and can, consequently, inhale more air per minute, receiving a higher 
ED as a result. Although some studies did not show a strong relationship between ED 
and lung function parameters, they did show a decrease in lung function post-exercise 
(Gong et al., 1986; Jörres et al., 2000; Schelegle & Adams, 1986). The average ED of 
ozone did not differ between the Control + O3 (383.9 ppm∙l) and the Heat + O3 trials 
(366.5 ppm∙l). Even though these values are approximately a third of the ED presented 
in other studies (Gibbons & Adams, 1984; Gong et al., 1986), there was a significant 
correlation with the athletes’ performance, measured as the average speed attained by 
the runners during the trials. While not a strong relationship (R=-0.27), it was 
statistically significant. This relationship means that the decrease in the athletes’ 
average speed maintained throughout the trial and, hence, a decrease in performance can 
partially be explained by the amount of ozone, that is the ED, they inhaled during their 
run. In fact, in both conditions that had ozone, the athletes presented a 1% increase in 
their performance time irrespective of the temperature. Although this finding is in 
contrast with the study of Gong et al. (1986), who reported a weak and non-significant 
correlation between performance and ED, it is an important finding because ED had 
previously only been related to decreases in pulmonary function and increases in airway 
neutrophilia (Gibbons & Adams, 1984; Gong et al., 1986; Mudway and Kelly, 2004). 
The exercise protocols used in the literature are quite different and this results in 
different ED exposures between the studies.  
 
This study provides evidence that both heat and heat combined with ozone (0.1 ppm) 
have a detrimental effect on athletes’ performance in an 8 km time trial. Ozone alone 
had little effect on this variable. Lung function was not impaired after the exercise in 
any of the environmental conditions tested. The results of this study are important for 
athletes exercising or competing during summer time in large polluted cities or close to 
them because they can encounter similar environmental conditions as used in this study. 
The next chapter will present an analysis of outcome of this study related to the 












Chapter 5: Oxidative Stress and CC16 Secretion: 






The previous chapter showed that while lung function of runners performing an 8 km 
time-trial run was not affected by environmental conditions – ozone, heat and humidity 
– their performance was significantly impaired with heat and humidity and with heat, 
humidity and ozone pollution combined. This chapter presents and discusses the 
inflammatory responses and oxidative stress of these runners after the exercise trials in 
these different environmental conditions.   
 
Ozone-Pollution and Airway Inflammation  
The literature has shown a lack of consistency in the airway inflammation response of 
individuals exercising in an ozone-polluted environment (Devlin et al., 1996; Krishna et 
al., 1998; Holz et al., 1999; Blomberg et al., 1999). The conflicting results may be 
explained by differences in the exercise protocols used, the ED of ozone inhaled by the 
participants, and the training status of participants in the studies. Moreover, differences 
in methods and timing of the airway sampling can also influence the results. It seems 
that when individuals are exposed to a high ED of ozone an increase in airway 
inflammation markers can be detected as soon as 1 h after exposure, as shown in the 
study of Devlin et al. (1996) in which the participants performed 2 h of high 
intermittent exercise exposed to a high ozone concentration of 0.4 ppm. Also, 1 h after 
exposure Holz and colleagues (1999) observed a significant increase in airway 
neutrophilia and IL-8 when participants completed 3 h of light intermittent exercise 0.25 
ppm of O3. Nevertheless, this response was not seen when the participants performed 
the same exercise bout exposed to a lower O3 concentration (0.12 ppm). It has been 
shown, however, that neutrophil influx reaches its peak in the airways 6 h after 
exposure (Mudway & Kelly, 2004). Before this time point, some studies using lower 
ED of ozone have detected increases in inflammatory mediators, such as vascular 
adhesion molecules, suggesting an initial inflammatory response (Blomberg et al., 


















2 h heavy intermittent 
cycling 
0.4 ppm 
1 h post-exposure = ↑ neutrophil, IL-6 
and LDH in BAL 




2 h intermittent cycling 
0.12 ppm 
6 h post-exposure = ↑ neutrophil, IL-8 
in BAL  




2 h intermittent cycling 
0.2 ppm  
1.5 h post-exposure: no effect on 
neutrophil count or percentage in BAL, 
but ↑ in inflammatory mediators 
Holz et al., 1999 *Mild 
asthmatics + 
nonasthmatics 
3 h intermittent cycling 
0.12 ppm 
0.25 ppm 
↑ neutrophil percentage and count in 
sputum (0.25 ppm O3) 





Average 35 km cycling 
Average 0.076 ppm 
Post-exercise = ↑ in serum CC16  




2 h intermittent cycling 
0.2 ppm 
2 h and 4 h post-exposure = ↑ in serum 
CC16 
*Non-smokers, male and female, the study does not report their physical fitness level. 
  
The studies mentioned above used healthy individuals as participants. As mentioned 
previously the fitness level of the individuals can alter the outcome of the study due to a 
difference in the airway pool cell composition found in trained individuals. Active 
individuals that have an endurance training regime, present at baseline a higher 
neutrophil number in the airways compared with the general population. This has been 
shown with different sports such as running (Bonsignore et al., 2001), swimming (Belda 
et al., 2008) and rowing (Morice et al., 2004). This number would also be higher after a 
competition or after intense training, indicating that lung inflammation can be 
stimulated by both acute and chronic exercise (Denguezli et al., 2008). In sports like 
swimming, this can be linked to the constant inhalation of chlorine and its derivatives 
(Belda et al., 2008). In non-asthmatic amateur runners, the presence of an increased 
neutrophil number in the airways, after a marathon, was speculated to be, at least in 
part, linked to a prolonged period of hyperventilation. The high airflow might cause 
epithelial damage through shear stress on the epithelial wall which leads to an influx of 
neutrophils to this region (Bonsignore et al., 2001; Morice et al., 2004). This may be the 
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same mechanism that leads to higher neutrophil levels in the airways at rest in 
individuals that train regularly (Bonsignore et al., 2001; Denguezli et al., 2008).  
Nevertheless, this shear stress mechanism is still unclear and requires further 
investigation.  
 
Lung Inflammation and CC16  
Exposure to ozone has also been linked to lung epithelial injury (Christian et al., 1998), 
resulting in an increase in permeability of the lung epithelial barrier. As detailed in 
Chapter 2, for the assessment of lung injury and toxicity, CC16 protein has been shown 
to be a sensitive and suitable biomarker (Bernard et al., 1994; Hermans & Bernard, 
1999). This small protein is produced by Clara cells, found exclusively in the 
pulmonary airways (Hermans & Bernard, 1999), and by similar cells in the nasal 
mucosal epithelial (Benson et al., 2004; Lindahl et al., 1999). CC16, measured in the 
blood, is derived almost exclusively from the airways (Hermans & Bernard, 1999). As a 
result of pulmonary inflammation and increase in the permeability of the lung epithelial 
barrier, the concentration of this protein in the blood has been shown to alter (Hermans 
et al., 1999). Few studies have evaluated the effect of exercise alone on this protein. 
Nevertheless, these studies showed that CC16 levels in the blood are increased after 
exercise. This occurred in spite of the differences in duration, i.e. 30, 45 or 60 min of 
exercise; or the type of the exercise, i.e. fire fighting tasks, high intensity exercise and 
swimming (Nanson et al., 2001; Carbonelle et al., 2002). More investigation is needed 
to address specific questions that have resulted from these research studies, such as the 
mechanism leading to this increase and the influence of exercise intensity and duration.  
 
Because ozone is known to increase lung inflammation and because CC16 is a marker 
of lung inflammation, most studies investigating the relationship between this protein 
and exercise have also used an ozone-polluted environment. As described in Chapter 2, 
Broeckaert et al. (2000b) and Blomberg et al. (2003) found an increase in CC16 levels 
in the blood following 2 h of exercise in the presence of ozone. One study was a field 
study and the participants were trained cyclists (Broeckaert et al., 2000b), whereas the 
other study (Blomberg et al., 2003) was conducted in the lab with healthy individuals. 
Even though both studies had the same duration, the intensity varied and so did the ED 
of ozone - factors which make it difficult to compare them directly. Nevertheless, by 
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looking at the results, it seems reasonable to conclude that the combination of ozone and 
an exercise bout is sufficient to affect the lung epithelium integrity. It would have been 
interesting if these studies had also analyzed if the lung concentration of CC16 had 
altered. This data would have been useful to strengthen the conclusion of epithelial 
damage instead of the possibility of an increase in the secretion of this protein into the 
lungs and its consequential greater diffusion into the bloodstream.  
  
Ozone-Pollution, Heat and Oxidative Stress  
As well as stimulating lung inflammation, the inhalation of ozone can increase the 
reactive oxygen species and free radicals in the lungs. This process occurs mainly by 
two different mechanisms. The first would be by reacting directly with constituents of 
the respiratory tract lining fluids (RTLF) and the underlying epithelium (Pryor et al., 
1995). Antioxidants present in the RTLF, such as glutathione, uric acid and ascorbic 
acid, have been suggested to have an important role in neutralizing part of the radical 
generation, hence reducing the ozone induced oxidative stress (Samet et al., 2001). The 
second mechanism by which ozone can increase the oxidation process is indirectly 
because by exacerbating the inflammatory response in the lungs, there will be an 
increase in the reactive oxygen species (ROS) production by the immune cells through 
the respiratory burst process (Corradi et al., 2002). These processes combined could 
overwhelm the local and systemic antioxidant network leading to an increase in the 
oxidative process. In addition, it is important to remember that an exercise bout can 
already provide stimulus to the increase in radicals in the body (Fisher-Wellman & 
Bloomer, 2009). Nevertheless, the literature is still inconclusive in regard to the 
exacerbation of the lung oxidative stress process following exposure to ozone and 
physical activities. Therefore, it is difficult to establish the degree of oxidative stress 
that athletes would have if exercising in such conditions and how it would affect their 
performance.  
 
The studies mentioned in this section were all conducted in a thermoneutral 
environment. However, the potential effects of thermally stressful environmental 
conditions on aspects of lung inflammation, lung injury and oxidative stress also need to 
be considered. Indeed, hyperthermia has been shown to promote oxidative stress in vitro 
(Mitchell & Russo, 1983; Flanagan et al., 1998; Lord-Fontaine & Averill-Bates, 2002) 
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and in vivo (McAnulty et al., 2005a). In vitro studies, using indirect methods to measure 
oxidative stress, provided evidence that cells exposed to heat stress can become 
antioxidant depleted, GSH in particular (Mitchell & Russo, 1983; Lord-Fontaine & 
Averill-Bates, 2002). The study of Flanagan and colleagues (1998) was the first to 
directly measure, by the use of electron paramagnetic resonance spin trapping method, 
the increase in free radical production by cells exposed to hyperthermia. This excess 
production of free radicals was speculated to be generated at the mitochondrial electron 
transport chain. Hyperthermia has also been associated with an increase in the 
conversion of xanthine dehydrogenase into xanthine oxidase which also leads to an 
increase in free radical production (Mitchell & Russo, 1983). McAnulty et al. (2005a) 
investigated plasma oxidative stress markers of healthy moderately trained males 
exercising in two different environmental conditions. The control condition was set at 
25ºC with 40% humidity, whereas the other environment was hot (35ºC) and humid 
(70%). The participants ran on a treadmill at 50% of their VO2 max for the same duration, 
which was established as the time taken for the participant’s core temperature to reach 
39.5ºC in the hot and humid environment. Running in the hot and humid environment 
significantly increased F2-isoprostane plasma levels, indicating a higher oxidative stress 
in this condition. Even though the authors did not assess the catecholamine production, 
these were suggested to have contributed to the increase in oxidative stress since 
catecholamines are known to contribute to the formation of reactive species and also 
increase when the person is exercising in the heat. Therefore, also taking into 
consideration that ozone increases oxidative stress and is a warm season pollutant, it is 
realistic to analyse these environmental factors together.  
 
This chapter will present the results related to lung inflammation and oxidative stress of 
runners performing an 8 km time trial run in the four different environmental conditions 
outlined in Chapter 4 allowing comparison of these results with the performance and 
lung function results previously presented. The hypothesis was that ozone alone would 
increase the analyzed variables of inflammation and oxidative stress and that addition of 
heat and humidity would increase this impact further. In addition, this study used the 
nasal lavage procedure in order to assess the upper respiratory airways. Therefore this 
chapter also presents the methods and results of a second study conducted to evaluate 






The data for this chapter was collected as part of the same project that originated the 
data presented in Chapter 4. Therefore, most aspects of the methodology, such as the 
participants’ of the study and the exercise protocol are the same. Further tests carried 
out specifically in this study and that were not described in Chapter 3 are fully 
explained in this section.  
 
5.2.1 Experimental Procedures  
In summary, the exercise protocol consisted of an 8 km time trial run, where runners 
controlled their own speed, but they did not have access to the value of the speed. After 
the exercise trial the participants had blood samples taken and went through the nasal 
lavage procedure. The environmental conditions were Control: filtered air at 20 ºC + 
50% relative humidity (rh); Control + O3: 0.1 ppm O3 at 20 ºC and 50% rh; Heat: 
filtered air at 31 ºC and 70% rh; Heat + O3: 0.1ppm O3 at 31 ºC and 70% rh.  
 
To analyze the impact of the different environmental conditions on respiratory 
inflammation and oxidative stress of the runners, the following variables were assessed:  
• Inflammatory markers: nasal lavage neutrophils, IL-8 and IL-6; plasma and 
nasal lavage CC16 concentrations; plasma fibrinogen; nasal lavage albumin, 
LDH and C-reactive protein (CRP) concentration; 
• Oxidative stress markers: plasma and nasal lavage GSH/protein, nasal lavage 
uric acid concentration and trolox equivalent antioxidant capacity of plasma and 
nasal lavage.  
 
Sample Collection: Immediately post-exercise intravenous blood samples were 
collected in two 6 ml vacuum tubes containing EDTA. The plasma was aliquoted into 
eppendorfs (500 µl) and immediately stored at -80 °C until further analysis. Nasal 
lavage was collected around 15 min post-exercise according to methods described in 
section 3.2.4. The cells were separated, counted and differentiated according to their 
morphological appearance. The supernatant was aliquoted into eppendorfs (500 µl) and 
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immediately stored at -80 °C until further analysis 
 
Biochemical Analysis: Full descriptions of the procedures used in this study are given in 
Chapter 3. In brief: Nasal lavage pro-inflammatory cytokines, IL-6 and IL-8, were 
measured using commercially available enzyme linked immunoabsorbent assay 
(ELISA) kits (R&D, Abingdon, UK) in accordance with the manufacturer’s 
instructions. Similarly, CC16 was also measured using an ELISA kit (DiaMed 
EuroGen, Belgium). The total antioxidant capacity of nasal lavage was measured by a 
colourimetric assay (Cayman Chemical Company, Boldon, UK) that compares the 
capacity of the antioxidants in the sample to prevent ABTS oxidation with that of a 
water-soluble tocopherol analogue: Trolox. The result is quantified as milimolar trolox 
equivalents. The nasal lavage GSH and total protein were both measured. The results 
are expressed as GSH/protein in order to allow comparisons between samples of 
different dilutions. In addition, Nasal lavage albumin and uric acid concentrations were 
measured using quantitative colourimetric assay kits (BioAssay Systems, Cambridge, 
UK) according to manufacturer’s instructions as detailed below. Finally, plasma acute 
phase proteins were also measured with details of the methods given below. 
 
Albumin: Nasal lavage albumin concentrations were measured using quantitative 
colourimetric assay kits (BioAssay Systems, Cambridge, UK) according to 
manufacturer’s instructions. After the nasal lavage samples thawed, 5 μl of the samples 
and albumin standards (0 –5 g·dl-1) were added in duplicate into a clear bottom 96 
microwell plate. The working reagent was prepared and 200 μl added to each well. 
After 5 min at room temperature the absorbance was read at 620 nm, the concentrations 
of each sample were obtained from the standard curve and the average value of the 
duplicate used.  
 
Uric acid: Uric acid concentrations in nasal lavage were measured using quantitative 
colourimetric assay kits (BioAssay Systems, Cambridge, UK) according to 
manufacturer’s instructions. The nasal lavage samples were thawed before initiating the 
experiment. Into a clear bottom 96 microwell plate, 5 μl of the standards (0 – 12 mg·dl-
1) and samples were added in duplicate. The working reagent was freshly prepared 
mixing 10 volumes of reagent A, 1 volume of reagent B and 1 volume of reagent C; 
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200μl of the working reagent was added to each well. The plate was incubated at room 
temperature for 30 min. Following this period the absorbance was read at 595 nm, the 
concentrations of each sample were obtained from the standard curve and the average 
value of the duplicate used.  
 
Acute phase Protein: Plasma content for the acute phase proteins fibrinogen and C-
Reactive protein (CRP) were measured by double antibody sandwich ELISA. Samples 
were thawed and diluted in PBS + 0.1% Tween 20 as follows: 1 in 30,000 for 
fibrinogen and 1 in 25 for the CRP. For these assays, 96 microwell plate were used. 
These were coated with the capture antibody for each acute phase protein and left 
overnight.  The following morning the plates were washed (PBS + 0.1% Tween 20) and 
100 µl of standard and samples were added to the microwells in duplicate and 
incubated, at room temperature, for a 2 h period. The plates were then washed and the 
appropriate detection antibody (100 µl) was added to each microwell.  Following a 1 h 
incubation period, at room temperature and in the dark, the plates were washed again 
and chromagenic substrate (100 µl) was added. For the colour to develop, the plates 
were left for 15 min in the dark, after which 0.5 M sulphuric acid (100 µl) was added to 
stop the colour development. The absorbance was read with a 490 nm wavelength 
(Dynex MRX II, West Sussex, UK). All rabbit anti-human coating and HRP detection 
antibodies were purchased from DakoCytomation, Denmark. 
 
Statistical Analysis 
All data were checked for normality before statistical analysis. Results are represented 
as mean values ± standard deviation (SD). Data were analyzed using General Linear 
Model ANOVA (Minitab15 Statistical Software) with Tukey’s Post-hoc test. Statistical 
significance was accepted at P < 0.05. In order to verify any association between the 
variables in the Heat + O3 trial a correlation matrix was conducted, with a subsequent 
multiregression analysis (Minitab15 Statistical Software). 
 
5.2.2 Nasal Lavage Reliability Study  
5.2.2.1 Participants 
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Six healthy volunteers took part in this study (mean ± SD, 27 ± 2.5 year; 69.6 ± 10.8 kg; 
172 ± 7.5 cm). The participants had to be non-smokers and moderately active. In the 
same way as in the other studies all participants received explanation about the study’s 
objective, and were aware of possible risks and discomforts they might experience. All 
participants signed an informed consent form and completed a health history 
questionnaire before the commencement of data collection.  
 
5.2.2.2 Experimental procedures 
The Nasal Lavage Reliability Study had a total duration of 4 weeks. First, the 
participants went through a familiarisation trial were they practiced going through the 
nasal lavage procedure. After that, once a week, during the first 4 weeks the participants 
were submitted to the nasal lavage procedure. The nasal lavage samples were collected 
from the participants at the same time of day.  
 
The nasal lavage procedure was performed as previously described in Chapter 3. From 
the samples, total cell counts, neutrophil counts, albumin, CC16, IL-6 and uric acid 





5.3.1 Neutrophil Counts 
In the nasal lavage fluid, the predominant cells were neutrophils and epithelial cells 
(Figure 5.1). The results for nasal lavage neutrophil counts post-exercise are presented 




Figure 5.1. Nasal lavage cells. Epithelial cells and neutrophils present in the nasal lavage fluid. 
A- Neutrophils; B- Neutrophils and an epithelial cell; C- Epithelial cells. 
 
5.3.2 Inflammatory markers 
Cytokines and albumin  
Nasal lavage IL-6 concentration was not detected with the assay used. The IL-8 
concentration, on the other hand, was detected, though it did not vary between trials. 
Similarly, albumin concentrations did not vary between trials (Table 5.2). The intra-
assay coefficient of variation for the duplicate samples was 2.6% for IL-8 and 3.1% for 
albumin. 
 
Acute Phase Proteins and LDH  
. No differences between trials were encountered for plasma CRP, plasma fibrinogen or 
nasal lavage LDH concentrations (Table 5.2). The intra-assay coefficient of variation 
for the duplicate samples was 2.9% for CRP, 1.3% for fibrinogen, and 2.5% for LDH. 
 
Clara Cell Protein 
CC16 concentration was measured both in the nasal lavage and plasma samples. Figure 
5.2 shows the mean values for the nasal lavage CC16 concentration in each trial. One 
subject exhibited a very high expression of CC16 for all the trials. This participant was 
considered an outlier and eliminated from the analysis of this protein because he was at 
least 1.5 times above the interquartile range when the values were placed in a boxplot 
(Minitab15 Statistical Software). Nasal lavage CC16 concentration in the Heat + O3 trial 
was therefore significantly greater compared with the Control trial (P=0.03). The intra-


























Figure 5.2.  Individual nasal lavage CC16 concentration. Mean value for each trial is 
represented by  ______ . §§ Significantly different from Control trial (P < 0.05).  
 
 
As for the CC16 concentration in the plasma samples, no differences were found 
between the trials (Table 5.2). The intra-assay coefficient of variation for the duplicate 
samples was 2.7%. 
 
Table 5.2. Inflammatory markers from nasal lavage and plasma samples. 
 Control Control + O3 Heat Heat + O3 
NL Neutrophil Counts (x104) 2.3 ± 3.6 3.4 ± 3.0 3.2 ± 3.6 2.1 ± 2.1 
NL IL-8 (pg·ml-1 ) 66.9 ± 56.4 68.2 ± 74.4 53.3 ± 24.0 49.9 ± 35.7 
NL Albumin (mg·ml-1) 0.48 ± 0.03 0.52 ± 0.06 0.49 ± 0.03 0.49 ± 0.03 
Plasma CRP (ng·ml-1) 175.8 ± 125.4 199.7 ± 160.9 211.9 ± 112.5 257.3 ± 218.2 
Plasma Fibrinogen (mg·ml-1 ) 5.13 ± 0.6 5.45 ± 0.9 5.32 ± 1.5 5.08 ± 0.9 
NL LDH (units·ml-1) 315.3 ± 218.8 334.6 ± 146.1 261.6 ± 77.1 259.8 ± 122.7 
§§ 





Plasma CC16 (ng·ml-1 ) 46.6 ± 10.5 48.5 ± 12.6 40.7 ± 9.6 44.5 ± 11.8 
No differences were observed in any of the variables. Values are mean ± SD.   
 
5.3.3 Oxidative Stress Markers 
Nasal lavage and plasma GSH/Protein 
There was a significant increase (P=0.036) in the nasal lavage GSH/protein 
concentration when the Heat + O3 trial was compared with the Control (Figure 5.3). In 
addition, there was also a significant inter-subject variability (P=0.001). The intra-assay 
coefficient of variation for the duplicate samples was 3.6%. As for the plasma 
GSH/Protein concentration there were no differences between the trials (Table 5.3). The 




























Figure 5.3. Individual GSH/Protein concentration in nasal lavage. Mean value for each trial is 
represented by  ______ . §§ Significantly different from Control trial, P < 0.05.  
 
Trolox Equivalent Antioxidant Capacity (TEAC) 
No significant differences between the trials were observed for either the plasma TEAC 
or nasal lavage TEAC samples (Table 5.3). In addition, a significant inter-subject 
variability was found for both the nasal lavage (P=0.035) and plasma samples 
 §§ 









(P=0.001). Intra-assay coefficient of variation was 4.3% for the duplicate samples. 
 
 
Nasal lavage Uric Acid Concentration 
 No differences were found between trials for the nasal lavage uric acid concentration 
(Table 5.3). There was a significant inter-subject variability (P=0.03). The intra-assay 
coefficient of variation for the duplicate samples in this assay was 1.7%.  
 
Table 5.3. Oxidative stress markers in plasma and nasal lavage. 
 Control Control + O3 Heat Heat + O3 
 
Plasma TEAC         
(Trolox mM) 
 
1.83 ± 0.78 
 
1.69 ± 0.63 
 
1.74 ± 0.71 
 
2.05 ± 0.24 
NL TEAC (Trolox mM) 0.019 ± 0.018 0.014 ± 0.013 0.014 ± 0.012 0.013 ± 0.012 
Plasma GSH/Protein 
(mmoles·mg-1) 
1.18 ± 0.21  1.09 ± 0.27 1.46 ± 0.21 1.31 ± 0.21 
NL Uric Acid (mg·dl-1) 0.45 ± 0.06 0.42 ± 0.06 0.45 ± 0.09 0.45 ± 0.09 
Values are mean ± SD.   
 
5.3.4 Correlations 
A multiregression analysis was conducted to verify if there was any relationship 
between the percentage change in performance observed in the Heat + O3 trial 
compared with the Control trial and the analyzed inflammatory and oxidative stress 
markers in the Heat + O3 trial. A significant negative correlation was observed between 
time to complete the Heat + O3 trial with the nasal lavage TEAC (R=- 0.70, P=0.036), 
and similarly with the nasal lavage GSH/protein concentration (R=- 0.69, P=0.041) 
(Figure 5.4).  
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Figure 5.4. Relationship between percentage increase in time to complete the Heat + O3 trial 
with the percentage change in nasal lavage TEAC (A) and with the nasal lavage GSH/protein 
concentration (B). 
 
5.3.5 Nasal Lavage Reliability Study 
All participants were highly tolerable to the nasal lavage procedure. The mean recovery 
of the fluid was 5.2 ± 0.2 ml. This value did not change significantly among the 5 
lavages and were highly reproducible in the same individual. 
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The predominant cells in the nasal lavage were neutrophils and epithelial cells. 
Occasionally macrophages were also present and in even smaller numbers eosinophils 
and monocytes. The results for neutrophil counts in the nasal lavage during the 4-week 
study are presented in Table 5.4. This suggests an initial inflammatory process. 
Nevertheless, the albumin concentrations did not vary between the 4 weeks of the study 
nor did the CC16 concentrations (Table 5.4). These were however, reproducible in the 
same individual. Nasal lavage uric acid and IL-6 could not be detected in the samples. 
In the case of uric acid this could possibly be due to a low concentration of this 
antioxidant, whereas the assay for IL-6 might not have been sensitive enough to detect 
the diluted levels of this cytokine in the lavage. 
 
Table 5.4. Inflammatory markers in nasal lavage (Reliability Study) 
 Week 1 Week 2 Week 3 Week 4 CV* 
 
Total cell count (x104) 
 
1.9 ± 0.9 
 
2.2 ± 0.9 
 
2.2 ± 1.2 
 
1.8 ± 0.6 
 
6.4% 
Neutrophil count (x104) 0.28 ± 0.1 0.22 ± 0.08 0.38 ± 0.15 0.23 ± 0.08 5.8% 
Neutrophil percentage 14.7 ± 5.2 10.4 ± 6.3 17.2 ± 8.1 12.7 ± 5.6 6.3% 
CC16 (ng·ml-1) 381 ± 146 401 ±145 483 ± 78.8 437 ± 189 4.1% 
Albumin (mg·ml-1) 0.09 ± 0.06 0.10 ± 0.06 0.11 ± 0.09 0.11 ± 0.09 7.2% 
Values are mean ± SD.  
* Coefficient of variation calculated using the root mean squared error (RMSE) term from the 
ANOVA (Minitab15 Statistical Software). 
 
5.4 DISCUSSION  
 
The key findings of the main study of this chapter were that there was no significant 
change in airway inflammation in any condition compared to Control. The nasal lavage 
CC16 concentration was significantly elevated in the Heat + O3 trial compared to 
control, evidence of an early epithelial damage. In addition, in the same trial (Heat + 
O3), there was an increase in the nasal lavage GSH/protein concentration suggesting an 
up-regulation in the antioxidant defences in the upper respiratory airways in response to 
oxidative stress. Note that this response was greater compared with the Control, but not 
with heat alone or ozone alone. Neither heat nor ozone alone affected markers of 
inflammation, epithelial damage or oxidative stress. Furthermore, there was a 
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significant correlation between percentage decrease in performance, during the Heat + 
O3 trial, and decrease in antioxidant status of the athletes’ nasal lavage.  
 
There are various different methods that can be used to assess an individual’s airways 
for inflammatory and oxidative stress markers. Some studies in the literature have used 
bronchoalveolar lavage and bronchial biopsies, procedures that sample the lower 
respiratory airways. These methods, however, have the disadvantages of being invasive 
procedures, technically difficult to carryout and they need to be performed in a medical 
environment where the subject is anaesthetized (Jӧrres et al., 2000; Ratto et al., 2006). 
In addition, bronchoalveolar lavage and bronchial biopsies cannot be repeated at 
different time points. Nasal lavage and induced sputum have also been used in research 
studies evaluating the respiratory airways. These two procedures sample the upper 
respiratory airways and central airways respectively. They have been shown to be easily 
tolerated by the participants, and the nasal lavage, in particular, can be repeated at 
multiple time points (Mudway et al., 1999; Schock et al., 2004). We, thus, decided to 
use the nasal lavage technique in the present study for those reasons and because the 
nasal epithelium is the first to come into contact with inspired pollutants (Hernández-
Escobar et al., 2009) which makes it a relevant area of study.  
  
In the Nasal Lavage Reliability Study the main finding was that the nasal lavage 
sampling method is a reliable technique. Of note is the fact that attention was given to 
conduct the lavage in a standardized way. Not only was the researcher familiar with all 
the technical steps, but the same oral instructions were given to all the participants every 
time they went through this procedure. The reproducibility of the nasal lavage was 
evaluated in two different ways. First, the reproducibility of the sampling technique was 
assessed by analysing the total fluid recovered. This result was shown to be highly 
reproducible in the same individual once they became familiar with the procedure. 
Second, the reproducibility of the nasal lavage was evaluated by the number of cells and 
mediators recovered from each lavage. The following parameters were examined: total 
cell count, neutrophil count and percentage, IL-6, albumin, CC16 and uric acid. The 
parameters that could be detected were also reproducible. This result is in accordance 
with the study of Nikasinovic-Fournier and colleagues (2002) that also analysed the 
reproducibility of the nasal lavage technique for a range of inflammatory markers. This 
reliability study is of essence to strengthen the outcome of the studies in this thesis, 
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which used the same protocol for the nasal lavage technique to assess the upper 
respiratory tract inflammatory and oxidative stress markers.  
 
The present study is, to date, the first to analyse the neutrophil response to ozone and 
heat challenge combined. There was a large variation between individuals in terms of 
inflammatory response. For some athletes, an additive effect was found when heat was 
combined with ozone. For others, however, the mixture of these two variables caused a 
decrease in the neutrophil count when compared with either O3 or heat alone. Still 
others did not show variations between the trials. This reinforces the evidence that 
people respond very individually to ozone exposure representing their different intrinsic 
responses to the inflammatory or toxic effects of O3 (Passanante et al., 1998; Holz et al., 
1999; Blomberg et al., 1999; Mudway et al., 2006). In addition, this variation in 
individual susceptibility to ozone may account for the inconsistent neutrophil response 
observed. 
 
The lack of an increase in neutrophil numbers observed in the current study 
corroborates other studies (Blomberg et al., 1999; Holz et al., 1999; Morrison et al., 
2006; Mudway et al., 1999). Morrison et al. (2006) did not observe an increase in 
neutrophil counts post-exposure to 0.1 ppm of O3 using the bronchoalveolar lavage 
method. In the same way, lack of early increase in neutrophil counts post-ozone 
exposure was also observed in other studies using either nasal lavage (Mudway et al., 
1999) or sputum induced technique (Holz et al., 1999) with 0.2 ppm and 0.125 ppm of 
O3 respectively. The lack of airway neutrophilia can most likely be explained by the ED 
of O3 inhaled by the participants and the airway sampling occurring within the first hour 
after exercise cessation. Post-exercise changes in blood neutrophil count usually 
presents a biphasic response, characterized by an initial increase during the exercise, 
returning back to basal levels 30-60 minutes after, and a greater increase in the 
neutrophil count peaking around 2-4 h post-exercise (Mackinnon, 1999). Moreover, 
studies have shown that after exposure to ozone, neutrophil influx into the airways 
reaches a peak around 6 h post-exposure (Mudway & Kelly, 2004). This occurs due to 
the necessity of migration, a process that can be summarized by four main events: 1. 
rolling; 2. chemotaxis activated stimulus by chemokines, such as IL-8; 3. arrest and 
adhesion; 4. migration into the tissue (Kuby, 1997) (Figure 2.1). Blomberg et al., (1999) 
observed an increase in the expression of vascular adhesion molecules 1 h post-
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exposure to ozone; however, it had not yet resulted in a movement of neutrophils into 
the airways. Similarly, Morrison et al. (2006) reported no changes in neutrophil counts 
in bronchoalveolar lavage 1 h post-exposure to a high O3 concentration (0.4 ppm). 
Nonetheless, 6h after exposure, there was a significant increase in this cell number. On 
the other hand, Krishna and colleagues (1998) reported that no changes occurred in any 
kind of inflammatory cells in the bronchial submucosa when measured 6 h following 
exposure to 0.2 ppm of ozone. Although there is some evidence supporting the lack of 
airway neutrophilia up to 6 h after exposure to this oxidative gas, there are other studies 
that did report an early increase in neutrophil numbers in the lungs after exposure to 
high levels of O3 such as 0.25 ppm and 0.4 ppm (Devlin et al., 1996; Holz et al., 1999). 
These contrasting findings highlight the importance of the airway sampling time and the 
technique used, as the different techniques sample different airway compartments 
producing different results. The decision to use nasal lavage as the method to sample the 
upper respiratory airways in this study, as mentioned previously, was due to the fact that 
it is a reproducible and well-tolerated procedure as demonstrated in the Nasal Lavage 
Reliability Study, which concurs with other studies (Nikasinovic-Fournier et al., 2002; 
Mudway et al., 1999). In addition, the nasal epithelium is the first to come into contact 
with inspired pollutants and, therefore, protects the lower airways (Hernández-Escobar 
et al., 2009). Even though, during high intensity exercise, such as the one performed in 
this study, athletes may tend to breathe predominantly through their mouths, the nasal 
lavage technique is still useful to detect changes in the upper respiratory airways as 
elucidated further on.   
 
The present study also assessed a variety of inflammatory markers in nasal lavage and 
plasma samples post-exercise. The IL-6 concentrations were not detected in the nasal 
lavage samples. Although it has been shown to be detectable in NL (Keman et al., 
1998), other studies that have analyzed the impact of ozone on this cytokine have used 
different sampling methods (Krishna et al., 1998; Christian et al., 1998; Blomberg et 
al., 1999). Moreover, no differences were encountered for the IL-8 concentrations 
between trials, corroborating the findings of Blomberg et al. (1999). This result could 
be due to the sampling time point. Todokoro et al. (2004) conducted an in vitro study 
where they observed that the IL-8 production started to increase after the second hour 
post ozone exposure and, only after 6 h, did the up-regulation of this cytokine become 
apparent. Therefore, we might have missed this time point. This could also be true for 
the other markers measured, such as nasal LDH and albumin concentrations, plasma 
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levels of fibrinogen and C-reactive protein (CRP). There were no significant changes in 
these inflammatory markers; however, an increase trend could be observed for the CRP. 
Similarly, Blomberg et al. (1999) did not detect any change post O3 exposure in either 
LDH or albumin levels present in the airways. The lack of changes in the nasal lavage 
concentration of albumin is also in accordance with other studies (Mudway et al., 1999; 
and Morrison et al., 2006). It could also be speculated that the O3 concentration together 
with exercise were not sufficient to elicit a high level of airway inflammation and lung 
epithelial damage.  
 
On the other hand, CC16, was the only inflammatory marker that showed a variation 
due to the environmental condition. This protein has been linked to having an important 
role in decreasing the inflammation of the respiratory tract and protecting it against the 
harmful effects of oxidative stress (Broeckaert & Bernard, 2000). Most athletes 
presented an increase in this protein level after the Heat + O3 trial when compared with 
the Control. It is possible that this increase was due to a higher release of this protein by 
the Clara cells. The majority of studies investigating this protein analyzed mainly its 
variation in plasma or serum, even though it is easily quantified by the nasal lavage 
method (Johansson et al., 2005). The assessment of CC16 serum levels can also be used 
as a specific biomarker of the airway epithelium integrity. If there is an increase in the 
permeability of the lung epithelial barrier, which can happen following exposure to 
ozone (Christian et al., 1998), there may be an increased diffusion rate of CC16 to the 
blood (Broeckaert et al., 2000b). Nevertheless, in the present study, no alterations in 
plasma CC16 were observed. It is possible that the ED of ozone was not strong enough 
to elicit sufficient lung injury to induce CC16 leakage to the blood. Another hypothesis 
is that there was not sufficient time to detect an increase in this protein due to the blood 
sampling time point. Blomberg et al. (2003) detected an increase in this protein only 2 
and 4 h after participants performed 2 h of moderate intermittent exercise exposed to 0.2 
ppm of O3. In the same study, other epithelial permeability markers, such as albumin 
and total protein concentration, were also assessed; however, they did not show a 
significant increase. This data supports the idea that serum CC16 is a more sensitive 
marker of altered lung epithelial permeability than traditional markers. The high inter-
subject variability in CC16 concentration, both in plasma and nasal lavage, in the 
current study can be justified by its diurnal variation (Helleday et al., 2006) and 
possibly by individual sensitivity to ozone.  
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Once ozone is inhaled, antioxidants present in the RTLF have a significant role in 
protecting important components of the tract fluids and minimizing the oxidation 
process of the underlying epithelium (Van der Vliet et al., 1995). Studies analyzing the 
effect of ozone inhalation and airway antioxidant consumption have indeed shown 
significant alterations in airway antioxidants, such as uric acid, ascorbic acid and GSH 
(Housley et al., 1995; Mudway et al., 1999; Blomberg et al., 1999). No changes in nasal 
lavage uric acid levels were found in the current study. This contrasts to one of the 
major findings reported by Mudway et al. (1999). They observed a significant decrease 
in the levels of this antioxidant during the exercise period and it remained depressed 
during the second hour of exercise. The values had, however, been restored to pre-
exercise levels 1 h post-exposure. Even though a series of nasal lavages were performed 
throughout the experimental protocol, the authors reported no washout effect for uric 
acid. In the Mudway et al. (1999) study, there were both female and male participants 
and they were not trained individuals. They took part in an exercise protocol that 
consisted of a 2 h intermittent exercise (mean ventilation of 20 l·min-1) with 0.2 ppm of 
ozone exposure. Differences in ED of ozone, exercise protocol, sampling time and 
subjects taking part in the studies might explain the differences in the results. In the 
Nasal Lavage Reliability Study this antioxidant could not be detected in the nasal lavage 
samples. This was an unexpected result. However, a possibility would be that, because 
the participants in the reliability study did not perform an exercise bout this antioxidant 
might not have been up-regulated in the RTLF. In addition, the runners that took part in 
the main study might initially have had a high uric acid concentration in the airways in 
comparison with the non athletic population of the reliability study. This might be 
possible because athletes are known to have increased antioxidant defence mechanisms 
(Powers et al., 1999) as detailed in Chapter 2. 
 
The trolox equivalent antioxidant capacity was measured both in the plasma and in the 
nasal lavage fluid of the runners in the current study. Despite a decreasing trend 
observed for the nasal lavage trolox equivalent antioxidant capacity after the Heat + O3 
trial, the values did not bear significance, a result which corroborates previous evidence 
(Blomberg et al., 1999). There are different explanations for this outcome. First, 
measuring antioxidant concentration is an indirect method for analysing oxidative stress 
and possibly not the most accurate one (Bailey et al., 2003). Even though nasal lavage 
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was collected post-exercise, there was a time period that might have been sufficient for 
the up-regulation of certain antioxidants. Studies have shown that there are different 
optimal time points for sampling oxidative stress biomarkers in the plasma (Michilidis 
et al., 2007), and this is also true for cells in vitro (Stone et al., 1998) and in the lungs 
(Rahman & MacNee, 2000). In addition, other researchers have documented how 
training causes an enhancement in the antioxidant enzyme activity in various tissues and 
a decrease in free radical generation, which attenuates the degree of exercise-induced 
oxidative stress (Kanter, 1998; Vollaard et al., 2005; Wilson & Johnson, 2000). The 
type and duration of the training plays an important role in the up-regulation of the 
endogenous antioxidants, with long-duration high-intensity endurance training having 
been shown to be most effective (Powers et al., 1999). As detailed in the methods, the 
subjects that took part in the present study were well-trained endurance runners and 
hence, their antioxidant defence system would have been well-adapted to cope with 
oxidative stress. The aim of the present study was not to compare the variation of 
different measures pre and post trial, but to see how a potentially harmful environment 
combined with an intense exercise affects the athletes. Therefore, it is not possible to 
establish if there was a change in the oxidative status of the runners’ pre and post-
exercise - a known limitation of the study. 
 
The lack of changes in the athletes’ trolox equivalent antioxidant capacity might also be 
explained by the increase in the nasal lavage levels of GSH/Protein. These were 
significantly increased after the Heat + O3 trial in comparison with the Control trial. 
Ozone alone or heat alone did not have an effect on this variable, suggesting an additive 
or potentiative effect of these environmental stressors. It could be speculated that the 
increase in the GSH/protein concentration in the airways is a reflection of a local up-
regulation mechanism or indeed a systemic response to protect the airways against 
oxidative stress. The large inter-individual variation can be explained by the diurnal 
variation of GSH (Blanco et al., 2007) and the individual sensitivity to ozone. This 
finding is in accordance to the study of Blomberg and colleagues (1999) and can be 
interpreted as a result of increased GSH release from airway epithelial cells (Wu et al., 
2004) or an unknown storage site. Another possible explanation might be that there was 
an increase in plasma levels of GSH derived from the liver which, thus, resulted in an 
augmented diffusion into the lungs. However, a significant increase in the plasma levels 
of GSH/Protein in the Heat + O3 trial was not observed, this strengthens the probability 
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of a local up-regulation mechanism. 
 
A further finding of this study was the relationship between an increase in performance 
impairment and the decrease in antioxidant status in the airways. Both nasal lavage total 
antioxidant capacity and nasal lavage GSH/Protein presented this negative correlation 
with the performance in the Heat + O3 trial. This is interesting because it suggests that 
the antioxidants present in the airways have an impact on the performance outcome in a 
hostile environment such as the one encountered in the Heat + O3 trial. Although, in this 
study, we did not assess the athletes’ antioxidant status pre-exposure, it could 
potentially be used as a marker of susceptibility, but for that, further research is 
required. Moreover, it will be of interest to investigate whether antioxidant 
supplementation would have any positive effect in a similar exercise and environmental 
condition.  
 
To conclude, the findings of this research suggest that the nasal lavage procedure used 
in this study was reliable and reproducible to assess markers of inflammation. In 
addition, it can be suggested that an 8 km time trial run performed in a hot, humid and 
ozone-polluted environment (0.1 ppm) elicits an early epithelial damage characterized 
by increase in CC16 concentration in the airways. Moreover, an increase in the 
antioxidant concentration in the upper respiratory airways in that same trial, as indicated 
by the nasal lavage GSH/protein, suggests a protective mechanism against the oxidative 
stress stimulated by the high intensity exercise in association with ozone, heat and 











Chapter 6: Effect of vitamin supplementation on 
athletic performance, lung function and antioxidant 





In Chapter 5, two correlations between nasal lavage antioxidant concentration post-
exercise and performance were observed. These correlations suggested the possibility 
that antioxidant availability in the RTLF during an intense exercise bout in an 
environment that promotes oxidative stress, beyond that stimulated by the exercise 
alone, might have a beneficial effect on the performance. Hence, based on these 
correlations and the other results reported in the previous chapters (Chapters 4 and 5), 
the rational for the study presented in this chapter and in Chapter 7 was elaborated. This 
chapter will present and discuss the results related with the athletes’ performance, lung 
function and antioxidant status, while the subsequent chapter has as a focus, aspects of 
the airway and systemic inflammatory responses. 
 
The Indiscriminate Use of Multivitamin Supplementation 
Multivitamin supplementation is a practice that is carried out widely and in an 
indiscriminate manner. It is estimated that around 70% of the USA population, at least 
occasionally, make use of dietary supplements and 40% intake them on a regular bases. 
The dietary supplements that are most commonly taken are multivitamins, calcium, 
vitamin C and vitamin E (Hathcock et al., 2005). In the UK, the consumption of 
supplements is also a common practice. It was estimated that in the years of 1998 and 
1999 an amount of £347 million and £326 million respectively were spent in vitamins 
and minerals supplements purchase from pharmacies, health stores and grocery stores 
throughout the UK. This amount does not include products that were sold via the 
internet. Vitamin E sales alone account for approximately £79 million per year, whereas 
vitamin C is at the top of the list accounting for an annual sale of around £252 million in 
the UK (Expert Group on Vitamins and Minerals – EVM – 2003). What is quite 
intriguing is that these data are from developed countries where the population that has 
the money to buy vitamin supplementation also has the money to buy good quality food 
that can provide the recommended daily allowance of vitamin and minerals. A factor 
that can stimulate the sales of such products is that the benefits of vitamins are quite 
well established. Vitamin C, a water-soluble antioxidant found in the cytosol of cells 
and in the extracellular fluid, is most commonly known to help prevent or recover from 
flu and colds, even though its benefits surpass this. Indeed, the roll of this vitamin in the 
prevention and treatment of the common cold has been subject to controversy over 
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the last years. Even today, public interest in the topic is still high and vitamin C 
continues to be widely sold and used as a preventive and therapeutic agent for this 
common ailment (Douglas et al., 2004). Nonetheless, Hemilä et al. (2009) analyzing all 
previous known publications on the topic, reached a key conclusion: vitamin C 
supplementation is ineffective in reducing the incidence of colds in the normal 
population; thus, routine mega-dose prophylaxis is not rationally justified for 
community use. There were, however, studies that showed consistent and statistically 
significant minor benefits on duration and severity of the cold for those using regular 
vitamin C supplementation. This indicates that vitamin C does play some role in 
respiratory defense mechanisms. Trials which introduced high doses of vitamin C at the 
onset of cold symptoms, have not been shown to reduce neither the duration nor 
severity of symptoms. Yet evidence shows that it could be justified in persons exposed 
to brief periods of severe physical exercise and/or cold environments (Hemilä et al., 
2009). 
 
As for vitamin E, it has an important antioxidant property and is considered one of the 
major inhibitors of lipid peroxidation in vivo (Halliwell & Gutteridge, 2007). This is the 
case because it exerts the important function of maintenance of membrane integrity by 
protecting virtually all cells of the body against lipid peroxidation (Institute of 
Medicine, 2000). Besides being a potent antioxidant, this vitamin also has an anti-
inflammatory role presenting beneficial effect in cardiovascular diseases, such as 
attenuating the release of inflammatory mediators related to such diseases (Singh & 
Jialal, 2004). The necessity of supplementing a well balanced diet with these vitamins is 
still controversial. In fact, Bruunsgaard et al. (2003) conducted a 3-year experiment, 
with a healthy male cohort population, in which the participants were either taking both 
vitamin E (136 IU ·day-1) and C (500 mg·day-1) supplementation (n=55) or placebo 
(n=52). The 36-months of antioxidant supplementation had no detectable effect on 
systemic inflammation markers. In addition, as shown in Chapter 2, a review study, 
analyzing over 47 antioxidant supplementation research papers on all-cause mortality, 
showed a negative effect of some supplements, such as vitamin E, which was associated 
with an increase in mortality. Vitamin C, despite not presenting a negative effect, did 
not show any evidence that it might increase longevity (Bjelakovic et al., 2007). 
Therefore, although vitamin C and E have known beneficial effects, healthy individuals 




Physical Activity and the Use of Vitamins 
The matter changes slightly when we add another factor: physical activity. As 
elucidated previously in Chapter 2, it is clear that muscle contraction increases the 
production of ROS and free radicals, specifically during intense and prolonged physical 
activity (Powers et al., 1999; Sen & Roy, 2001). Although there is an increase in the 
radical concentration during exercise, this does not always result in an increase in 
oxidative stress. This process will only take place, if the oxidant concentration surpasses 
the antioxidant concentration of the organism (Powers et al., 2004). In addition, the low 
concentration of radicals in the muscles plays an important signalling role in the muscle 
contractile function. These radicals are essential for force generation and for exercise 
adaptation. Nevertheless, as the radicals start accumulating in the contracting muscles 
the oxidation of proteins and lipids might cause, amongst other things, contractile 
dysfunction leading to inhibition in force production and contributing to the 
development of acute fatigue (Reid, 2001). Whether that would justify the 
supplementation of antioxidant vitamins by exercising individuals or even athletes in 
order to improve performance and attenuate oxidative stress is a significant matter.  
 
To answer such a question, an aspect that should be taken into consideration is the 
adaptive antioxidant response to exercise. Studies have shown that the production of 
reactive species during exercise is important for cellular adaptations, enzyme expression 
and gene expression all of which lead to antioxidant up-regulation both in the muscle 
and systemically (Reid, 2001; Gomez-Cabrera et al., 2005; Gomez-Cabrera et al., 2008; 
Ji, 2008; Radak et al., 2008) independently of the training status of the individuals 
(Ristow et al., 2009). In an animal study, Gomez-Cabrera et al. (2005) reported the 
importance of reactive species, produced during exercise, to muscle cell adaptations 
through the regulation of molecular signalling events. They showed that after an 
exhaustive exercise bout there was a stimulation of mitogen-activated protein kinase 
(MAP Kinase). Such enzymes and signalling pathways activate transcription factors 
such as nuclear factor kappaB (NF-kB), responsible for increasing the expression of 
cellular enzymes involved in antioxidant defence, such as inducible nitric oxide 
synthase (iNOS), endothelial nitric oxide synthase (eNOS) and manganese superoxide 
dismutase (Mn-SOD), but also inflammation (e.g. TNFα). Of practical importance, this 
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study showed that the mice group that had been administered with allupurinol – an 
antioxidant inhibitor of xanthine oxidase - did not show such adaptations. It is with 
caution that we extrapolate results from animal studies to the human population, 
however, a recent investigation reported similar results with humans. Ristow and 
colleagues (2009) analyzed the combination of vitamin C (1000 mg·day-1) and E (400 
IU·day-1) in muscle enzymes that regulate the antioxidant defence system of the 
muscles. This study was conducted with two groups: one of previously untrained 
individuals and another of trained individuals. Both groups underwent a 4-week training 
period; and, regardless of their previous training status, the study showed that the 




Figure 6.1. Proposed mechanism of the role of exercise in the up-regulation of cellular 
antioxidant enzymes and the prevention of this process by ingested antioxidants. Adapted from 
Gomez-Cabrera et al. (2005).  
 
On the other hand, antioxidant supplementation might also diminish oxidative stress 
produced by exercise, but the literature on this topic lacks consistency. Nieman et al, 
(2002) reported no effect on the performance or lipid peroxidation markers of runners 
that were supplemented with vitamin C (1 week, 1000 mg·day-1) and who completed an 
ultramarathon race. Traber (2006) reported that a 6-week supplementation of 
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vitamin C (1000 mg·day-1) and E (400 IU·day-1) had a positive effect in attenuating 
increases in lipid peroxidation after a long distance running event, but that it did not  
affect inflammation, muscle or DNA damage. Goldfarb et al. (2005) showed that a 2-
week supplementation of vitamin E (400 IU·day-1), C (1000 mg·day-1) and selenium (90 
μg·day-1) did not attenuate plasma lipid peroxidation (measured as malondialdehyde 
concentration) or GSSG during the first 24 h after an eccentric bout of exercise, but did 
attenuate malondialdehyde concentration at the 48 h time point. The participants were 
non-resistance trained females and the exercise comprised 4 sets of 12 repetitions of 
elbow flexions. A similar result was found by Davison and Gleeson (2006) who 
analysed the effect of 2-weeks of vitamin C supplementation (1000 mg·day-1) on 
plasma malondialdehyde concentration and immunological markers after 2.5 h of 
cycling at 60% VO2max. The participants of this study were endurance-trained males. In 
this case, the authors reported that the plasma malondialdehyde concentration was 
unaffected by the exercise and the temporal response was not influenced by vitamin C 
supplementation. In a subsequent study, Davison et al. (2007), supplemented two 
groups of recreationally active individuals during a 4-week period with either placebo or 
a vitamin combination (1000 mg·day-1 of vitamin C and 400 IU·day-1 of vitamin E). 
After 2.5 h of cycling (60% VO2max), the plasma F2-isoprostane concentration was 
significantly increased post-exercise and the vitamin supplementation had no effect on 
this marker. However, the lipid peroxidation, measured by plasma TBARS, was lower 
in the supplemented group compared to the placebo after the exercise bout. The authors 
explained that because of the lack of specificity of the TBARS assay this result alone 
should not be considered as evidence of a decrease in oxidative stress in the 
supplemented group. In addition, the time course of the two oxidative stress markers 
measured in the study differ. Therefore, perhaps measurements should be made more 
frequently after exercise and during a longer post-exercise period, and not just 
immediately and 1 h post-exercise as in that study, although that would obviously be 
difficult to do practically with human subjects.  
 
Vitamin C and E Supplementation in Performance Outcome 
The available evidence does not provide a consensus about the effect of vitamin C and 
E supplementation and the decrease in oxidative stress following exercise. Most studies 
have looked mainly into the lipid peroxidation aspect of oxidative stress, however, there 
are other aspects that could be relevant - such as DNA and RNA damage (Kanter, 
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1998). Another point of interest is the effect of a decrease in oxidative stress during 
exercise and its effect on performance. In fact, most studies with a long duration aerobic 
exercise show no effect on performance. Gomez-Cabrera et al. (2006) investigated the 
effect of acute allupurinol ingestion (300 mg) in runners prior to a marathon 
competition (23rd Marathon of Valencia). The study showed that the antioxidant 
abolished the NF-kB activation in peripheral blood lymphocytes of the runners. In 
addition, malondialdehyde as a marker of lipid peroxidation, was significantly increased 
after the marathon in the placebo group but not in the allopurinal group. Worthy of note 
is the fact that, there was no difference in performance between the supplemented and 
the placebo groups.     
 
The lack of a beneficial effect in performance has also been shown in other studies with 
vitamin supplementation. Most studies specifically investigating vitamin C 
supplementation have failed to show its beneficial effects in exercise-induced oxidative 
stress and in performance. Peters et al. (2001), investigating the effect of vitamin C 
supplementation in athletes performing an ultramarathon race, reported no enhancement 
in performance compared with a placebo group. The athletes were supplemented for a 
week (1000 mg·day-1) and presented a significantly higher plasma vitamin C 
concentration pre-race compared with the placebo group. Nevertheless, after the race 
the plasma concentration in the placebo group had increased compared to its pre-race 
values, but in the supplemented group it was similar to the pre-race values. This 
suggests a possible attenuation of vitamin C mobilization in the supplemented runners. 
This result diverges partially from the ones presented by Palmer et al. (2003)  where 
athletes were supplemented for a 1-week period with vitamin C (1500 mg·day-1) also 
prior to an ultramarathon race. An increase in the vitamin C concentration post-race in 
both groups was observed, but the supplemented group maintained a higher level 
compared with the placebo. In that study, vitamin C supplementation also had no 
beneficial effect in performance and did not attenuate oxidative stress levels measured 
by lipid oxidation markers following the race. The authors suggested that the lack of 
supplementation effect both in oxidative stress and consequently in performance 
outcome, would be due to the location of this water-soluble vitamin in hydrophilic 
compartments. Thus, vitamin E intake would be more appropriate to protect against 
lipid peroxidation.  
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Nieman et al. (2004) tested that theory by supplementing triathletes with 800 IU·day-1 
of α-tocopherol, during a 2-month period prior to an Ironman competition (Triathlon 
World Championship in Kona, Hawaii). Plasma α-tocopherol levels were significantly 
higher before the race, and this difference was maintained post-race. Unexpectedly, 
however, not only did the vitamin supplementation not attenuate the oxidative stress, 
measured by the F2-isoprostane concentration, but after the race it had increased almost 
two-fold. In addition, the cytokines that were measured - IL-1, IL-6 and IL-8 - were 
significantly higher post-race when compared to the values of the placebo group. Not 
surprisingly, there was no significant difference in the performance time between the 
supplemented and placebo groups. The authors suggested that this unforeseen result 
may have occurred due to the dualist behavior that vitamin E can have. As explained 
previously, vitamin E can also act as a pro-oxidant under certain conditions, such as 
high oxidation and low levels of other antioxidants (Rietjens et al., 2002). Moreover, 
the athletes participating in this study did not refrain from taking other vitamins or 
nutrients, which could also have influenced the results. The pro-oxidant effect of 
vitamin E was also shown in another study using the same high-dose supplementation 
protocol (2 months of 800 IU·day-1 of α-tocopherol) and testing highly trained athletes. 
Although the plasma α-tocopherol levels were elevated in the supplemented group pre 
and post-race, that did not result in a better performance but increased the lipid 
peroxidation in the triathletes (McAnulty et al., 2005b). Additionally, a study conducted 
using an animal model reported that high levels of vitamin E supplementation led to a 
decrease in muscle force production (Coombes et al., 2001). 
 
In a further attempt to investigate the effect of antioxidant supplementation on an 
extremely intense and long-duration exercise, Traber (2006) supplemented athletes prior 
to an ultramarathon trail run. A group of female and male athletes were divided into two 
groups: supplemented and placebo. Both groups went through a 6-week 
supplementation period, one receiving both vitamin E (400 IU·day-1) and C (1000 
mg·day-1), the other placebo. The supplemented group presented significantly higher 
levels of plasma antioxidants, but that did not result in an enhanced performance for that 
group. In addition, there was no difference on exercise-induced DNA damage, muscle 
damage or recovery. Interestingly, the author did report that the supplemented group 
had a lower oxidative stress post-run measured by a decreased in lipid peroxidation (F2-
isoprostane), but it had no effect on inflammation. This suggests that the combination of 
both vitamin C and vitamin E might be beneficial in protecting the runners against lipid 
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peroxidation when performing such a long and intense exercise. Nevertheless, the 
authors also reported that the women, in both groups, presented lower F2-isoprostane 
concentration when compared with their male counterparts. This is not unexpected since 
estrogen has shown to have anti-inflammatory and antioxidant properties (Massafra et 
al., 2000; Bloomer & Fisher-Wellman 2008; Iqbal et al., 2008). This raises the question 
whether including both men and women in the same study might have influenced the 
results. It is important to point out that the participants of this study were recreationally 
trained (VO2 max 58 mlO2·kg-1·min-1), making these results relevant to the physically 
active population but not to elite athletes or sedentary individuals. A summary of the 
studies mentioned above is provided in Table 6.1. 
 
Table 6.1. Studies of vitamin supplementation on performance and oxidative stress markers  
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While some of the mentioned studies have the advantage of being field studies, they 
also have the limitation of comparing two different groups of runners. These individuals 
could present different responses to vitamin supplementation and also to the oxidative 
stress of the exercise. It would, therefore, be a better study-design to analyse the same 
runners in both situation: placebo and supplementation. Furthermore, the exercise used 
in these studies (ultramarathon and ironman) are extremely intense and of long duration. 
Moreover, some of the studies had elite athletes with a high-training regimen as 
participants. Hence, their antioxidant defence mechanism was already adapted to protect 
them against certain levels of oxidative stress (Child et al., 1999; Powers et al., 2004; 
Bloomer & Fisher-Wellman, 2008), and the natural increase in plasma antioxidants 
might probably have abolished the effect of additional vitamin supplementation. This, 
therefore, supports the theory that supplementation of these calibre of athletes is of no 
benefit.  
 
There is a lack of studies in the literature investigating the effect of these vitamins 
supplementations on performance outcomes. The majority of studies have focused 
mainly on the oxidative and inflammatory response after a bout of exercise, though the 
exercise mode, duration and intensity vary considerably between studies, as well as the 
antioxidant dosage and duration of supplementation. These facts might account for the 
inconsistency in the outcomes. The immunological responses will be explored in detail 
in the next chapter.  
 
Even though more investigation is needed in relation to the benefits, optimal dosage 
strategy and combination of antioxidant supplementation for active individuals, so far 
little evidence exists to recommend vitamin intake for the purpose of improving athletic 
performance. Indeed, from the available literature there has not been a consistent 
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positive result when it comes to vitamin supplementation improving performance of 
trained individuals. Nevertheless, it might be more relevant to increase antioxidant 
intake when, besides the increase in radicals derived from the exercise bout, there are 
other factors that lead to an increase in the oxidant process which favour oxidative 
stress. These factors can be a hot environment or a polluted one. In the case of the 
influence of heat, it has been reported, in studies with animals, in vitro studies 
(Flanagan et al., 1998) and studies with humans (McAnulty et al., 2005a), that both a 
raise in core temperature and exercising in a hot environment increases the cellular 
radical production. Such production can contribute to the oxidative process and cellular 
damage.  
 
Vitamin C and E Supplementation in Individuals Exposed to Ozone-Pollution  
 
As for the oxidant stimulus of air pollution, specifically the potent oxidant gas ozone, a 
variety of studies have shown that exercising in an ozone-polluted environment can 
induce oxidative stress, lung inflammation and decrease in lung function as explained in 
detail in Chapter 2 (Devlin et al., 1996; Jörres et al., 2000; Ratto et al., 2006). The 
respiratory tract lining fluid is the first barrier encountered by inspired gases and, 
therefore, it has a network of antioxidants, such as ascorbic acid, GSH, α-tocopherol and 
uric acid to provide protection against oxidative stress (Mudway et al., 1999a; van der 
Vliet et al., 1999; Mudway et al., 2001). For this reason, studies have attempted to 
investigate the relationship between antioxidant ingestion and increase in antioxidant 
availability in the respiratory tract lining fluid that would provide additional sacrificial 
substrates for ozone, which could, consequently, decrease oxidation reactions occurring 
within this fluid and within the underlining epithelial cells. Unfortunately studies have 
shown that in practice this relationship is not so simplistic, with factors - such as 
individual sensitivity to ozone - playing an important role (Mudway et al., 1999b; 
Mudway et al., 2001). Once inspired, ozone has the potential to cause direct oxidation 
by reacting with electron donors, which would be the antioxidants present in the RTLF; 
and by reacting with unsaturated compounds, such as unsaturated lipids (Pryor, 1994). 
In addition, ozone can also cause indirect oxidation by activating lung inflammation that 
in turn, would increase the production of ROS which could cause damage beyond the 
lungs (Pryor et al., 1995). Ozone has been shown to deplete the endogenous antioxidant 
defences, inducing inflammation and oxidative damage in the airways (Mudway et al., 
1999a; Mudway et al., 1999b; Mudway et al., 2001). 
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By increasing the availability of the antioxidants present in the RTLF it can be theorized 
that there would be an increase in the reaction with ozone, limiting its interaction with 
the unsaturated molecules as a consequence. In addition, an excess in antioxidants 
concentration might also confer protection by neutralizing free radical species, derived 
from these initial reactions or inflammatory cells (Pryor et al., 1995; Mudway et al., 
2001). Few studies have investigated this proposed benefit of increasing antioxidant 
availability in individuals exposed to ozone-pollution by supplementing the participants 
with vitamins C and E. Indeed, some studies have shown some protective effect when 
participants are supplemented with a mix of antioxidants. Romieu et al. (1998) 
conducted a field study in which 34 workers (shoe-cleaners) exposed to pollution 
(Mexico City), participated in a double blind supplementation/placebo crossover design 
study. The supplementation consisted of a combination of different antioxidants (650 
mg vitamin C + 100 IU vitamin E + 15 mg b-carotene) ingested during a 10-week 
period. The washout period was 2 weeks. The average daily ozone concentration was 
0.07 ppm, and on 55% of the days the concentration exceeded the Mexican standard of 
0.11 ppm. A protective effect of antioxidant supplementation against ozone exposure on 
lung function (FEV, FVC, FEF25-75) was reported. The authors, however, did mention 
that individuals who consumed antioxidants first presented less lung function 
impairment after consuming placebo than subjects that initially ingested placebo. The 
authors attributed this result to the short washout period, especially for vitamin E, which 
accumulates in the tissues, but they did not investigate this issue. Field studies such as 
this one have some limitation such as the interference of other pollutants and the 
concentration of the analyzed pollutant throughout the long period in which the study 
was conducted. In addition, the participants of this study were not exercising while 
exposed to the pollution. 
  
Two subsequent field studies, conducted with amateur and recreational cyclists 
(Grievink et al., 1998; Grievink et al., 1999), reached similar results in relation to 
antioxidant supplementation providing some protection against acute effects of ozone 
on lung function. Grievink et al. (1998) observed two groups of cyclists, during a 3-
month period. One group was supplemented with vitamin C (650 mg·day-1), vitamin E 
(100 IU·day-1) and β-carotene (15 mg·day-1), while the other ingested placebo. This 
study was conducted during the summer months, and the lung function of the cyclists 
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was measured before and after training or competition on 4 to 14 occasions. Of note, the 
supplementation started 1 week before the first measurement and was maintained during 
the study period, this could have influenced the result as the participants were not all 
tested on the same occasions. The mean temperature throughout the study period was 
23ºC and the ozone concentration averaged 0.05 ppm. In the subsequent study by the 
same group (Grievink et al., 1999), the same protocol was followed in relation to the 
exercise and measurements during the summer; however, the supplementation protocol 
varied slightly (3 months of daily vitamin C 500 mg and vitamin E 150 IU). In this 
study, even though it was reported that the supplementation was able to partly 
counteract the decreases of lung function, the authors also mentioned that when 
participants that had not complied fully with the supplementation were excluded from 
the analysis the effects of ozone on lung function were no longer seen. The average 
temperature and ozone concentration in this study were lower than in the previous 
study: 17ºC and 0.04 ppm respectively. Both studies presented some disadvantages. 
Firstly, they analysed 2 different groups of individuals, making comparison challenging 
as the effects of ozone have been shown to vary a lot from one individual to another. 
Secondly, the placebo group and the vitamin group were not balanced in relation to 
individuals presenting respiratory allergies or asthma. In addition, in the latter study 
(Grievink et al., 1998), the placebo group, acting as the control, was not taking any pills, 
therefore, it was not blinded. Thirdly, some individuals that were in the supplemented 
group were already taking antioxidants prior to the start of the study. And, finally, it 
was reported that the adjustment for environmental temperature as a possible 
confounder was difficult due to the high correlation with ozone. All in all, it is 
important to view these results with caution because a variety of uncontrolled variables 
could have influenced the outcome.  
 
In the study of Samet et al. (2001), participants first underwent a 1 week period of 
vitamin C-restricted diet. After this, one group received supplementation (250 mg 
vitamin C + 50 IU vitamin E + 12 oz of carrot and tomato juice), while the other group 
received placebo and was still on the restricted diet. The supplementation period 
consisted of a 2-week period after which the subjects underwent a 2 h low-intensity 
exercise protocol in a high ozone-polluted chamber (0.4 ppm). After exposure, subjects 
completed a respiratory symptom questionnaire, performed lung function tests and 
underwent a bronchoalveolar lavage. There were no differences between the 
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supplemented group and the placebo group in respect to the respiratory symptom 
questionnaire. This suggests that dietary antioxidants do not minimize the perceived 
harmful effects of ozone. In addition, there were no differences in neutrophil counts or 
other inflammatory markers in the bronchoalveolar lavage fluid. Nevertheless, the 
authors did report attenuation in lung function impairment in the subjects who ingested 
the antioxidant mixture. Contrary to this finding, Mudway et al. (2006) did not report 
any changes in lung function when they conducted a double-blind crossover study. The 
supplementation (500 mg vitamin C + 150 IU vitamin E daily) period used in this study 
was smaller than most supplementation protocols: just 1 week, with a 2-week washout 
period. The exposure protocol consisted of 2 h of intermittent cycling in a chamber with 
0.2 ppm of ozone. In addition to the lack of changes in lung function, there were no 
differences in airway inflammation, which was assessed 6 h post-exposure. It is 
important to point out that, after the supplementation protocol, the subjects did present 
an increased concentration of plasma ascorbic acid and α-tocopherol. This increased 
concentration, however, was not observed in the respiratory airways when it was 
accessed 6 h after the ozone exposure. Nevertheless, the authors did report movement of 
α-tocopherol from the plasma into the RTLF following ozone the ozone challenge. A 
summary of the studies presented above is provided in Table 6.2. 
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In general, the few studies that have attempted to investigate the effects of vitamin 
supplementation on exercising individuals exposed to ozone-pollution have not 
presented a major positive outcome. This could be due to the population investigated, 
the supplementation protocol, the exercise bout and the study design. In addition, they 
did not research the influence of these antioxidants on performance in a polluted 
environment. And, as an increase in ozone-pollution is related to an increase in 
environmental temperatures, investigating these factors together is needed in order to 
provide a more relevant environmental condition and applicable results.  
 
The rationale for the study presented in this chapter is based on previous findings 
related to the relationship between high levels of antioxidant and performance 
improvement in a hot, humid and ozone-polluted environment (Chapter 5). It was 
hypothesized that supplementation with the antioxidants vitamin C and E would 
decrease oxidative stress and alleviate respiratory symptoms experienced by trained 
runners when performing a high intensity exercise in those adverse conditions. This, in 
turn, would be translated into an improvement in performance when compared with the 
same athletes ingesting placebo. Results from previous studies investigating the effect 
of supplementation with these vitamins, alone or combined, have been inconclusive. 
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Possible reasons for these divergences comprise differences in exercise mode, fitness 
level of participants and study methodology. Due to the high antioxidant consumption, 
specifically in the form of vitamins, by the physically active community and by a large 
portion of the general population, make this an important topic for research, especially 
when coupled with the fact that large urbanized areas might provide an additional 




Detailed descriptions of certain methods used in this study have been fully elucidated in 
Chapter 3. Any specific methodology used in this study will be fully described here, the 
others, previously described, will be summarized.  
 
6.2.1. Participants 
Ten well trained male runners took part in this study (mean ± SD, age = 29 ± 8.1 years; 
mass 67.0 ± 4.9 kg; height = 175.5 ± 5.7 cm; max2OV  = 65.8 ± 4.2 mlO2∙kg-1∙min-1). 
The participants were all competitive runners who had to achieve a criterion max2OV  
minimum value of 60 mlO2∙kg-1∙min-1. The adequacy of each subject’s max2OV  was 
tested during the familiarization trial (see section 3.1.1 for further details). One of the 
runners dropped out of the study after his first experimental trial due to the severity of 
respiratory symptoms that he experienced while performing the time-trial run in the 
ozone polluted environment.  
 
6.2.2 Experimental Procedures  
This study took place during the autumn and winter months and had a randomized 
double-blinded crossover design. After the familiarization trial, the participants were 
randomly assigned to initiate a 2-week supplementation period of vitamins C (500 
mg·day-1) and E (100 IU·day-1) or placebo (500 mg·day-1 of sucrose). They were 
instructed to take the pills once a day with their breakfast and the last supplementation 
was taken on the morning of the exercise protocol. After a 1-week washout period the 
athletes initiated a further 2-week supplementation, with the participants that initially 
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took the vitamins taking now the placebo and vice-versa (Figure 6.2). The pills for the 
vitamins and placebo looked exactly the same and when asked if they knew what they 
were taking all participants said they had no idea. In addition, they were asked to refrain 
from any physical activity 24 h before the exercise trials. 
 
 
Figure 6.2. Double-blind randomized crossover study design. 
 
On the exercise trial day the participants arrived at the lab at 8:40am, and remained 
seated for 5 minutes before their blood pressure was measured to check if it was within 
the normal range. During this 5-minute period they completed a health questionnaire 
(Appendix IV) to assess if they were in good health to take part in the exercise trial. If 
they presented signs of cold or flu they did not take part in the exercise and were asked 
to return 2 weeks after they recovered. The participants then had blood samples taken, 
gave a saliva sample, performed the lung function test (FVC, FEV1, FEF25-75 and PEF) 
and the nasal lavage procedure. The exercise trials took place in the environmental 
chamber, details are given in section 3.2. The exercise consisted of an 8 km time trial 
run on a treadmill (Woodway, PPS 55 Med, Germany), which the participants were 
required to complete as fast as they could. The runners controlled their own speed, but 
they did not have access to the value of the speed. The environmental condition was 
0.1ppm of O3 at 31 ºC and 70% rh. Immediately post-exercise and 6 h after the exercise 
the athletes went through the same tests: blood samples were taken, saliva sample, lung 
function and nasal lavage. The subjects were asked to write down the food they 
consumed during the first exercise trial day and on the next trial to repeat it. The 
exercise protocol was the same used previously and has been detailed in section 3.3. 
The athletes had access to water ad libitum during the first trial, however this water 
intake was measured and the same amount was made available on the second trial.   
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Assessment of Respiratory Symptoms. The severity of respiratory symptoms was 
assessed by a written questionnaire after the athletes completed the exercise protocol as 
described previously in section 3.3.1.  
 
To analyze the impact of the supplementation protocol on the antioxidant status and 
oxidative stress of the runners, the following variables were assessed: 
• In nasal lavage: Vitamin C concentration, vitamin E concentration, trolox 
equivalent antioxidant capacity, GSH/Protein, and MDA as a marker of lipid 
peroxidation. 
• In plasma: Total antioxidant concentration, vitamin C concentration, vitamin E 
concentration, GSH/Protein and MDA. 
 
6.2.3.1 Biochemical Analysis 
Total antioxidant and Vitamin C 
The Vitamin C content in the plasma and nasal lavage samples was measured using a 
Ferric Reducing Ascorbate assay (FRASC, BioVision). The plasma samples used for 
this colourimetric assay were collected with a vacutainer containing sodium heparin as 
an anticoagulant. In this assay Fe+3 is reduced to Fe+2 by any antioxidant present in the 
sample, thus allowing the determination of the total antioxidant concentration present in 
the sample. In addition, the ascorbic acid concentration can also be obtained by the 
addition of ascorbate oxidase, which is added into parallel samples removing any 
ascorbic acid present, leaving a background value which is then subtracted from the 
total (samples without addition of ascorbate oxidase). In brief, 100 μl of samples and 
standards were added in duplicate to a 96 microwell plate. For the samples, one well of 
the pair was to determine the total antioxidant present, while the second well was for the 
ascorbate depletion (background well). The ascorbic acid standards were prepared with 
distilled water and varied 10 – 2 nmol. Ascorbate oxidase (10μl) was then added to the 
background well and 10 μl of distilled water to the total antioxidant well. The plates 
were then incubated at room temperature for 15 min to allow the depletion of the 
ascorbic acid. Following that, 100μl of the Reaction Mix (80% FRASC Buffer + 10% 
Ascorbic Acid Probe + 10% FeCl3 solution) was added to each well. The plate was read 
immediately using a wavelength of 593nm in a 96 well plate reader. The standard curve 
was obtained on a linear/linear fitted line plot against absorbance and the 
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concentration of ascorbic acid calculated by the difference between the total antioxidant 
well and the background well.   
 
Vitamin E  
The vitamin E concentration of the plasma and nasal lavage was measured using high 
performance liquid chromatography (HPLC) with the method described by Siluk et al. 
(2007). Unfortunately due to problems with the equipment this procedure could not be 
done accurately. The method used was as follows. Stock solution of the standard was 
prepared diluting the α-tocopherol (6.0M) standard with the mobile phase (70% 
acetronitrile + 30% methanol) to a concentration of 1 mg·ml-1. For each sample (200μl) 
were added 20 μl of the standard solution and 200μl of purified water, the resulting 
solution was vortex for 10 sec. After adding 400μl of ethanol the solution was vortexed 
for another 10 sec. Hexane (800μl) was added to the solution which was then vortex for 
3 min, and then centrifuged at 3500g for 10 min at 10 ºC. After these procedures, 700μl 
of the hexane layer was transferred to a glass tube and the hexane was evaporated under 
a stream of nitrogen. The resulting pellet was re-suspended in 200μl of methanol and 
vortexed for 30 sec. The mixture was transferred to an amber vial and 20μl was injected 
into the HPLC system for analysis. The chromatography was carried out using a Varian 
Prostar HPLC System (Varian Prostar AutoSampler, 410, NL) with a Zorbax Eclipse 
XDB-C18 column (150 mm x 4.6 mm i.d., 5 μm particle size). A Shimadzu UV-160A 
spectrophotometer was used to determine the absorbance of the solutions. The column 
was thermostated at 30 ºC, and the flow rate set at 1 ml·min-1, the excitation wavelength 
was set at 295 nm and the emission wavelength set at 330 nm. Unfortunately due to 
problems with the HPLC equipment this procedure could not be carried out 
appropriately. 
 
Lipid Peroxidation Marker 
In an attempt to measure lipid peroxidation, in plasma and nasal lavage, the assay that 
quantifies MDA, as a marker of this oxidative stress process, was used. Initially, the 
samples were thawed and 200µl of each sample was placed into two eppendorfs – one 
to be the blank sample and the other containing the reagent. MDA (1,1,3,3-
tetramethoxypropane, in 20mM Tris-Hcl, pH 7.4) standards were prepared to a final 
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concentration of 0-20µM.  An aliquot of 10µl 0.5M BHT in acetonitrile was added to 
the samples and standards followed by the addition of 650µl of diluted reagent 1 (three 
volumes of 10.3mM N-methyl-2-phenylindole in acetonitrile, diluted with one volume 
of 100% methanol HPLC grade). For the blank samples instead of reagent 1 a solution 
made up of 75% acetonitrile and 25% methanol was added. Each eppendorf was gently 
vortexed before adding 150µl of reagent 2 (15.4M methanesulfonic acid). After that, the 
solution was mixed and incubated at 45ºC for 60min. Samples were then centrifuged at 
15,000g for 10 minutes (1K15, Sigma Laboratory centrifuges, Osterode, Germany). The 





All data were checked for normality before statistical analysis. Data were analyzed 
using General Linear Model ANOVA (Minitab15 Statistical Software) with Tukey’s 
Post-hoc test. Statistical significance was accepted at P < 0.05. In order to verify any 
association between the variables a correlation matrix was conducted, with a subsequent 
multi-regression analysis (Minitab15 Statistical Software). Data are expressed as mean 




6.3.1. Medical questionnaires  
One of the participants presented asthma but it was under medical control, and another 
presented hay fever. This research was conducted during the autumn and winter period 
therefore, the hay fever problem was not an issue.  
 
6.3.2. Plasma and Nasal Lavage Antioxidant Concentration 
The vitamin C and the total antioxidant concentration of the plasma were measured 
using the FRASC assay. This assay was not sensitive enough to measure the values in 
nasal lavage. Therefore, the antioxidant concentration of the nasal lavage fluid was 
measured using the TEAC assay, which was known to work with the nasal lavage 
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samples as it was successfully used in the previous study.    
 
Vitamin C 
The plasma vitamin C concentration was significantly higher when the athletes ingested 
the vitamin supplementation both pre and post-exercise compared to the placebo values 
(Figure 6.3). There was a trend for the plasma vitamin C to increase immediately after 



































Figure 6.3. Total plasma vitamin C concentration. § Significant differences between trials at the 
pre-exercise time point (P < 0.01); §§ Significant differences between trials at the post-exercise 
time point (P < 0.05). Mean ± SD. 
 
 





Similarly to the previous result, the total antioxidant concentration in the plasma was 
significantly higher pre and post-exercise in the Vitamin trial compared with the 
Placebo trial. In addition the post-exercise values for plasma total antioxidant 
concentrations, in both the Vitamin and Placebo trials were significantly elevated 
compared with their respective pre and 6 h-post values. This percentage increase did not 






































Figure 6.4. Total plasma antioxidant concentration. § Significant differences between trials at 
the pre-exercise time point (P<0.01); §§ Significant differences between trials at the post-
exercise time point (P<0.05); ** Significantly different from pre-exercise and 6 h- Post exercise 
time points in the same trial (P<0.01). Mean ± SD. 
 
Nasal lavage trolox equivalent antioxidant capacity (TEAC).  
The TEAC of the nasal lavage did not vary between the trials (P =0.059) as was seen in 
the plasma samples. Nevertheless at the post-exercise time point there was a significant 
increase in the antioxidant capacity of the nasal lavage in the Vitamin trial compared 
with the pre and 6 h-post values. This pattern was not observed for the Placebo trial. At 































Figure 6.5. Trolox equivalent antioxidant capacity of nasal lavage. ** Significant increase 
compared to pre-exercise and 6 h-post exercise within the same trial (P<0.05). Mean ± SD.  
 
Plasma and nasal lavage GSH/Protein 
No significant differences were observed between trials or between time points for 
either the plasma or nasal lavage GSH/Protein concentration (Table 6.3.). There was a 
trend for an increase in this antioxidant concentration post-exercise in the Vitamin trial, 
but it did not reach statistical significance. The intra-assay coefficients of variation for 
the duplicate samples were 4.1% and 3.4% for the plasma and nasal lavage samples 
respectively. 
 
Table 6.3. GSH/protein concentration in plasma and nasal lavage in both trials. 
 Vitamin Trial Placebo Trial 
 Pre Ex Post Ex 6H-Post Ex Pre Ex Post Ex 6H-Post Ex 
 
Plasma 
GSH/protein x10 3 
(μmoles·mg-1) 
 
1.2 ± 0.7 
 
0.9 ± 0.2 
 
1.1 ± 0.3 
 
1.2 ± 0.6 
 
1.0 ±  0.3 
 
0.8 ± 0.3 
NL GSH/protein 
(μmoles·mg-1) 
0.08 ± 0.03 0.11 ± 0.03 0.08 ± 0.05 0.09 ± 0.05 0.09 ± 0.04 0.09 ± 0.06 
Values are mean ± SD. 
Lipid Peroxidation 
The MDA assay was carried out in an attempt to measure lipid peroxidation in the 
plasma and nasal lavage samples. The assay however was not sensitive enough to 
** 
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quantify the MDA levels of the samples.  
 
6.3.3 Performance variables 
The results for total time to complete each trial are presented in Figure 6.6. There was a 




























Figure 6.6. Individual time to complete the 8 km run.  
 
There was an average increase of 49 sec in the time to complete the Placebo trial 
compared with the Vitamin one. This difference is equivalent to a 2.6% improvement in 
the performance when the runners were taking the vitamin supplementation. The 95% 
Confidence Interval (lower; upper limits) for the trials for this variable was: (-98.2; 6.0). 
Results for heart rate, RPE, speed, expired air and 2OV  for each of the trials are 
presented in Table 6.4. There were no differences between the trials for the variables 
analysed.  
Table 6.4. Effect of exercise trial on heart rate, RPE, speed, expired air and oxygen 
consumption.  
 Vitamin Trial Placebo Trial 
 
Average Speed (km·h-1) 
 
15.5 ± 1.2 
 
15.1 ± 1.2 
  Vitamin        Placebo 
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Mean Heart Rate (beats·min-1) 172 ± 9 167 ± 12 
Peak Heart Rate (beats·min-1) 191 ± 9 192 ± 12 
Mean RPE 15 ± 1.2 15 ± 1.2 
Peak RPE 18 ± 1.5 19 ± 1.2 
Expired Volume (l·min-1) 110.1 ± 13.2 122.6 ± 30.9 
2OV  (mlO2∙kg-1∙min-1) 59.0 ± 3.3 61.2 ± 8.1 
Values are mean ± SD. 
 
6.3.4 Lung Function 
Changes in lung functions pre, post and 6 h-post run were compared within and between 
trials. No significant differences were found for any of the analyzed variables (FVC, 
FEV1, FEF25-75 and PEF) within the same trial or between trials (Table 6.5). In addition, 
when the runners’ pre and post FEV1 was analyzed it was seen that none of them 
presented exercise induced asthma, which is characterized by a 10% or more decrease in 
this variable (Rundell & Jenkinson, 2002). 
 
Table 6.5. Lung function measures for both trials. 
 Vitamin Trial Placebo Trial 




5.1 ± 1.2 
 
4.9 ± 1.2 
 
5.0 ± 0.9 
 
5.0 ± 0.9 
 
4.7 ± 1.2 
 
5.0 ± 0.9 
FEV1 (l) 4.1 ± 0.9 4.2 ± 0.9 4.1 ± 0.9 4.2 ± 0.9 4.0 ± 0.9 4.3 ± 0.9 
PEF (l·min-1) 621 ± 96 616 ± 105 574 ± 108 609 ± 75 576 ± 111 601 ± 108 
FEF25-75 4.0 ± 1.2 4.5 ± 1.5 4.2 ± 1.5 4.2 ± 1.2 4.4 ± 1.8 4.9 ± 1.5 
Values are mean ± SD. 
 
6.3.5 Respiratory Symptom Questionnaire 
An overview of the respiratory symptoms reported by the subjects in response to the 
trials is given in Figure 6.7. In the Placebo trial there is a trend to increase the severity 
of respiratory symptoms experienced by the athletes. However, this does not reach 
significance in any symptom or in the overall score. In response to the question of 
whether they felt that they would be able to perform maximally in a competition in 
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the environmental conditions tested, all ten runners reported they would not be able to 
perform maximally in the Placebo trial and two out of nine subjects reported they would 
be able to perform maximally in the Vitamin trial. One subjects dropped out of the 
study after his first trial due to difficulty in breathing. After the completion of the study 










There was a significant positive correlation between the increase in antioxidant 
concentration after the vitamin supplementation and the difference in performance 
between the two trials. That is, participants who presented a higher antioxidant 
concentration had a better improvement in their time to complete the 8 km run. This 
was true for the plasma vitamin C levels pre exercise, the plasma total antioxidant 
concentration pre-exercise, and the nasal lavage total antioxidant concentration post-
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Figure 6.8. Relationship between improvement in performance and increase in the plasma total 
antioxidant concentration pre-exercise (A), plasma vitamin C concentration pre-exercise (B), 




In this chapter the hypothesis tested was that the combination of vitamin C and E 
supplementation would increase both the systemic and the airway antioxidant 
concentration. As a consequence, this would decrease the oxidative stress and 
respiratory symptoms of the participants running in a hot, humid and ozone-polluted 
environment, thus, resulting in an improvement in their performance when compared 
with the ingestion of placebo. The main findings of this study were: (1) the 
supplementation protocol significantly increased the plasma antioxidant concentration 
pre and post-exercise compared with the placebo ingestion; (2) there was a significant 
increase in the nasal lavage antioxidant capacity post-exercise in the Vitamin trial; (3) 
there was a 2.6% improvement in the time to complete the trial when the participants 
ingested the vitamins; (4) significant positive correlations were found between 
antioxidant concentration and improvement in time to complete the run in the hot 
polluted environment.   
 
Vitamins C and E were used as supplements in this study because these two 
antioxidants are present in the RTLF, they have strong antioxidant properties and 
together they have been shown to present a synergistic effect in the protection against 
C 
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oxidative stress (Mudway et al., 2001; Rietjens et al., 2002). In addition, vitamin E is 
the major lipophilic antioxidant in human tissues, including in the airways (Cross et al., 
2006); and vitamin C has been linked to aspects of lung health, such as improvement in 
lung function (Romieu et al., 2006), positive effect on exercise-induced 
bronchoconstriction in asthmatic individuals and decrease in respiratory symptoms post-
exercise (Teckenburg et al., 2007). Moreover, the supplementation with these two 
vitamins has been shown to provide some protection in humans exposed to ozone-
pollution (Romieu et al., 1998, Grievink et al., 1998; Grievink et al., 1999; Samet et al., 
2001; Sienra-Monge et al., 2004).  
 
A supplementation protocol of two weeks with 500 mg·day-1 of vitamin C was chosen 
as being able to saturate the plasma and maintain a steady state after 1 week of ingestion 
(Jacob et al., 1987). A dose of 100 IU·day-1 of vitamin E was selected, based on the 
benefits reported by studies which used this concentration (Grievink et al., 1998; 
Romieu et al., 1998), and the 2-week supplementation period has been shown to be 
sufficient for plasma concentration of α-tocopherol to reach a steady state (Fisher et al., 
2004). These values are higher than the RDA (Institute of Medicine, 2000), but they are 
also the lowest concentrations that have shown to provide benefits in supplementation 
studies, as previously described. As the participants of this study maintained their 
training protocol throughout the duration of the study, a longer supplementation 
protocol could potentially interfere with their training adaptations (Gomez-Cabrera et 
al., 2008b; Ristow et al., 2009). The supplementation protocol used in the present study 
was shown to be effective in increasing the plasma total antioxidant and vitamin C 
concentrations at baseline compared with the Placebo trial. This trial difference was 
maintained for both the total antioxidant and the vitamin C concentrations immediately 
after exposure, but after 6 h there were no significant differences between the two trials. 
In addition, post-exercise there was a significant increase in the plasma total antioxidant 
concentration in both trials compared with their respective pre values. As for vitamin C 
concentration, there was a similar increasing trend post-exercise in both trials. This 
pattern of vitamin C change in the plasma is corroborated by other studies (Palmer et 
al., 2003; Traber, 2006), that also show an increase in this vitamin after the exercise in 
both groups taking vitamin or placebo. A significant increase in plasma total antioxidant 
concentration after exercise and the lack of a significant increase in the vitamin C levels 
suggests that the exercise and adverse environmental conditions are stimulating the up-
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regulation or mobilisation of a network of antioxidants. Vitamin E could possibly have 
contributed to that, however we were unable to measure the vitamin E concentration due 
to technical problems.  
 
In the study of Mudway et al. (2006), subjects went through a 1-week supplementation 
period with 500 mg of vitamin C and 150 IU of vitamin E before being exposed to 0.2 
ppm of ozone and performing a 2 h intermittent cycling exercise. Analysis of the plasma 
showed that vitamin C concentration was significantly elevated before commencing the 
exposure protocol, and peaked immediately post-exercise, before returning to pre- 
exercise exposure levels 6 h later. This pattern was not observed for the Placebo trial, 
which did not show any variation in this antioxidant concentration throughout the trial.  
As for plasma vitamin E, the 1-week supplementation period was sufficient to 
significantly increase the basal concentration, and there was a progressive increase over 
the 8 h experimental period. Bronchial wash and the bronchoalveolar lavage was 
conducted 6 h after the exposure protocol. When analysing the airways, the authors 
reported no significant increase in vitamin C in either trial. On the other hand, the 
vitamin E levels were increased after exposure, and this response appeared more 
pronounced in the supplementation trial. It is worth noting that, while the 6 h time point 
is appropriate to measure markers of inflammation, such as neutrophil influx to the 
airways, it might be too late to analyse the low molecular weight antioxidant 
concentration in the respiratory tract and evaluate its relationship with the plasma 
concentration of the same antioxidant.  
 
In the present study the vitamin C and E of the airways were not successfully measured, 
possibly because of the high dilution of vitamin C in the nasal lavage, and because of 
technical problems for the vitamin E. It was possible, however, to measure the trolox 
equivalent antioxidant capacity of the nasal lavage. At baseline there was no difference 
between the Vitamin and Placebo trial. Immediately after the exercise it was observed 
that an increase in the nasal lavage trolox equivalent antioxidant capacity occurred only 
in the Vitamin trial. It can be speculated that the higher antioxidant concentration in the 
plasma allowed a more efficient up-regulation of the antioxidant defences in the upper 
respiratory airways. Even though this mobilization from the plasma to the airways 
might not be so simplistic, it has been suggested to occur in other studies that assessed 
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different antioxidants, such as a-tocopherol, vitamin C, GSH and uric acid (Mudway et 
al., 1999b; Blomberg et al., 1999; Mudway et al., 2001; Schock et al., 2004; Mudway et 
al., 2006). In fact, an increased vitamin C intake has been shown to boost this 
antioxidant concentration in the RTLF within 2 h of intake. This fast redistribution of 
vitamin C between the plasma and the airways, measured by Schock et al. (2004) using 
nasal lavage procedure, most likely occur by passive diffusion, facilitated mainly 
because of the high vascularisation of the nasal mucosal tissue. This fact might also 
facilitate the mobilization of other antioxidants from the plasma to the nasal mucosa 
region. Nevertheless, due to the lack of data on the vitamin C and E status in the nasal 
lavage it is impossible to speculate how these vitamins actually contributed to the 
increase in the nasal lavage antioxidant capacity in the present study. The lack of 
increase of these vitamins in the lower airways reported in studies that have used 
vitamin supplementation analysing the lower airways could be attributed to a failure of 
the supplementation to enhance the antioxidant defences in those regions of the airway. 
In addition, the supplementation protocol and the time point used to assess the airway 
antioxidant status could also account for those outcomes (Mudway et al., 1999b; 
Mudway et al., 2006).  
 
Most studies that have analysed the performance of subjects after supplementation with 
vitamin C and E have used as an exercise protocol an actual competition such as an 
Ironman (Nieman et al., 2004; McAnulty et al., 2005b), or an ultramarathon (Palmer et 
al.,  2003; Mastaloudis et al., 2004; 2006). These studies failed to show a benefit in 
performance with the use of vitamin supplementation, even though the plasma levels of 
the supplemented antioxidants were elevated before and during the races. These studies 
have the limitation of comparing two groups of athletes; in addition, most of them used 
long supplementation period that varied from 6 to 8 wks and high supplementation 
dosage, factors which might have interfered with the training adaptations or stimulated 
the pro-oxidant effect of the vitamins (Gomez-Cabrera et al., 2008b; Ristow et al., 
2009). Moreover, these studies are not directly comparable to the present one because 
they were not analysing the effect of ozone-pollution and temperature on the outcome of 
the results, therefore it is with caution that the results are compared. In the present study 
the time to complete the Vitamin trial (31:05 min) was an average of 49 sec faster 
compared with the Placebo trial (31:54 min), although this difference did not reach 
statistical significance (P=0.075). Nevertheless, it is important to point out that while it 
is not a statistically significant result, the difference in performance observed between 
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the two trials was of 2.6%. As mentioned previously in Chapter 4, according to Hopkins 
and Hewson (2001) this improvement in performance observed after the 
supplementation period is over 5 times higher than the necessary improvement (0.5%) 
suggested to be significant in a short-duration competition environment; or more than 
twice the necessary improvement (1%) to significantly increase an athlete’s chance of 
winning a medal in a marathon or half-marathon competition. It therefore, seems 
reasonable to speculate that this improvement in performance might be ecologically 
relevant. Due to the lack of studies in the literature analysing the performance outcome 
in a polluted environment after vitamin supplementation these results cannot be 
compared to others. 
 
Still in regard to the performance outcome, some interesting correlations were observed. 
First, individuals that presented a more pronounced increase in the baseline plasma total 
antioxidant concentration with the supplementation protocol also presented a higher 
improvement in their performance in the Vitamin trial compared to the Placebo 
(R=0.82, P<0.01). This correlation was even higher for the increase in baseline plasma 
vitamin C concentration and performance (R=0.96, P<0.01). A third important 
correlation was the positive relationship between the post-exercise increase in nasal 
lavage trolox equivalent antioxidant capacity in the Vitamin trial and the improvement 
in performance outcome (R=0.81, P<0.01). Observing those correlations it can be 
speculated that the ozone susceptibility of an individual that is exercising could be 
influenced by the antioxidant availability in their plasma and airways. In addition, the 
correlation between nasal lavage trolox equivalent antioxidant capacity post-exercise 
and performance seems to suggest that it is not the initial absolute antioxidant status in 
the upper respiratory airway which is critical in the performance outcome, but rather the 
capacity to up regulate a protective response to the oxidative stimulus. In the previous 
study (Chapter 5) this correlation between performance outcome and antioxidant status 
in the upper respiratory airways was also observed when the participants performed in 
the Heat + O3 trial. 
 
It was also observed that even though the runners, when in the Vitamin trial, were all 
taking the same quantity of daily vitamins, the individual baseline values varied widely 
from 13.3 nmol·ml-1 to 19.2 nmol·ml-1 of total antioxidant and from 5 nmol·ml-1 to 8 
nmol·ml-1 for plasma ascorbic acid. This is in agreement with the study of Jacob et al. 
(1987) that showed a difference in vitamin C absorbance in individuals having the same 
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vitamin intake and in fact the same diet (there values varied from 1 to 1.8 mg·dl-1). In 
the present study we did not control the runners’ diet throughout the study, and this 
might explain the individual differences in the plasma total antioxidant concentration 
and also in the plasma vitamin C levels. In addition, the individual differences in the 
plasma ascorbic acid response to the vitamin supplementation could also be attributed to 
different body pools of this vitamin. That is, the plasma vitamin C levels only represent 
a portion of the total body ascorbic acid pool, this difference could thus represent a 
variation of vitamin C binding in different tissues and cells, for instance in red and 
white blood cells (Jacob et al., 1987).  
 
As for differences in plasma vitamin E variation between individuals in response to 
dietary supplementation, although we did not specifically measure its concentration, this 
could also contribute to the individual differences in plasma total antioxidant 
concentration. Studies have shown that the absorption of this vitamin can vary between 
individuals because of differences in the expression and activity of intestinal vitamin E 
transporters and the availability of lipids. The absorption efficiency of this vitamin is 
also influenced by the food with which it is ingested. In addition, its variation in plasma 
can also be a result of plasma fluctuations in lipoprotein concentration, and selective 
lipid and vitamin E uptake in different tissues (Traber, 2006; Rigotti, 2007).  
 
A limitation of the present study was the small sample size because of difficulty in 
recruiting participants. Nevertheless, the crossover design of this study helps to balance 
this number, as each participant acted as their own control. One of the main reasons for 
this difficulty was the fitness level criteria established for the runners. On one hand, the 
high level of the runners presents as an advantage of this research, because most lab 
studies recruit individuals with low activity levels or moderately active. Therefore, it is 
possible to extrapolate our results to the athletic community and also to the moderately 
active individuals. On the other hand, such a lengthy research where the runners have 
not only to dedicate their time, but also change their habits for the research purposes, 
does decrease the number of interested individuals. In addition, a couple of runners that 
were interested in the study and did fit the VO2 criteria of the study were already taking 
multivitamin supplementation and did not want to stop taking them. Another individual 
was training for a marathon and could not fit the trials with his training programme; and 
one runner dropped out after experiencing severe respiratory distress during his first 
trial, later it was revealed that he was on his Placebo trial. The individual that dropped 
 137 
out reinforces that some athletes are more sensitive to the effects of ozone-pollution and 
heat, and it would be relevant (but difficult ethically) to specifically analyse aspects that 
might exacerbate this susceptibility, such as the antioxidant concentration in the 
airways. Analysing his plasma pre antioxidant levels he was within the lower range of 
the participants values for the Placebo trial: 12.8 nmol·ml-1 for total antioxidant 
concentration and 3.8 nmol·ml-1 for ascorbic acid concentration.  
 
To assess the oxidative stress levels in this study GSH concentration was measured in 
both plasma and nasal lavage, but, we did not manage to measure MDA levels, as a 
marker of lipid peroxidation, in either the plasma or nasal lavage samples.  Palmer et al. 
(2003) reported no differences in markers of lipid peroxidation (F2-isoprostane and lipid 
hydroperoxides) in a vitamin C supplemented group compared to a placebo group after 
an ultramarathon race, despite higher plasma levels of this antioxidant in the 
supplemented group. Conversely, Traber (2006) reported that individuals supplemented 
with both vitamin C and E did present a lower F2-isoprostane level after an 
ultramarathon compared with individuals that consumed placebo; and the F2-isoprostane 
concentrations were inversely correlated with the vitamin C and E levels, providing 
further evidence that the antioxidant were responsible for preventing the lipid 
peroxidation. The latter study however, was conducted using two different groups of 
individuals with both male and female subjects, and the author did report that the female 
runners presented less oxidative stress after the race. It is difficult to know to which 
extent this might have influenced the group result. Davison and Gleeson (2006) reported 
no changes in MDA following a 2-week vitamin C (1000 mg·day-1) supplementation 
protocol and after a 2.5 h of cycling exercise compared with when the participants 
ingested placebo. Of note, these studies were looking into the effect of vitamin 
supplementation on oxidative stress after a bout of exercise, but without any additional 
stressor of ozone or heat and humidity.  
 
As detailed in Chapter 2, GSH is a water-soluble low-molecular-weight antioxidant that 
is synthesized in all types of cells (Anderson, 1998). It is found in high concentration in 
the airways, and in addition to its important functions in the body, including its 
antioxidant capacity, GSH also has a role in mediating the immune response (Lu, 1999; 
Wu et al., 2004). These factors make it relevant to analyse this antioxidant in the 
context of the present study. There were no differences in the baseline levels of GSH 
either in the plasma or nasal lavage samples of the runners comparing the Vitamin and 
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the Placebo trial. Immediately after the exposure protocol there was a non-significant 
decrease in the plasma GSH/Protein levels, this decrease was accentuated at the 6 h time 
point in the Placebo trial, but in the Vitamin trial the GSH/Protein levels started to 
increase. As for the nasal lavage samples, immediately after the exercise there was a 
non-significant increase in the GSH/Protein levels in the Vitamin trial. After 6 h these 
values were at the same level as pre-exercise. There was no change in the nasal lavage 
GSH/protein pattern in the Placebo trial. The increase in the nasal lavage GSH 
immediately after the exposure might have contributed to the significant increase in the 
total antioxidant capacity observed in the nasal lavage at this time point, which was 
statistically significant in the Vitamin trial. It can be speculated that there was a stronger 
up-regulation of antioxidants in the respiratory tract lining fluid when the runners went 
through the supplementation period which would thus lead to less oxidative damage. 
The increase in nasal lavage GSH levels has been reported in other studies where 
individuals exercised in a polluted environment (Blomberg et al., 1999); and was also 
reported in Chapter 5 only after the runners exercised in the Heat + O3 environment.  
 
The present study does not support the protective role of vitamin supplementation 
against ozone exposure on lung function reported by some studies (Romieu et al., 1998; 
Grievink et al., 1998; Grievink et al., 1999). It was hypothesized however, that the 
vitamins might improve the participant’s lung function especially because of the 
relationship of vitamin C with lung health and improvement in respiratory symptoms 
(Romieu et al., 2006; Teckenburg et al., 2007). Nevertheless, it is not known to what 
extent the vitamin C concentrations were increased in the RTLF in the present study. In 
the Vitamin trial the runners had a tendency to experience less shortness of breath, 
cough, pain on deep inspiration and overall total respiratory symptoms compared to 
when they performed in the Placebo trial. Although these values did not reach statistical 
significance it is another result that might help to explain the trend of improvement in 
the runners’ performance. Physiological variables measured throughout the run, such as 
heart rate and RPE, did not differ between the trials. The participant that had asthma did 
not differ in any way from the group values. Studies conducted with asthmatic 
individuals exposed to ozone has shown no evidence of an increased sensitivity in 
respect to either lung function decrements, magnitude of change in neutrophil numbers 
in the airways or lipid peroxidation in comparison to non-asthmatics (Mudway et al., 
2001; Stenfors et al., 2002). It was, therefore, based on these facts that we included this 
runner in our sample.  
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The novelty of this study lies on the analysis of the effect of vitamin supplementation on 
the performance, lung function, oxidative stress and inflammation (results will be 
presented in the next chapter) of well trained runners exercising in an environmentally 
relevant and challenging condition. Even though there are some studies analysing these 
factors separately there is a lack of knowledge on how these variables interact together. 
In addition, methodological differences between studies may account for the 
inconsistency in the results, making this a challenging area of research. Overall, the 
analysis of the results in this chapter suggest that 2 weeks of a low dose of vitamin C 
and E supplementation might present some benefits for the performance outcome of 
trained individuals when taking part in a race in a ozone-polluted, hot and humid 
environment. These benefits will however depend on the regulation of the antioxidants 
uptake and metabolism of each subject. Further mechanisms that might influence this 











Chapter 7: Investigating vitamin supplementation 
on immunoendocrine responses and lung 
inflammation of runners exercising in a hot, humid 




The aim of this chapter is to further investigate the effects of vitamin C and E 
supplementation on well trained individuals performing an 8 km time-trial run in a hot, 
humid and ozone-polluted environment. In this chapter, the results of lung epithelial 
injury, airway and systemic inflammation of these runners are presented and analyzed.  
 
Lymphocytes 
Lymphocytes constitute around 20-40% of the circulating white blood cells and they are 
part of the adaptive immunity. When these cells come into contact with a foreign 
molecule or antigen for the first time they have the ability to recognised and produce a 
specific response against that pathogen. This response involves the proliferation and 
differentiation of lymphocytes into their specialized functional roles. Some lymphocytes 
will turn into effector cells which operate to eliminate the recognized antigen. While 
others lymphocytes differentiate into memory cells that will be quickly mobilized in the 
event of a subsequent exposure to that same antigen, allowing for a more rapid immune 
response. It is the specificity and memory of the adaptive immunity that distinguishes it 
from the innate immunity. The latter can act against any foreign antigen without prior 
exposure. In addition, cells from the innate immune system, i.e. neutrophils, contribute 
to the stimulation of the lymphocytes presenting proteins of the foreign antigen and also 
secreting a variety of inflammatory mediators, such as cytokines, that contributes to the 
activation of the adaptive immunity (Makinnon, 1999).  
 
Lymphocytes have a very distinct biphasic response to exercise. During and 
immediately after exercise these immune cells are mobilized from peripheral lymphoid 
organs. This results in an increase in the number of lymphocytes in the circulation. The 
intensity and duration of this lymphocytosis will depend on the type, duration and 
intensity of the exercise performed (Steensberg et al., 2002.; Mooren et al., 2002; 
Simpson et al., 2006). Nevertheless, around 1 to 3 h after exercise cessation, this 
lymphocytosis is substituted by lymphopenia, resulting in levels of lymphocyte below 
the pre-exercise values for several hours (Simpson et al., 2006). The severity and 
duration of this decrease will again depend on type, duration and intensity of the 
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exercise performed, as well as the training status of the individual (Steensberg et al., 
2002; Mooren et al., 2002; Simpson et al., 2006). This decline in lymphocyte count and 
other alterations in the immune system, observed during early recovery from certain 
types and high intensity exercise, create an “open window” of decreased host protection. 
This open window period of weakened immunity, which can last between 3 and 72 h, 
represents a vulnerable time period for the individual, during which there might be an 
increased susceptibility to contracting and developing an infection if there is contact 
with any pathogen (Nieman & Bishop, 2006).  
 
Lymphocytes, neutrophils, and indeed all nucleated cells respond to a stress stimulus by 
increasing their defence mechanism, such as an up-regulation of protective enzymes and 
antioxidants. Khassaf et al. (2003) reported that an 8 week supplementation period with 
500 mg·day-1 of vitamin C increased the baseline expression of the lymphocytes’ 
protective enzymes, but blunted the adaptive response of these cells to an exercise bout 
stimulus. The exercise consisted of 45 min of one-leg cycling at 70% of the subjects’ 
VO2 peak. It is possible that the long supplementation period caused the vitamin C to act 
as a pro-oxidant, thus, leading to the increased adaptation measured at baseline. Another 
explanation would be that the vitamin C stimulated modification in the expression of 
genes which code for specific protective enzymes such as catalase and SOD. After the 
stress stimulus, the attenuation of the adaptive response of the lymphocytes could be 
attributed to a reduced local oxidative stress due to the high concentration of vitamin C 
reducing, hence, the need for further adaptation within these cells. Whether the lack of 
up-regulation in the protective enzymes after the exercise bout is beneficial or 
deleterious to the cell is a topic of discussion. It is important to note that Khassaf et al. 
(2003) investigated the response to only one exercise bout after the supplementation 
period. In addition, the participants of the study were untrained individuals. It would be 
interesting to see how lymphocytes adapt to the supplementation protocol together with 
an exercise training programme as training does provide a stimulus to the enhancement 
of protective enzymes and antioxidant content of tissues (Powers et al., 2004; Ji, 2008). 
A recent study (Gomez-Cabrera et al., 2008b) investigated the effect of an 8 week 
supplementation period with vitamin C (1000 mg·day-1) on muscle cell adaptation and 
training efficiency in both humans and rats. The results of the study suggested that the 
supplementation had an adverse effect on the training adaptations affecting the 
endurance capacity. This was caused mainly by a decrease in mitochondria biogenesis 
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and an attenuation of the expression of antioxidants enzymes in skeletal muscle that 
occurs with endurance training.  
 
In addition to vitamin C, lymphocytes and neutrophils also contain vitamin E. These 
immune cells take up this antioxidant from the plasma in order to increase their 
antioxidant concentration and, therefore, be able to maintain an optimal functional 
capacity (Cases et al., 2005). A long and intense endurance exercise bout, i.e. half-
marathon, has been shown to enhance the vitamin E concentration in lymphocytes and 
neutrophils of trained individuals. In addition, a month of supplementation with vitamin 
C (152 mg·day-1) and E (75 IU·day-1) significantly increased the vitamin E content of 
neutrophils, after the exercise bout, compared to when the subjects ingested placebo. 
The increase of this vitamin, observed in the leukocytes, occurred despite any changes 
in the vitamin E content of the plasma. This suggests that determination of vitamin E in 
the immune cells can represent a redistribution of plasma vitamin E and might be a 
useful measure to assess the functional status of this vitamin in the body (Cases et al., 
2005).  
 
Immunoendocrine Response to Vitamin C and E Supplementation  
As mentioned in the beginning of this chapter, usually after a prolonged exercise bout 
there is a decrease in the number and function of immune cells. Increase in the 
circulating concentration of the stress hormone cortisol is one of the factors known to 
contribute to this depression of the immune system observed after exercise (Nieman, 
1994; Mackinnon, 1999). Cortisol is a glucocorticoid hormone produced by the 
hypothalamic-pituitary-adrenal axis, and is considered a stress hormone due to its 
increased release in response to stressful situations, which include psychological stress, 
a rise in core temperature and metabolic demands during exercise (Jimenez et al., 2007; 
Peak et al., 2007; Webb et al., 2008). Moreover, the cortisol release has been well 
established as a function of the duration and intensity of the exercise, with higher 
intensity and longer duration exercises, i.e. marathon race, stimulating a greater release 
of this hormone from the adrenal axis (Tremblay et al., 2005, Karkoulias et al., 2008).  
 
There have been a number of studies which have investigated the supplementation of 
vitamin C and E on the inflammatory and cortisol responses to exercise. Most studies 
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that have used a combination of both vitamins have shown a positive outcome of the 
supplementation in blunting the cortisol response and decreasing the release of certain 
inflammatory cytokines such as IL-6 (Fisher et al., 2004; Davison et al., 2007). 
Nevertheless, these findings are not unanimous and analysis of the literature has shown 
that various factors can influence this outcome. These factors include the type of 
exercise used, which influences the release of reactive species; the supplementation 
protocol and bioavailability of the vitamins during the exercise trial; and the 
endogenous antioxidant defences of the participants of the study, which will be 
augmented if they are trained individuals (Peake et al., 2007). In addition, research is 
still needed to clarify how a decrease in circulating levels of cortisol might be linked 
with an improved immune function and therefore, a reduction of infection after exercise. 
It has been speculated that cortisol and some cytokines might contribute to a decreased 
neutrophil function and also stimulate the release of immature neutrophils with 
decreased stimulation capacity, from the bone marrow. Circulating cortisol also 
enhances exercise-induced neutrophilia by inhibiting the ability of the neutrophils to 
bind to the endothelial and to infiltrate into the tissue (Steensberg et al., 2003). 
Antioxidant supplementation is theorized to be beneficial in decreasing the immune-
depression after intense exercise because it would contribute to attenuate cortisol release 
and neutrophilia; as well as, increasing the antioxidant content of the immune cells 
which might result in a potentiation of its function together with the protection from 
oxidative damage. 
 
Peters et al. (2001) did indeed show a reduction in post-exercise cortisol levels in 
athletes who ingested vitamin C (1000 mg·day-1) for a 1-week period prior to a 90-km 
ultramarathon race. Nevertheless, there was no difference in leukocyte counts after the 
ultramarathon. The effect of vitamin C supplementation on cortisol however, was not 
observed by Palmer et al. (2003) when athletes were supplemented for a 7 day period 
with vitamin C (1500 mg·day-1) also prior to an ultramarathon race. The authors 
reported that vitamin C had no influence in cortisol increases post-exercise. Also 
investigating the effect of vitamin C alone, Davison and Gleeson (2006) looked into the 
immunoendocrine responses to an exercise bout. Contrary to the former study, the 
supplementation protocol consisted of 2 weeks of vitamin C (1000 mg·day-1), and the 
exercise was shorter and of lower intensity: 2.5 h of cycling at 60% VO2max. The authors 
reported that even though the supplementation was effective in decreasing the blood 
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neutrophil count post-exercise, there was only a trend, but not a statistically significant  
decrease in the cortisol levels (P=0.08) post-exercise compared to when placebo was 
ingested. In addition, there were no differences between the placebo and the 
supplemented trials for plasma IL-6. Similarly, Nieman et al. (2004) reported the 
absence of any effect on plasma cortisol levels post-exercise, in this case following an 
ironman triathlon competition. In this study (Nieman et al., 2004), however, the athletes 
had gone through a 2 month supplementation period with vitamin E (800 IU·day-1) 
alone. In addition to a lack of influence on cortisol release, analysed cytokines, such as 
plasma IL-6, were elevated in the supplemented group after the race. As explained 
previously, this could possibly be due to the pro-oxidant effect of vitamin E.  
 
It seems that there is more convincing evidence showing the reduction of plasma 
cortisol, after an exercise bout, when there is a combined supplementation of vitamin C 
and E. In the study of Fisher et al. (2004), two groups went through a 4 week 
supplementation period with either a combination of vitamin C (500 mg·day-1) and E 
(400 IU·day-1) or placebo. After the supplementation period, the participants performed 
an exercise protocol consisting of 3 h of dynamic two-legged knee-extensor exercise at 
50% of their individual maximal power output. The authors reported an increase in 
cortisol concentration during recovery in the Placebo group, while this cortisol response 
was completely blunted in the supplemented group. In addition, other markers of 
inflammation, including IL-6 and CRP, were reduced post-exercise in the supplemented 
group. The authors suggested that the decrease in IL-6 might have contributed to the 
decrease in systemic cortisol concentration as this cytokine is known to stimulate the 
release of cortisol from the adrenal axis into the circulation (Steensberg et al., 2003). 
Fisher et al. (2004), however, did not analyse the neutrophil response to the exercise or 
supplementation. A similar decrease in cortisol level post-exercise was observed by 
Davison et al. (2007) after a similar supplementation protocol (4 weeks, vitamin C 1000 
mg·day-1; vitamin E 400 IU·day-1). The exercise protocol consisted of a 2.5 h cycle at 
60% of the participants’ VO2max. Even though there was a decrease in the stress 
hormone level there were no changes in neutrophil numbers or function compared to the 
placebo ingestion. The authors explained that, before the exercise, there was a trend for 
higher cortisol concentration in the supplemented group, and that this could be related 
to the lack of changes in neutrophil count and function post-exercise in that group. In 
addition, it is possible that a shorter supplementation period would be more effective in 
preventing auto-oxidation of the immune cells as shown by Alessio et al. (1997). These 
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suggestions however, are just speculations and more research in this area is necessary. 




Table 7.1. Summary of studies analysing the effect of vitamin supplementation on cortisol and 
inflammation markers. 
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All in all, some of the studies mentioned above support the beneficial role of vitamin E 
and C supplementation in decreasing cortisol secretion after an exercise bout. As 
cortisol is released in response to stress it could be speculated that additional stressors 
such as ozone pollution and heat plus humidity would further stimulate the release of 
 147 
this hormone. In fact, these multiple stressors might possibly induce immunoendocrine 
responses that exacerbate the exercise-induced alterations. Therefore, a greater benefit 
might be seen in the reduction of exercise-induced immune depression if the ingestion 
of vitamin C and E could blunt the cortisol response to exercise in an adverse 
environment. There is a lack of available information regarding the effect of vitamin 
supplementation on inflammation of individuals exercising in an ozone-polluted 
environment. Most studies have focused mainly on the effect of exercise alone or 
pollution alone on oxidative stress and/or lung function. In the study of Mudway and 
colleagues (2006), discussed previously, no benefit of supplementation was observed 
after exposure to ozone in relation to inflammatory responses. The supplementation 
consisted of a 1-week period of vitamin C (500 mg·day-1) and E (100 mg·day-1) 
ingestion, and the exercise protocol performed after this period was an intermittent 
cycling exercise for 2 h exposed to 0.2 ppm of ozone. After the exercise, there was no 
difference between the vitamin group and the placebo group with respect to the increase 
in neutrophil count in the airways, assessed by BAL. The authors also reported no 
differences in other inflammation markers in the airways, such as IL-6 and IL-8, and 
also no differences in indices of altered respiratory epithelial injury measured by total 
protein and albumin concentration. Of note, the authors did report an increase in the 
plasma levels of vitamin C and E in the supplementation group, before and after 
exercise, however, this did not reflect an increase in the vitamin concentration of the 
airways. It could be speculated that the supplementation did not succeed in increasing 
the antioxidant defences in the lower airways and, hence, the protection mechanism was 
not enhanced by the supplementation. The authors did not measure the systemic 
inflammation of the participants.   
 
This chapter seeks to answer some of the gaps in the literature regarding vitamin 
supplementation and inflammatory response of trained runners taking part in a time-trial 
run in a hot, humid and ozone-polluted environment. The hypothesis was that the 
vitamin C and E would be successful in decreasing the immune depression induced by 
the exercise bout. In addition, there would be a reduction in the lung epithelial injury, 
which is usually observed with exposure to ozone. These factors would, hence, 
contribute to an improvement in the runners’ performance, after they went through the 





The data for this chapter was collected as part of the same project that originated the 
data presented in Chapter 6. Therefore, most aspects of the methodology, such as the 
participants’ of the study and the study design are the same. Further tests carried out are 
fully explained in this section.  
 
7.2.1 Experimental Procedures 
The experimental procedures have been detailed in section 6.2. In summary, ten well 
trained male runners took part in this study. After the familiarization trial, the 
participants were randomly assigned to initiate a 2-week supplementation period of 
vitamins C (500 mg·day-1) and E (100 IU·day-1) or placebo. The study’s design was 
double-blinded crossover.  On the exercise trial day the participants arrived at the lab at 
around 8:40am. After having their blood samples drawn, saliva sample collected, lung 
function tested and nasal lavage procedure conducted, the participants went to the 
environmental chamber to perform the 8 km time trial run. The environmental condition 
was set at 31 ºC and 70% rh with 0.1ppm of ozone. Immediately post-exercise and 6 h 
after the exercise the athletes went through the same tests: blood samples were taken, 
saliva sample, lung function and nasal lavage procedure.  
 
To analyze the impact of the supplementation protocol on lung epithelial injury and 
inflammation, and systemic inflammation the following variables were assessed:  
• In saliva: cortisol concentration 
• In the nasal lavage: neutrophil count and percentage, IL-8, total protein, 
CC16. 
• In plasma: lymphocyte count and percentage, neutrophil count and 
percentage, CC16. 
Variables measured in the blood samples were not adjusted for plasma volume loss, as 
no significant changes in plasma volume were found between time points. The plasma 
volume of the blood samples was calculated according to the method described by Dill 
and Costill (1974). 
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7.2.2 Saliva collection and cortisol analysis 
All participants were seated during the saliva collection. They were instructed to 
swallow any fluid in their mouth to remove old saliva before providing unstimulated 
saliva sample. For the collection of the sample the participants leaned forward, with 
their head tilted down, allowing the saliva to dribble into pre-weighed collecting tubes 
(Sterilin, UK) with minimal orofacial movements to avoid stimulation of the salivary 
glands. Whole saliva was collected for a 5 min period. This procedure was performed 
according to the method previously described by Allgrove et al. (2008). Once collected 
the saliva samples were immediately put on ice and stored in a freezer with the 
temperature below -80°C until analysis.  
 
Salivary Cortisol Assay 
Salivary cortisol concentrations were measured using an RnD Systems kit (Abigdon, UK) 
in accordance with the manufacturer instructions. This assay is based on the competitive 
binding technique in which cortisol present in a sample competes for sites on an antibody 
with a known amount of cortisol (Cortisol Conjugate: horseradish peroxidise labelled 
cortisol). The following methodology was used: first, the saliva samples were thawed and 
diluted 1 in 5 with the Calibrator Diluent RD5-43. Cortisol standards were also prepared 
with the Calibrator Diluent and the concentration varied from 10 – 0.156 ng.ml-1. Samples 
and standards were added (100 μl) in duplicate in the 96 microwell plate provided by the 
manufacturer. The Cortisol Conjugate (50 μl) was then added into each well, followed by 
50 μl of the Primary Antibody Solution. The plate was then incubated for 2 h at room 
temperature on a microplate shaker. After this, the plates were washed 4 times and 200 μl 
of the Substrate solution added to each well. Again the plate was incubated for 30 min and 
protected from light. Following this, 50 μl of Stop solution was added to each well and the 
plate was read with a 450 nm wavelength with correction set to 570 nm. Cortisol 
concentration from each sample were obtained from the standard curve and the average 
value of the duplicate used.  
 
Statistical Analysis 
All data were checked for normality before statistical analysis and if necessary 
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transformed. Data were analyzed using General Linear Model ANOVA (Minitab15 
Statistical Software) with Tukey’s Post-hoc test. Statistical significance was accepted at 





7.3.1 Nasal Lavage Cells and IL-8 
The nasal lavage neutrophil count and percentage are shown in Table 7.2. There were 
no trial differences or time differences for the neutrophil count. In the Placebo trial the 
neutrophil count at the 6 h-post exercise time point seemed to increase but did not reach 
statistical significance. This increase pattern was not seen in the Vitamin trial. Similarly, 
there were no group differences in nasal lavage neutrophil percentage, but there was a 
significant increase at the 6 h time point for the Placebo trial (P < 0.05). 
 
For the IL-8 concentration a significant time and trial difference was observed. At the 6 
h time point the Placebo trial presented a significantly higher IL-8 concentration 
compared to the Vitamin trial (P < 0.01). In addition at this same time point, in the 
Placebo trial, the IL-8 concentration was significantly higher compared with the pre and 
post-exercise time points (P < 0.001) within the same trial. In the Vitamin trial this 
cytokine also presented significantly higher values at the 6 h time point compared with 
the pre-exercise values (P < 0.01) (Table 7.2).  
 
Table 7.2. Neutrophil and IL-8 in the nasal lavage samples of both trials 
 Vitamin Trial Placebo Trial 





0.43 ± 0.46 
 
0.49 ± 0.48 
 
0.55 ± 0.65 
 
0.32 ± 0.41 
 
0.51 ±  0.52 
 
1.04 ± 1.25* 
Neutrophil 
percentage 
16.3 ± 20.3 17.5 ± 12.3 22.6 ± 17.2 13.1 ± 13.5 19.9 ± 17.8 25.2 ± 22.6 
IL-8 (pg∙ml-1) 10.5 ± 9.2   50.8 ± 27.4  75.8 ± 43.2*§  9.7 ± 8.8 57.9 ± 31.0 126.6 ± 103.2**  
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§ Significant difference between trials at that time point (P < 0.01). *Significantly higher 
compared to Pre-exercise values in the same trial (P < 0.05). ** Significantly higher compared 
to Pre and Post-exercise value, Placebo trial (P < 0.001). Values are mean ± SD. 
 
7.3.2 Plasma immune cells 
Table 7.2 presents the values for white blood cell counts, lymphocyte counts and 
percentages as well as neutrophil counts and percentages for both trials. There were no 
differences between trials at any of the time points analyzed. A significant increase, 
compared to pre and post-exercise values, was observed for the white blood cell count 6 
h after the exercise in both trials. The same is true for the neutrophil count and 
percentage. Lymphocyte count was significantly increased post-exercise compared with 
pre-exercise values only in the Placebo trial. Nevertheless, in both the Vitamin and 
Placebo trials, the lymphocyte percentage was significantly decreased at the 6 h time 
point compared with the post-exercise percentage.  
 
Table 7.3. Immune cells in the plasma samples of both trials 
 Vitamin Trial Placebo Trial 





5.04 ± 0.93 
 
5.80 ± 0.84 
 
8.63 ± 2.70** 
 
5.56 ± 0.69 
 
7.01 ± 1.29 
 
8.73 ± 1.77** 
Lymphocyte 
count (109∙l-1) 
1.72 ± 0.36 2.06 ± 0.42 1.72 ± 0.33 1.95 ± 0.45 2.58 ± 0.90* 2.16 ± 0.30 
Lymphocyte 
percentage 
32.8 ± 9.27 35.7 ± 6.39 22.3 ± 8.61† 35.3 ± 7.08 36.3 ± 8.25 25.5 ± 5.46† 
Neutrophil 
count (109∙l-1) 
2.59 ± 0.78 3.06 ± 0.75 6.08 ± 2.88** 2.82 ± 0.69 3.68 ± 0.87 5.66 ± 1.62** 
Neutrophil 
percentage 
50.8 ± 8.94 52.3 ± 8.61 68.3 ± 11.9** 50.5 ± 8.88 52.7 ± 9.93 64.0 ± 6.99** 
No differences between trials. * Significantly higher than pre-exercise in the same trial 
(P<0.01); † significantly lower than post-exercise values within the same trial (P<0.01); 
significantly higher compared to pre and post-exercise values within the same trial (P<0.001). 
Values are mean ± SD. 
 
7.3.3 Salivary Cortisol 
One third of the runners were unable to provide an adequate saliva sample, that is an 
unstimulated saliva sample produced with little orofacial movements. Therefore, the 
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data regarding cortisol has only been analyzed for the same six runners in both of their 
trials. The cortisol data is presented in Figure 7.1. There was no difference between 
trials for cortisol concentration in any of the analyzed time points. Nevertheless, in the 
Placebo trial there was a significant increase in this hormone immediately after the 
time-trial run (post-exercise time point), with its values returning back to baseline 6 h 
after the exercise (P<0.05). The intra-assay coefficient of variation for the duplicate 






























Figure 7.1. Salivary cortisol concentration. ** Significantly different from pre and 6 h-post-
exercise values within the Placebo trial (P<0.05). Values are mean ± SD. 
 
7.3.4 Clara Cell Protein in Nasal Lavage and Plasma 
To analyse lung inflammation and lung epithelium injury CC16 was measured both in 
the nasal lavage and in the plasma. There were no differences between the Placebo and 
the Vitamin trial in any of the analyzed time points. Both trials presented the same 
pattern of CC16 variation across time. However, it was only in the Placebo trial that a 
significant increase in this protein concentration was observed at the post-exercise time 
point. This occurred both in the plasma samples and the nasal lavage samples of the 
Placebo trial (Figure 7.2). The intra-assay coefficient of variation for the duplicate 






















































Figure 7.2. CC16 concentration in nasal lavage (A) and plasma (B) samples. ** Significantly 
higher compared with pre-exercise and 6 h-post exercise time points in the Placebo Trial (P < 
0.01). Values are mean ± SD. 
 
 
7.4 DISCUSSION  
 
In this chapter the effect of vitamin C and E supplementation on the immunoendocrine 
responses and lung epithelial injury in runners taking part in an 8 km time-trial run in a 






that the vitamin supplementation provided some protection against lung epithelial injury 
and lung inflammation. In addition, there was an attenuation of the salivary cortisol and 
plasma lymphocyte increase immediately after the exercise protocol when the runners 
were taking the vitamins. Nevertheless, there were no other differences in the plasma 
immune cells. 
 
As reported in Chapter 6, the supplementation protocol that the participants in this study 
went through was sufficient to increase their plasma baseline levels of vitamin C and 
total antioxidant concentration. In addition, the supplementation also allowed for an up 
regulation of the antioxidant capacity in their upper respiratory airways. That was 
observed immediately after the exercise protocol. When the plasma immune cells were 
analysed, no difference in the neutrophil counts or percentage was found when the 
Vitamin trial was compared with the Placebo trial. Nevertheless, this immune cell was 
increased at the 6 h time point in both trials. There is a lack of studies in the literature 
analysing the systemic inflammation in response to vitamin supplementation combined 
with exposure to ozone. Mudway et al. (2006) analysed the inflammatory markers in the 
lower respiratory airways in response to vitamin C and E supplementation and exposure 
to ozone. Similarly, they reported that there was an increase in the neutrophil count 6 h 
after the exercise and exposure protocol, but no difference was observed between the 
Vitamin and the Placebo trial. In the present study, the airway inflammation was 
analysed using the nasal lavage method. Although we did not encounter differences 
between the trials for neutrophil count, there was an increase in the neutrophil 
percentage in the Placebo trial at the 6 h time point compared with the pre-exercise 
values. It seems possible that the increase in antioxidant capacity, observed in the nasal 
lavage immediately after the exercise, might have provided some protection against the 
local oxidative stress, which resulted in a smaller inflammatory response. Another 
factor that corroborates this result was the IL-8 concentration in the nasal lavage. This 
cytokine, as described earlier, is an important mediator of the immune function and is 
chemotactic for neutrophils, thus, an increase in IL-8 is usually accompanied by an 
increase in this immune cell (Holz et al., 1999). In the present study, an increase at the 6 
h time point was observed for nasal lavage IL-8 concentration in both trials. 
Nevertheless, the values in the Placebo trial were significantly higher when compared 
with the Vitamin trial; and, as described previously, so was the neutrophil percentage.  
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It seems, therefore, possible to speculate that the vitamin supplementation did provide 
some protection against the inflammatory response in the upper respiratory airways of 
the runners. Another result that reinforces this speculation is related to the CC16 
concentration in the nasal lavage and plasma. As mentioned in Chapter 2 and 5, this 
small sized protein secreted by the Clara cells has a role in protecting the respiratory 
tract against inhaled particles, such as pollutants (Robin et al., 2002). In addition, their 
quantification is also used as a marker of lung epithelial integrity (Broeckaerte et al., 
2000a). An increase in CC16 was observed, both in the plasma and in the nasal lavage 
fluid, immediately after the exercise protocol, with its values returning back to baseline 
after 6 h. This increase was only statistically significant in the Placebo group. It is 
possible that this increase, both in plasma and nasal lavage, was the result of two 
different but synergistic mechanisms. As previously explained, ozone can cause lung 
epithelial injury (Christian et al., 1998); therefore, it is possible that the higher 
antioxidant concentration in the airways of the runners after the supplementation might 
have reacted with the ozone, partially neutralizing its oxidative effects on epithelial 
cells. This would not have occurred when the athletes where taking the placebo and, as 
a result, there would have been damage to the lung epithelial cells, including the tight 
junctions . This would allow for a greater diffusion of CC16 into the plasma, hence, the 
higher plasma concentration of this protein immediately after the exercise in the Placebo 
trial. The mechanism responsible for a significant increase in the nasal lavage CC16 
concentration in the Placebo trial would be that the lower antioxidant concentration in 
the airways in this trial allowed oxidative stress and hence an early inflammatory 
process to be initiated. This might have stimulated the Clara cells to secrete more CC16 
into the respiratory tract lining fluid. To date there is little information on the effect of 
exercise and pollution on CC16, and this is the first study (to my knowledge) 
investigating the additional effect of vitamin on this protein. Thus, it is difficult to 
establish the exact mechanisms by which these vitamins affect the secretion and 
production of CC16. Mudway and colleagues (2006) also investigated the lung 
epithelial permeability in their previously-mentioned study. They assessed the 
concentration of albumin in the bronchoalveolar lavage, but reported no differences 
between the vitamin and the placebo trial. It has been shown, however, that CC16 
would be a better and more sensitive marker to assess the lung epithelial injury 
(Hermans & Bernard, 1999). 
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Another immune-modulator effect observed for the vitamin supplementation was that it 
blunted the cortisol increase post-exercise. This result was observed despite the fact that 
only a limited number of participants were able to provide an adequate saliva sample for 
analysis. This effect of vitamin supplementation on cortisol levels is in accordance with 
some studies (Peters et al., 2001; Fisher et al., 2004; Davison et al., 2007), but not all 
(Palmer et al., 2003; Nieman et al., 2004; Davison & Gleeson, 2006). Most studies that 
have not demonstrated an attenuation of the exercise-related increase in circulating 
cortisol used only vitamin C or only vitamin E as supplements. Taken together, these 
findings suggest that a combined supplementation is more appropriate in reducing the 
cortisol responses, and this study provides further evidence for that. Even though it has 
been suggested that cortisol contributes to an increase in circulating levels of immature 
neutrophils (Steensberg et al., 2003), this was not verified in the present study - as 
reported at the beginning of this section there was a similar increase in plasma 
neutrophils in both trials 6 h after the exercise protocol. We did not, however, 
investigate the neutrophil function, which might have been different between the trials. 
Davison et al. (2007) also reported a decrease in cortisol levels after an exercise bout, in 
participants that underwent a supplementation protocol (4 weeks, vitamin C 1000 
mg·day-1; vitamin E 400 IU·day-1). In addition, the authors also reported no change in 
plasma neutrophil count and no differences in neutrophil function. Even with similar 
results, it is important to keep in mind the differences between studies in relation to 
supplementation protocol, exercise protocol, subjects’ fitness levels, and most 
importantly for the present study the additional stress of ozone, heat and humidity.  
 
Cortisol has also been shown to stimulate the lymphopenia response of lymphocytes 
observed after an intense exercise bout, contributing to the “open window” period 
(Nieman, 1994). In the present study, at the 6 h time point there was a significant 
decrease in lymphocyte percentage in both trials, and no difference in the lymphocyte 
total count. This result is in line with the cortisol response, in that at the same time 
point, there were no significant differences between trials. In fact, in the Placebo trial, 
there was a significant increase in the cortisol levels immediately after the exercise bout 
when compared to the pre-exercise levels, but there were no differences between the 
trials in any time point. It seems possible that the higher cortisol concentration post-
exercise, in the Placebo trial, was not sufficient to cause a decrease of the circulating 
lymphocytes at the 6 h time point. A significant increase in lymphocyte count 
immediately after the exercise was found, however, only in the Placebo trial. This 
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increase would be influenced by another hormone, adrenalin. Strong increases in 
circulating levels of adrenalin, observed in exercise with intensities above 60% VO2max, 
(as in the current study) influence the increase in circulating levels of lymphocytes 
(Nieman, 1994). It is hard to say if this was the case in the present study and if vitamin 
supplementation has any effect on adrenalin secretion, as we did not investigate this 
hormone. 
 
The cortisol levels in the present study were measured in the saliva, while in the studies 
mentioned above it was measured in serum or plasma. Salivary cortisol has been shown 
to be significantly correlated with cortisol levels in the blood (Gozansky et al., 2005; 
Cadore et al., 2008). Therefore, this difference in methodology between studies most 
likely does not affect the results here. The present study suggests that it is possible that 
vitamin C and vitamin E have an effect on the hypothalamic-pituitary-adrenal axis 
influencing cortisol secretion as a consequence. This, however, appears to be 
independent of changes in the immune cell responses. Nevertheless, other immune 
markers, such as IL-6 and the immune cell functions, were not measured in the present 
study. Additionally, in spite of the fact that vitamin plasma levels are the most used 
parameter to determine the vitamin status, these may not reflect the functional status of 
vitamins. The redistribution of these vitamins from plasma into immune cells, such as 
lymphocytes and neutrophil, is an important mechanism that can help to enhance the 
immune response (Cases et al., 2005). The same would apply for the vitamin 
redistribution in the immune cells in the respiratory airways. As reported, in this 
chapter, there was a smaller increase in the neutrophil percentage and IL-8 
concentration in the upper respiratory airways in the Vitamin trial, suggesting that the 
increase in local antioxidant defences was indeed protective. However, it would be 
interesting to understand the redistribution of antioxidants present in the respiratory 
tract and those present within the airways inflammatory cells and respiratory epithelium 
cells.  
 
The lack of effect of vitamin supplementation in relation to the plasma markers of 
inflammation could possibly be because the ED of ozone inhaled by the participants of 
the present study was not enough to induce a systemic inflammation. This would occur 
because most of the time ozone is not able to infiltrate from the lung-air interface 
further than the RTLF and the membranes of cells (Pryor et al., 1995), due to its initial 
contact and neutralization by antioxidants in the RTLF. It could be speculated that only 
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when there is a high level of lung oxidative stress and inflammation would ozone result 
in a systemic response. In addition, if the immune cell variation in the plasma was due 
to the exercise effect and not the heat and ozone, it is possible that if the exercise 
duration was longer we would have observed higher levels of inflammation and hence, 
the higher plasma antioxidant concentration in the Vitamin trial could have helped to 
counteract the pronounced inflammation. On the other hand, the participants of this 
study were well trained runners who were used to taking part in competitions. Thus, it is 
possible that their antioxidant defences were already up-regulated to respond to the 
oxidative stress and inflammation experienced in the trials. In addition, it is likely that 
the participants had a balanced daily diet, ingesting the recommended levels of vitamins 
and minerals. The benefits of ingesting a higher level of antioxidant, through the 
vitamin supplementation, would mainly be beneficial for the protection of their lungs 
against inflammation, especially for the individuals capable of a higher up regulation of 
their antioxidant defences.  
 
To conclude, it has been demonstrated that 2 weeks of vitamin C and E supplementation 
helped to diminish the early inflammatory response observed in the upper airways of 
runners taking part in an 8 km time-trial run in a hot, humid and ozone-polluted 
environment. In addition, the supplementation also had an effect in blunting the cortisol 
increase and the blood lymphocyte count immediately after the exercise. Nevertheless, 
no effect of the supplementation was observed for total white blood cell count and 
neutrophils. Therefore, it seems that the supplementation with the vitamins has only a 
small beneficial effect on the systemic inflammation of the runners. Based on the results 
from this chapter and Chapter 6 it can be speculated that the availability of antioxidants 
and the up-regulation of these in the upper respiratory airways is linked to a better 












Chapter 8: General Discussion 
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This final chapter contains the main results of the studies comprised within this thesis, 
followed by a general discussion that ties them together and discusses the relevance of 
these findings and the practical implications within the field of Sports Sciences and 
Exercise Immunology. Furthermore, the limitations of the studies, within this thesis are 
outlined. Finally, the importance and direction of future studies is discussed. 
 
The general aim of this study was twofold: to investigate how ozone-pollution, heat and 
humidity would affect well-trained runners after performing an intense exercise bout 
and to examine whether antioxidant supplementation could have any positive effect on 
them. The main findings of the studies comprised within this thesis were: 
• The nasal lavage procedure used in this study was reliable and reproducible to 
assess markers of inflammation and oxidative stress in the upper respiratory 
airways. 
• Ozone-pollution, heat and humidity alone or combined did not affect the lung 
function of the runners immediately after performing an 8 km time-trial run.  
• Both a hot and humid, and a hot, humid and ozone-polluted environment have a 
detrimental effect on athletes’ performance in an 8 km time-trial run. Ozone 
alone has little effect on this variable. 
• A hot, humid and ozone-polluted environment elicits an early epithelial damage 
characterized by increase in CC16 concentration in the airways after an 8 km 
time trial run. Ozone or heat and humidity alone did not have an effect on this 
variable. 
• Performing an 8 km time trial run in a hot, humid and ozone-polluted 
environment resulted in a significant increase in the GSH/protein concentration 
in the upper respiratory airways, suggesting an up-regulation in the antioxidant 
defences in response to an increase in oxidative stress stimulated by the high 
intensity exercise in association with ozone, heat and humidity. 
• After the Heat + O3 trial, a significant negative correlation was observed 
between performance impairment and antioxidant status in the athletes’ nasal 
lavage. 
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• A 2-week supplementation protocol with vitamin C and E significantly 
increased the plasma antioxidant concentration at baseline and also after an 8 km 
time trial run in a hot, humid and ozone-polluted environment. In addition, there 
was also a significant increase in the antioxidant capacity in the upper 
respiratory airways after the run. 
• When taking part in the Vitamin trial, the participants’ time to complete the run 
improved 2.6% compared to the Placebo trial. Additionally, significant positive 
correlations were found between antioxidant concentration and improvement in 
time to complete the run.  
• The supplementation protocol protected the upper respiratory airways of the 
runners by decreasing lung injury, observed because of the lower CC16 levels 
both in the plasma and nasal lavage immediately after the run. In addition, 6 h 
after the run there was a lower IL-8 concentration and neutrophil percentage in 
the upper respiratory airways of the runners which also suggests that the 
supplementation was helpful in diminishing lung inflammation. 
• In addition, the supplementation also had an effect in blunting the cortisol 
increase and the blood lymphocyte count immediately after the exercise. No 
effect of the supplementation was observed for the total white blood cell count 
and neutrophils count, immediately after the run, or for any plasma immune cell 
6 h after the run. 
 
The results of this thesis suggest that individuals taking part in a competition in a hot, 
humid and polluted environment will possibly experience adverse effects related to their 
performance and lung toxicity. These can be minimized if the individuals go through a 
short supplementation period with a low dosage of vitamin C and vitamin E. It is 
important to highlight that some people can respond differently to the pollutant 
exposure and also to the vitamin supplementation. Factors that can increase the 
susceptibility to ozone-pollution include disease status, genetic predisposition and age. 
In the studies within this thesis, we could control for disease status and age, however, 
the genetic predisposition might have accounted for the large standard deviation of 
some results. In fact, it has been reported that polymorphisms in oxidative stress genes 
and inflammatory genes influence the response to ozone-exposure (Yang et al., 2009). 
In Chapter 4, a significant negative relationship was established for antioxidant 
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concentration in nasal lavage, after the run and the percentage of performance 
impairment when the runners exercised in the hot, humid and ozone-polluted 
environment. This suggests that how an individual’s body copes with oxidative stress 
and up-regulation of antioxidants also affects their susceptibility to ozone-pollution and 
their subsequent performance.  
 
Individual variation was also present in response to the vitamin supplementation. As 
elucidated in Chapter 6, some individuals presented a higher concentration of 
antioxidants in the plasma and nasal lavage after the supplementation protocol and also 
after the exercise bout. This could be explained by differences in vitamin absorption and 
metabolism, which can be influenced by dietary intake and possibly by genetic factors 
(Peake et al., 2007). In practical terms, athletes should be aware of long-term 
antioxidant supplementation interventions because it can act as a double-edged sword: 
they might provide some benefit to the athletes’ immune system, but antioxidant 
supplementation has also been shown to decrease training adaptation. The studies 
presented in Chapters 6 and 7 used a shorter supplementation period and vitamin dose 
compared to the majority of research studies that have analysed the effect of vitamin 
supplementation on exercising individuals. The results demonstrated that this shorter 
supplementation does provide some protection for individuals who are already well-
adapted to the oxidative stress burden of a high intensity exercise bout, but who are not 
used to having additional stressors such as heat, humidity and ozone-pollution 
influencing their performance.  Therefore, the speculation is that trained individuals 
might only benefit from antioxidant supplementation when they go through a much 
higher oxidative stress stimulus than they are used to. In addition, it is possible that 
individuals who have lower antioxidant defences in their body might benefit more from 
antioxidant supplementation when they are exposed to a situation which elicits high 
levels of oxidative stress. These results are of high practical relevance when one 
considers the high number of individuals who exercise outdoors and/or engage in 
competitive events and also the millions of pounds spent every year on antioxidant 
supplements, especially vitamin C and E.  
 
Another relevant finding was that ozone-pollution alone (at this low concentration) does 
not appear to majorly affect well-trained runners taking part in an intense exercise bout. 
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Even though some studies have suggested the contrary, there are various factors, which 
were previously described, that can influence this outcome. This result might not have a 
large practical implication because usually people are not exposed just to ozone but to a 
mixture of pollutants. It is ethically difficult to investigate higher levels of ozone and 
also the cocktail of pollutants that an athlete would normally experience in a polluted 
environment. Nevertheless, that result suggests that some well-trained individuals are 
prepared to cope with some degree of exposure to oxidant gases without developing 
major respiratory or performance distress.  
 
 
8.1 LIMITATIONS OF THE STUDIES COMPRISED WITHIN THIS THESIS 
 
One of the key limitations of the studies in this thesis was the use of an acute ozone 
exposure model. This does not reflect what occurs with active individuals who live in a 
polluted city or athletes who spend a period of days competing in a polluted city. 
Nevertheless, the aim of the studies was to analyse an acute exposure, this has provided 
insight to the early events that occur once ozone is inspired by exercising individuals.  
Another limitation, that has been mentioned previously, is the number of individuals 
that took part in the study. This, however, is a limitation that occurs with most research 
in the Sports Science area, and specifically in the field of Exercise Immunology. The 
use of high level runners besides adding to the novelty of the studies can also been seen 
as a limitation because it makes it challenging to extend these results to the general 
population. The use of the nasal lavage technique, in spite of its numerous advantages 
over the other techniques used to assess the respiratory airways, presents as a limitation 
the lack of research studies evaluating the similarity and difference in response between 
the upper and lower respiratory airways. In addition it would be interesting to 
investigate if the nasal lavage procedure can detect differences when individuals breathe 
predominantly through their mouth or nose.  
 
For Chapters 4 and 5, the study design presented the limitation of only obtaining blood 
and nasal lavage samples immediately post-exercise. It would have been useful to also 
get samples at the 6 h time point to be able to have a better understanding of the 
development of the inflammatory process over time. This limitation was resolved in the 
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study design for Chapters 6 and 7.  
 
Chapters 6 and 7 present as a limitation the lack of knowledge of the vitamin E 
concentration in the plasma and nasal lavage. This limitation was due to technical issues 
and unfortunately this procedure could not be conducted with another assay as was done 
with the vitamin C. In addition, there was an interest to investigate other end points 
related with oxidative stress and inflammation, however, lack of time and funding 
restricted this. 
 
8.2 RECOMMENDATIONS FOR FUTURE STUDIES 
 
Most studies reviewed in this thesis and the studies developed within the thesis have 
investigated the effect of an acute exposure to air pollution on exercising individuals. 
An important issue that needs to be addressed in further studies is the effect of chronic 
exposure to pollutants. This would have practical relevance for individuals who live in 
large industrialized areas and are exposed daily to pollution. In addition, it would 
provide information about adaptation processes that might occur, in the lungs, due to the 
repeated exposure to pollutants. Nevertheless, studies involving human exposure to a 
mixture of pollutants or multiple exposures would have severe ethical implications. A 
solution, however, would be for these studies to be conducted in cities with high 
pollution levels. Yet there would then be the limitations associated with field studies as 
contrasted with chamber exposures. Therefore, it is important to always keep in mind 
that all studies present limitations and that it is up to the researchers to minimize these 
limitations.  
 
In vitro studies are also necessary to investigate the specific mechanisms of antioxidant 
up-regulation and secretion from lung epithelial cells when in contact with pollutants. 
These studies would help to clarify the defence processes that occur in the lungs, the 
cell adaptation processes and the biochemical pathways that are activated when an 
individual is exposed to high level of pollution. A further step would be to analyse if 
chronic exposure would lead to gene modification as occurs with chronic exercise.  
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In respect to vitamin intake, it would be interesting to investigate how a lower 
supplementation period or even a high dose intake, before a competitive event in a 
polluted environment, would affect athletes’ performance, lung inflammation and 
oxidative stress. The idea behind this acute supplementation protocol is to cancel out the 
influence of the antioxidant ingestion affecting training adaptations, but to maintain its 
protective effect. Still in relation to vitamin supplementation, there is a continuous need 
for more in-depth investigation into the mechanisms involved in the protective role of 
vitamin E and C in mediating the ozone-induced damage and changes to molecules in 
the lungs. For this, the measurement of vitamin content in the immune cells, before and 
after vitamin supplementation together with the investigation to see if these immune 
cells are activated using flow cytometry method would be of essence to achieve a better 
understanding of this intervention.  
 
Another interesting point for future studies is the prevention of illnesses, mainly upper 
respiratory tract infections, by vitamin supplementation of athletes training or 
participating in events that are located in high pollution areas. This would clarify if the 
role of vitamin supplementation is just to protect the lung against oxidative stress and 
inflammation or if its benefits are longer term and clinically significant in providing 
protection in the respiratory airways. In addition, the investigation of different sports 
and different combinations of antioxidant supplementation would also provide better 
practical implications. 
 
Finally, taking into consideration that the ozone-pollution levels together with the 
temperature might continue to gradually increase throughout the years, it is very 
important to investigate the impact of ozone exposure in more vulnerable population 
groups. In these groups, which include the children and the elderly, the inhalation of 
ozone is of clinical relevance and, thus, the ingestion of vitamin supplementation might 






A Final Note 
 
Hopefully the results of the studies within this thesis have helped clarify and expand on 
a topic that still has many aspects to be investigated. The immune system is very 
complex and has a large network of cells and mediators regulating its response. This 
makes research in this area very challenging especially when other factors - which 
include exercise protocol, individual susceptibility and pollutant exposure - that have an 
array of variability are added to the investigation. Therefore, the outcomes of the studies 
are usually very specific to the factors analyzed and, in order to be able to generalize 
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APPENDIX I - GENERAL MEDICAL HISTORY QUESTIONNAIRE 
 
HEALTH SCREEN FOR STUDY PARTICIPANTS  
Name .............................................................................     
 
It is important that volunteers participating in research studies are currently in good health and 
have had no significant medical problems in the past.  This is to ensure (i) their own continuing 
well-being and (ii) to avoid the possibility of individual health issues confounding study 
outcomes. 
Please complete this brief questionnaire to confirm fitness to participate: 
 
1. At present, do you have any health problem for which you are: 
(a) on medication, prescribed or otherwise .............................. Yes     No      
(b) attending your general practitioner ..................................... Yes     No      
(c) on a hospital waiting list ..................................................... Yes     No      
 
2. In the past two years, have you had any illness which require you to: 
(a) consult your GP   ................................................................ Yes     No      
(b) attend a hospital outpatient department .............................. Yes     No      
(c) be admitted to hospital  ...................................................... Yes     No      
 
3. Have you ever had any of the following: 
(a) Convulsions/epilepsy .......................................................... Yes     No      
(b) Asthma................................................................................ Yes     No      
(c) Eczema ............................................................................... Yes     No      
(d) Diabetes .............................................................................. Yes     No      
(e) A blood disorder ................................................................. Yes     No      
(f) Head injury ......................................................................... Yes     No      
(g) Digestive problems ............................................................. Yes     No      
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(h) Heart problems ................................................................... Yes     No      
(i) Problems with bones or joints    ......................................... Yes     No      
(j) Disturbance of balance/coordination .................................. Yes     No      
(k) Numbness in hands or feet ................................................. Yes     No      
(l) Disturbance of vision .......................................................... Yes     No      
(m) Ear / hearing problems ....................................................... Yes     No      
(n) Thyroid problems ............................................................... Yes     No      
(o) Kidney or liver problems .................................................... Yes     No      
(p) Any kind of allergy (i.e food)  ............................................ Yes     No      
(q) High blood pressure………………………………………... Yes     No      
 
 
4. Has any, otherwise healthy, member of your family under the 
age of 35 died suddenly during or soon after exercise?  ............ Yes     No      
 
If YES to any question, please describe briefly if you wish (eg to confirm problem was/is 
short-lived, insignificant or well controlled.)  
.......................................................................................................................................................... 
.......................................................................................................................................................... 
     5.    Have you had a cold or feverish illness in the past month?    Yes      No      
     6.    Are you accustomed to vigorous exercise (1-3 hours per week)?    Yes      No      
 
 




APPENDIX II – SPECIFIC MEDICAL QUESTIONNAIRE 
 
Specific medical history related to this study 
YES      NO 
 
____     ____ 1.  Have you ever been diagnosed with asthma? If NO go to question 
5. 
____     ____ 2. Do you currently use any asthma medication? 
  Yes,  ____________________________________________  
____     ____ 3. Do you have any night-time, early morning or activity related 
asthma symptoms                 during the day? 
  Yes,  ____________________________________________  
4. When was your last asthma attack? 
__________________________________________________ 
____     ____ 5. Do you have any allergies? 
  Yes,  ____________________________________________  
____     ____ 6. Have you ever suffered from any heart and lung problems? 
  Yes,  ____________________________________________  
____     ____ 7.   Have you had any respiratory infections in the last 6 weeks? 
  Yes,  ____________________________________________  
____     ____ 8. Have you ever suffered from any other diseases not described 
above? 
  Yes,  ____________________________________________  
____     ____ 9. Do you smoke?  If YES, please specify. 
  Yes,  ____________________________________________  
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10. What is your occupation? 
   _________________________________________________  
____     ____ 11. Are you exposed to any sources of fumes or dust at work or 
elsewhere? 
  Yes,  ____________________________________________  
____     ____ 12. Do you have any pets (including birds)?  




__________________________________________________          
            Print Name 
   
 __________________________________________________         
                                Signature                                      
 
  Date: 
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APPENDIX III – PHYSICAL ACTIVITY QUESTIONNAIRE 
 
Name:____________________________________________________________ 
Date of birth: __________ 
Weight: ____________    Height: ___________ 
 
The following questions are designed to give us an indication of your current level of physical 
activity. 
 
Are you currently ENDURANCE TRAINING?    YES  NO 
 
If yes, how many days each week do you usually train? _________________ 
 
 How many minutes does each session last? __________________ 
 
Which type of exercise do you perform (ex: running, cycling)? 
_____________________________________________________________ 
 
Are you currently doing WEIGHT TRAINING?    YES  NO 
 
If yes, how many days each week do you usually train? _________________ 
 













Please complete the following brief questions to confirm your fitness to participate in 
today’s session: 
At present do you have any problems for which you are: 
 
1) On medication, prescribed or otherwise?   YES  NO 
 
2) Seeing your general practitioner?    YES  NO 
 
Do you have any symptoms of ill health, such as those associated with a cold or other 
common infection? 
        YES  NO  







Would you like to take part in today’s experiment?  YES  NO 
 
Signature……………………………………………….   
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APPENDIX V– BLOOD DONATION FORM 
 
EDINBURGH NAPIER UNIVERSITY School of Life Sciences 
Subject Declaration for Vene Puncture Blood Donation 
You have consented to donate blood in the School of Life Sciences. The School 
phlebotomists have all undergone an approved training course and have Hepatitis B 
immunity. The blood you are donating will be used for                                        the 
project entitled: Effect of antioxidant supplementation on athletes’ performance in 
an 8 Km time trial run in a hot, humid and ozone-polluted environment; but will not 
be screened for pathogenic organisms that could adversely affect the health of any 
exposed person. It is therefore important that you do not donate blood if any of the risk 
factors listed below apply to you. At the end of the experiment the cells will be disposed 
of and not stored for future experiments. 
Please read the list below and think very carefully if any apply to you. 
If any factors do apply please do not sign the declaration and do not offer your services 
as a donor. You do not have to say which risk factors apply. 
Risk Factors 
Recent –  
Ill-Health 
Contact with infectious diseases 
Vaccinations or immunisations 
In the last year- 
Tattoo or body piercing 
Childbirth 
Blood transfusion 
Tissue or skin graft 
Hormone treatment 
Major surgery 
Travel to a malarial area or in sub Saharan Africa, Asia or South America 
At any time – 
If you have lifestyle factors which would pose a risk please do not donate blood. 
Declaration 
I have read the risk factors and have considered my lifestyle factors and to the best of 
my knowledge none of them apply to me and I am in good health. I understand that my 
blood will be used for research purposes. 
 
Name of Donor: ........................................  Name of Phlebotomist: .........................................  
Signature of Donor: ...................................  Signature of Phlebotomist: ....................................  
Date: .........................................................  Date:..................................................................... 
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APPENDIX VI – RESPIRATORY SYMPTOMS QUESTIONNAIRE 
 
Post-Trial Questionnaire 
Name:         Date: 
Trial:  
 
Did you experience any of the following during the trial? Please choose one of the 
following options for each symptom. 
 
0 = Not present 1 = Minimal     2 = Mild      3 = Moderate 
4 = Severe   5 = Incapacitating 
 
Shortness of breath  0 1 2 3 4 5 
Cough    0 1 2 3 4 5 
Excess sputum  0 1 2 3 4 5 
Throat tickle   0 1 2 3 4 5 
Raspy throat   0 1 2 3 4 5 
Wheezing   0 1 2 3 4 5 
Congestion   0 1 2 3 4 5 
Pain on deep inspiration 0 1 2 3 4 5 
Headache   0 1 2 3 4 5 
Nausea   0 1 2 3 4 5 
Eye irritation   0 1 2 3 4 5 
 







During the test did you feel you would be able to perform maximally in competition? 
Please circle your answer 
 
Yes      No 
 
 
